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1. List of abbreviations 
aa Amino acid 
AB Antibiotic 
Ab Antibody 
BLAST Basic Local Alignment Search Tool 
b(p) Base (pair) 
BSA Bovine serum albumin 
°C Grade Celsius 
Chr Chromosome 






ddH2O Doubled distilled water 
DIC Differential interference contrast 
DMEM Dulbecco‘s modified eagles medium 
DMSO Dimethyl sulfoxide 
(c/g)DNA (Complementary/genomic) deoxyribonucleic acid 
dNTP Deoxyribonucleotide triphosphate	
E. coli Escherichia coli 
EDTA Ethylenediaminetetraacetate 
EGFP Enhanced green fluorescent protein 
Fig. Figure 
Fw Forward 
g Centrifugal force 
g Gramm 
G Gauge 
GOI Gene of interest 
h Hour(s) 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid	
HFF Human foreskin fibroblasts 
hpi Hours post infection 
HRP Horseradish peroxidase 
IC Intracellular 










LEA Late Embryogenesis Abundant 
LPS Lipopolysaccharide 
m Milli- or meter 
M Molar [mol/l] 
µ Micro- 
mAb Monoclonal antibody 
M-CSF Macrophage-colony stimulating factor 
min Minutes 
MOI Multiplicity of infection 
mol Mole 
MW Molecular weight 
n Nano- 
NO Nitric oxyde 
OD Optical density 
ON Oligonucleotide 
o/n Overnight 
pAb Polyclonal antibody 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline solution 
PCR Polymerase chain reaction 
p/s Penicillin/streptomycin 
PFA Paraformaldehyde 
pH Negative decimal logarithm of hydrogen ion 
concentration 
PVM Parasitophorous vacuole membrane 
RE Restriction enzyme 
Rev Reverse 
RKI Robert Koch-Institut 
(m/sgRNA) (Messanger/small guide) RNA 
ROS Reactive oxygen species 
rpm Rounds per minute 
RT Room temperature 






SAG1 Surface antigen 1 
SDS Sodium dodecyl sulfate 
SLiCE Seamless Ligation Cloning Extract 
SOB Super optimal broth 
SOC Super optimal broth with catabolite repression 
TA Annealing temperature 
Tab. Table 
TAE Tris-acetate-EDTA 
Taq Thermus aquaticus 
TBS Tris-buffered solution 
tE Elongation time 
Temp. Temperature 
Tg / T. gondii Toxoplasma gondii 
Tim Timentin 
Tm Melting temperature 
U Unit(s) 
UTR Untranslated region 
V Volt 









Toxoplasma gondii is an ubiquitous parasite that infect warm-blooded animals, humans included. Felids, 
mainly domestic cats, are definitive hosts for the parasite. T. gondii genotypes are grouped in three main 
clonal lineages characterized by different degrees of virulence in laboratory mouse models. Infection 
with type I T. gondii is lethal in laboratory Mus musculus, and also causes symptoms in 
immunocompromised individuals. On the contrary, mouse infection with less virulent types II and III 
develops into chronic infections with formation of parasite tissue cysts. However, the definition of T. 
gondii types according to virulence in laboratory M. musculus does not explain the observed persistence 
of type I strains in nature, since the lethal effect on mice prevents the parasite to reach cats. This implies 
that in nature, intermediate hosts for T. gondii which are resistant to virulent parasite infection must 
exist. 
Felids in Europe mostly prey on small mammals of Myodes glareolus and Microtus spp. (voles), and 
Apodemus spp., rather than Mus spp. Sexual parasite replication and oocyst formation only takes place 
in felid hosts and is essential to maintain genetic diversity of T. gondii. Therefore, felids -mostly 
domestic cats- are important players to understand transmission of T. gondii in nature. In addition to 
being the favored prey of cats, voles and Apodemus spp. display higher T. gondii prevalence than Mus 
spp.. In vivo experiments and genotyping of infected rodents in the wild also showed that M. glareolus, 
Microtus spp., and Apodemus spp. survive T. gondii infection to a larger extent than Mus spp., although 
tolerant M. musculus subspecies also exist. Taken together, these observations strongly suggest that 
rodents of M. glareolus, Microtus spp. and Apodemus spp. are more relevant intermediate hosts than 
Mus spp.. At the same time, Mus spp. have traditionally been used in laboratory studies of T. gondii 
infections and for defining parasite virulence. In this thesis, I establish relevant in vitro models of 
infection from wild rodent species, and simultaneously make use of existing laboratory tools to 
investigate resistance mechanisms at the molecular level. 
As mentioned, specific M. musculus subspecies are also tolerant to infection with virulent T. gondii 
genotypes. The protective mechanism has been shown to rely on the IFN-γ-induced Immunity Related 
GTPase IRGb2-b1. IRGb2-b1 is highly polymorphic in nature and inhibits the activity of the major 
parasite virulence factor ROP5. However, this gene is highly conserved in laboratory Mus strains and 
therefore, it is necessary to establish cell culture models from wild rodent populations which carry 
different genotypes. Thus, this work focuses on the protective role of this gene during T. gondii infection 
in species preyed more by cats, such as M. glareolus, Microtus spp. and Apodemus spp..  
The expanding field of eco-immunology suggests the use of alternative model systems to overcome 
limitations of laboratory rodents, such as the conserved Irg genes, to better mimic nature. These models 
include wild-derived colonies and cell cultures from rodent species of M. glareolus, Microtus spp. and 
Apodemus spp., which are natural reservoirs for pathogens and carry genetic heterogeneity which is 
lacking in traditional laboratory models. However, the lack of genomic references and reagents hampers 




With this project I contribute with valuable tools for research on voles, such as the supply of the 
recombinant M. glareolus IFN-γ cytokine (recMgIFN-γ) which is central for initiating an immune 
response towards intracellular pathogens. I have established novel M. glareolus-derived cell systems 
which allow in vitro infections in this species, and are especially valuable together with the IFN-γ 
cytokine. The provided recMgIFN-γ was also shown to cross-react with M. arvalis spp. and is therefore 
readily available for immunological studies in other vole species than M. glareolus. 
I have taken advantage of the tools I established - also including Bone Marrow-Derived Macrophages 
(BMDMs) and primary fibroblasts from voles - to investigate the M. glareolus resistance to T. gondii in 
vitro. Type II interferon is a central mediator in host responses to T. gondii infection and induces 
expression of my genes of interest, Irgb2-b1-like genes, in vole cells. All investigated vole systems 
showed a phenotype to virulent parasite infection which has been associated with in vivo resistance in 
Mus spp.. This phenotype consists in IFN-γ-mediated host cell death and a concurrent decrease in 
parasite burden. A decrease in parasite burden without occurrence of BMDMs cell death was observed 
for type II parasite infection, suggesting additional protective mechanisms. Furthermore, preliminary 
results on Irg-like genes from M. glareolus, Microtus spp. and Apodemus spp. in Germany confirm the 
expected high diversity in the IRGb2-like subunit, especially in residues at the putative interface with 
ROP5. This result suggests positive selection of these particular residues and a role of the protein during 
infection, similarly to Mus spp.. To investigate the role of IRGb2-b1-like proteins in the resistance 
phenotype in detail, I developed a cell culture-based system which allows establishment of cell lines 
stably transfected with wild-derived Irg-like genes. This setup allows evaluation of the effect of 
polymorphisms of Irg-like genes during T. gondii infection.  
Taken together, I have provided tools and tool establishment protocols to bring eco-immunology into a 
lab setting which allows molecular and mechanistic investigations of ecologically relevant species. 
Using these tools, I offer support for the hypothesis that non-Mus rodents, especially the vole M. 






Toxoplasma gondii ist ein weltweit verbreiteter Parasit, der warmblütige Tiere einschließlich des 
Menschen befällt. Endwirte sind Katzen (Felidae), insbesondere die Hauskatze. T. gondii Genotypen 
werden aufgrund ihrer unterschiedlichen Virulenz in Labormäusen mehrheitlich in drei klonale 
Abstammungslinien eingeteilt. Infektionen mit Typ I T. gondii verlaufen für Laborstämme von Mus 
musculus letal, bei immungeschwächten Individuen treten Symptome auf. Im Gegensatz dazu führt die 
Infektion von Mäusen mit den minder virulenten Typen II und III zu einem chronischen Verlauf mit 
Ausbildung von Gewebezysten. Die Einteilung von T. gondii gemäß der Virulenz in Laborstämmen von 
M. musculus kann die beobachtete Persistenz des virulentesten Typs in wildlebenden Tieren jedoch nicht 
erklären, da der Parasit durch den letalen Verlauf in Mäusen seinen Endwirt kaum erreichen kann. Dies 
impliziert, dass in der Natur Zwischenwirte für T. gondii existieren müssen, die gegenüber Typ I 
resistent sind. 
Katzen in Europa ernähren sich hauptsächlich von kleinen Säugetieren wie Myodes glareolus and 
Microtus spp. (Wühlmäuse), und Apodemus spp., weniger von Mus spp. Die sexuelle Fortpflanzung der 
Parasiten und die Bildung von Oozysten finden ausschließlich in katzenartigen Wirten statt und sind 
essentiell für die Erhaltung genetischer Diversität von T. gondii. Katzen, vor allem Hauskatzen, sind 
daher bedeutende Akteure für die Übertragung von T. gondii. Wühlmäuse und Apodemus spp. sind nicht 
nur die bevorzugte Beute von Katzen; sie zeigen darüber hinaus auch eine gegenüber Mus spp. erhöhte 
Prävalenz bzgl. T. gondii. In vivo Studien und Genotypisierung infizierter wildlebender Nager zeigten, 
dass M. glareolus, Microtus spp. und Apodemus spp. eine Infektion mit T. gondii in größerem Umfang 
überleben als Mus spp., wobei tolerante Unterarten von M. musculus durchaus vorkommen. In Summe 
legen diese Beobachtungen nahe, dass die Nager M. glareolus, Microtus spp. und Apodemus spp. als 
Zwischenwirte eine höhere Relevanz als Mus spp. besitzen. Gleichwohl ist es Usus, Mus spp. für 
Laborstudien zur Infektion sowie zur Definition der Virulenz von T. gondii zu verwenden. In dieser 
Dissertation stelle ich auf wilden Nagern basierte in vitro Infektionsmodelle vor und untersuche mit 
Hilfe etablierter Labortechniken Resistenzmechanismen auf molekularer Ebene. 
Wie bereits erwähnt sind spezifische Unterarten von M. musculus tolerant gegenüber der Infektion mit 
Typ I T. gondii. Der Schutz in diesen M. musculus Unterarten wurde auf das Enzym IFN-γ-induced 
Immunity Related GTPase (IRGb2-b1) zurückgeführt. IRGb2-b1 ist bei wildlebenden Tieren 
hochpolymoprh und inhibiert die Aktivität des zentralen parasitären Virulenzfaktors ROP5. 
In Labormäusen des Genus Mus ist dieses Gen hingegen hochkonserviert, wodurch es angemessener 
erscheint Zellkulturmodelle aus wilden Nagerpopulationen, die verschieden Genotypen enthalten, zu 
erstellen. Daher liegt der Fokus meiner Arbeit auf der protektiven Rolle dieses Gens bei der Infektion 
mit T. gondii in anderen Tierarten, die Katzen als Beutetiere dienen, nämlich M. glareolus, Microtus 




Das schnell wachsende Gebiet der Öko-Immunologie regt die Verwendung alternativer Modellsysteme 
an um die Beschränkungen von Nager-Laborstämmen, wie die besagten konservierten Irg Gene, zu 
überwinden und natürliche Systeme besser nachzubilden.  
Modelle dieser Art sind von wilden Populationen abgeleitete (engl. wild-derived) Kolonien und 
Kulturen aus Zellen der Nager M. glareolus, Microtus spp. and Apodemus spp., die natürliche 
Erregerreservoire darstellen und eine genetische Vielfalt besitzen, die man in traditionellen Labortieren 
nicht findet. Der Mangel an Referenzgenomen und Reagenzien erschwert jedoch den Fortschritt auf 
diesem Gebiet. 
Mit dieser Arbeit trage ich nützliche Werkzeuge zur Erforschung von Wühlmäusen bei, indem ich 
beispielsweise rekombinantes M. glareolus IFN-γ Zytokin (recMgIFN-γ) bereitstelle, das für die 
Initiierung einer Immunantwort gegen intrazelluläre Pathogene von zentraler Bedeutung ist. Ich habe 
neuartige von M. glareolus-abstammende Zellsysteme etabliert, die in vitro Infektionsstudien in dieser 
Spezies ermöglichen und besonders in Verbindung mit dem Zytokin IFN-γ ein deutlicher Zugewinn 
sind. Das bereitgestellte recMgIFN-γ besitzt außerdem eine nachgewiesene Kreuzreaktivität in M. 
arvalis spp. und steht daher auch für immunologische Studien in anderen Wühlmäusen als M. glareolus 
unmittelbar zur Verfügung. 
Ich nutzte die von mit etablierten Werkzeuge - inklusive aus Knochenmark abstammende gereifte 
Makrophagen (BMDMs) und primäre Fibroblasten aus Wühlmäusen - um die Resistenz von M. 
glareolus gegenüber T. gondii in vitro zu untersuchen. Typ II Interferon ist ein zentraler Vermittler der 
Immunantwort des Wirtsorganismus auf  T. gondii Infektion und induziert die Expression der hier 
untersuchten Gene, Irgb2-b1-like Gene, in Wühlmauszellen. Alle untersuchten Wühlmaus-Systeme 
besaßen einen Phänotyp bei Infektion mit virulenten (Typ I) Parasiten, der im Zusammenhang mit in 
vivo Resistenz in Mus spp. beschrieben wurde. Dieser Phänotyp besteht aus einem  IFN-γ-vermittelten 
Wirt-Zelltod und einer damit einhergehenden Abnahme der Parasitenlast. Eine Abnahme der 
Parasitenlast in Abwesenheit von BMDM-Zelltod wurde bei Infektion mit Typ II-Parasiten beobachtet, 
was weitere Schutzmechanismen vermuten lässt. Darüber hinaus bestätigen vorläufige Resultate zu Irg-
like Genen aus M. glareolus, Microtus spp. und Apodemus spp. in Deutschland die erwartete hohe 
genetische Vielfalt in der IRGb2-like Untereinheit, insbesondere im Hinblick auf die Aminosäuren an 
der putativen Grenzfläche zu ROP5.  
Dieses Ergebnis deutet auf positive Selektion genau dieser Aminosäuren und eine Rolle dieses Proteins 
bei der Infektion hin, ähnlich wie bei Mus spp. Um die Funktion der IRGb2-b1-like Proteine bei dem 
beobachteten Resistenz-Phänotypen eingehender zu untersuchen, entwickelte ich ein Zellkultur-
basiertes System zur Etablierung von Zelllinien, welche mit wild-derived Irg-like Genen stabil 
transfiziert sind. Dieses Setup gestattet es, die Auswirkungen von Polymorphismen in Irg-like Genen 




Insgesamt habe ich Werkzeuge sowie Protokolle zur Etablierung von Werkzeugen erarbeitet, um den 
Ansatz der Öko-Immunologie in eine Labor-Umwelt zu bringen, wodurch die molekulare und 
mechanistische Untersuchung ökologisch relevanter Arten möglich wird. Durch Anwendung dieser 
Werkzeuge stütze ich die Hypothese, dass nicht-Mus Nagetiere, insbesondere die Wühlmaus M. 
glareolus, in Deutschland ein bedeutendes Reservoir für T. gondii darstellen.
3. Introduction 
3.1 Toxoplasma gondii 
3.1.1 General introduction  
Toxoplasma gondii is an ubiquitous apicomplexan parasite first discovered in 1908 by Charles Nicolle 
in Tunisia in the native rodent Ctenodactylus gundi (1). T. gondii is generally transmitted by the fecal-
oral route and has a heteroxenous life cycle described in Fig. 1a. Sexual replication takes place in the 
intestinal tracts of felids, definitive hosts for the parasite, and leads to the dissemination in the 
environment of infectious oocysts. When oocysts are ingested by any non-felid warm-blooded mammal, 
the asexual expansion phase of the parasite happens. Actively replicating tachyzoites disseminate 
through the host system and, upon immune pressure, convert into a slowly replicative phase as 
bradyzoites. The latter form tissue cysts within skeletal muscles and the central nervous system and they 
are believed to persist throughout the whole host life (2). One of the reasons for T. gondii’s great success 
resides in the capability of horizontal infection between different intermediate hosts, e.g. from infected 
pigs to humans, since not only the oocyst form of the parasite is infectious, but the tissue residing 
bradyzoite form as well. This peculiarity allows the parasite to bypass the sexual phase of the cycle and 
is to date a unique characteristic within Apicomplexa (3). Therefore T. gondii can be acquired via food 
and toxoplasmosis is considered a zoonotic disease. It is estimated that one third of the world human 
population is currently infected with T. gondii (4), but country-specific diets or hygienic conditions 
might lead to even higher numbers. For examples, a recent study in Germany reported that half of the 
population is positive for anti-T. gondii antibodies, with a 24 % difference in prevalence between the 
former East and West of the country, likely due to different dietary habits (5) . 
Being part of the phylum Apicomplexa, T. gondii is characterized by the presence of the apical complex 
structure which mediates invasion, and of the apicoplast, a four membrane-bound organelle which is a 
residual of an endosymbiotic algae (3). The parasite has an obligate intracellular lifestyle and, during an 
active invasive process, forms a parasitophorous vacuole membrane (PVM) consisting of both host and 
parasite proteins. Indeed, during invasion T. gondii secretes numerous proteins in a time-controlled and 
regulated process from several secretory organelles (represented in Fig. 1b). First, micronemes secrete 
microneme proteins (MIC) which are essential for attachment to and invasion of the host cell. 
Subsequently, the elongated rhoptry organelles discharge rhoptry neck and bulb proteins, RON and ROP 
respectively, which are involved in invasion as well as mediating the first parasite defense towards host 
immune responses. The role of specific ROPs is further discussed in section 3.3.3. Finally, numerous 
dense granule proteins (GRA) are secreted in two distinct releases by the dense granule organelles and 
are crucial for host immune-modulation (reviewed in (6)). Altogether, these conserved groups of 
proteins highlight the parasitic ductile nature of T. gondii and provide evidence for the parasite 




Fig 1. Life cycle of T. gondii and structure of the tachyzoite form of the parasite. (a) The 
heteroxenous life cycle of T. gondii includes both a sexual phase in felids and an asexual stage in 
intermediate hosts. Image from Lilue et al. (7) (b) Schematic representation of T. gondii secretory 
organelles during the tachyzoite form of the parasite. Image from English et al. (8) 
3.1.2 T. gondii genotypes 
The global population of T. gondii can be divided into three main clonal lineages, named type I, II and 
III, and a more recently identified type 12 (9-11). Type II and 12 are the most common lineages found 
in Europe and North America, followed by type III (12). On the contrary, type I is rare in these areas 
and more frequently found in Asia (13). In the last years a more detailed genotyping based on 11 loci 
led to the re-classification into 15 haplogroups within 6 major clades (14). To date 231 T. gondii 
genotypes have been identified based on Polymerase Chain Reaction - Restriction Fragment Length 
Polymorphysm (PCR-RFLP) analysis (source: ToxoDB, (15)). With this new classification a multitude 
of atypical isolates with haplotypes different from previously defined strains were identified, mostly in 
South America. Analogous diversity has also been observed with a microsatellite genotyping-based 
approach (16).  
Even though less frequent, atypical and mixed genotypes have been also found in Europe. T. gondii type 
I alleles were already identified in European human cases in the initial study by Howe and Sibley (9). 
With the new reached consensus about genotyping criteria (17), knowledge about genotypes present in 
Europe is currently expanding, unveiling a diversity higher than expected. Type I and atypical genotypes 
were identified in domestic cats in Germany (18), farm animals from Portugal and Austria (19) as well 
as in human samples in Denmark (20). Surprisingly, a recent extensive screening of raw meat products 
in Poland found clonal type I and mixed genotypes in 10 % and 23 % of the T. gondii-positive samples 
respectively (21). These evidences highlight that, apart from the widespread clonal type II, other virulent 





3.1.3 ROP-mediated virulence of T. gondii genotypes  
Genotyping of strains is not only useful for classification purposes, but a correlation between parasite 
strains and virulence exists (22). T. gondii virulence has been defined in laboratory Mus musculus with 
type I being the most virulent clonal lineage. Different outcomes have been identified according to the 
way of infection –i.e. intraperitoneal, oral, subcutaneous and intranasal– and the parasite stage; however 
the most common approach and the one suggested as gold standard is intraperitoneal injection of 
tachyzoites (23). Further research is required to understand the reason underneath these differences and 
their impact on the current strains classification. All type I strains have a lethal effect on laboratory mice 
when tachyzoites are injected intraperitoneally, and host death occurs within 9 and 14 days post infection 
depending on specific parasite and mouse strains combinations (24). Type II and III have progressively 
less virulence (24).  
Comparisons between virulent and avirulent T. gondii strains led to the identifications of the two key 
virulence factors: the rhoptry proteins ROP18 and ROP5 (25-28). The allelic combination of these two 
highly polymorphic genes is predictive on T. gondii virulence in mice (29) and ROP5 deletion in type I 
strains is sufficient to completely attenuate acute virulence. These two proteins act as complex with 
ROP17 to phosphorylate and inactivate proteins mediating the host innate response (30), via a 
mechanism further explained in section 3.3.3. The ROP family has the highest number of copy number 
variation (CNV) within the T. gondii genome and has an elevated frequency of nonsynonymous versus 
synonymous mutations (31). Diversity within the ROP gene family, as well as in the family of surface 
antigens protein (SAG) genes, is what mostly differentiates T. gondii strains. This highlights the 
importance of the ROP family for T. gondii and supports the hypothesis of important roles of these genes 
as pathogenesis determinants. 
ROP virulent alleles are not only predictors of virulence for mice but also in human hosts (29). Indeed, 
type I strains are more frequently genotyped in symptomatic toxoplasmosis cases, such as ocular disease, 
congenital acquisition or reactivation of a chronic infection in immunocompromised patients (32). 
Humans lack the murine immune proteins specifically phosphorylated by the ROP triad, however novel 
targets of rhoptry proteins have been recently identified in human hosts. For example ROP18 
phosphorylates the transcriptional factor ATF6β resulting in a decreased antigen presentation in CD8+ 
T cells (33). Further, a role for ROP18 in the development of T. gondii-related encephalitis have been 
recently unveiled (34). Therefore a deeper understanding of virulent parasite strains distribution and 
identification of their natural reservoir has a major clinical importance. 
3.2 Reservoir of virulent T. gondii strains 
3.2.1 Dietary habits of cats 
T. gondii parasites persist in nature only if they reach the definitive hosts and are shed in form of 
infectious oocysts. Infection via environmental contamination and vertical transmission are thought to 
occur rarely in Felidae (3, 35). On the contrary, the main infection route in cats is represented by 
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ingestion of infective bradyzoite cysts from intermediate hosts. Interestingly this stage is also the most 
infective one for felids, suggesting how T. gondii evolved to support the main infection route (36). 
Recently, oocysts shedding from adult seropositive cats following re-infection has been observed (37), 
which questions the dogma of the single shedding event in a cat lifetime. This implies that ingestion of 
each infected prey might contribute to T. gondii spread in the environment. Therefore looking at felids’ 
preys could help us identifying important reservoir of T. gondii genotypes.  
The variety of Felidae that populates Europe is lower than in other parts of the planet, and is mostly 
represented by the domestic cat (Felis silvestris catus) and to a lesser extent by the wild cat (Felis 
silvestris silvestris) and a hybrid population of the two. Given the higher number and ubiquitous 
presence of these felid species, especially the domestic cat, their major role in T. gondii oocysts 
dissemination is expected. Information regarding dietary habits of cats indicate that their diet is mainly 
composed of small mammals, of which Rodentia is the most preyed order (38, 39). Birds and 
lagomorphs (hares and rabbits), despite being universally reported, are less often preyed. Within the 
Rodentia order, one of the least preyed species is Rattus spp., likely because of their bigger size and less 
palatability, whereas other small rodents species constitute their major diet item (38). Therefore, the 
focus of this thesis is on the most represented small rodent species and data from different studies in 
Europe are collected in Table 1.  
It is evident that European felids prey more on rodents of the family Cricetidae, e.g. the Arvicolinae 
bank vole Myodes glareolus (formerly Clethrionomys glareolus) and Microtus spp. –both referred as 
“voles” in the rest of the work–, or the Muridae Apodemus spp., rather than Mus musculus species –the 
latter named “mice”–. Despite variation in prey availability is known to cause changes in felids’ diet 
(38) which thus implies geographical differences, Apodemus spp. and Microtus spp. are overall the 
preferred preys. A comprehensive and recent review on dietary habits of European felids, confirms the 
mentioned non-murine rodent species being more preyed than Mus spp. (40). Most of the studies are 
based on morphological examination of feline stomach and gut content or scats, and less often based on 
preys brought home as trophies, the latter being less reliable since they do not imply ingestion. Of note 
is the study of Forin-Wiart et al. where for the first time metabarcoding of cat feces to determine prey 
composition was used (41). Overall, data are in accordance confirming that in Europe M. glareolus, 








Table 1. Prey items of European domestic, wild and hybrid cats. D = Domestic cats: W = Wild cats; 
H = Hybrid cats. 
Reference Location Cats 
Preyed species [%] 
Mus spp. Apodemus 
spp. 
Microtus spp. M. glareolus 
(42) Hungary D 7.0 13.8 37.7 9.6 
W 0.0 28.1 33.3 1.8 
H 1.6 9.4 25.0 18.8 
(43) France D 8.0 4.0 16.0 0.0 
W 5.0 33.0 13.0 10.0 
H 3.0 17.0 14.0 8.0 
(44) Italy W 0.2 64.9 11.2 12.2 
(45) Portugal W 0.0 71.3 35.4 0.0 
(46) UK D 4.3 11.4 9.8 3.8 
(47) Slovakia W 0.0 9.4 72.9 10.4 
(41) France D 0.2 1.3 27.3 2.7 
 
These small rodent species are widespread in Europe with slightly different habitats. Mus spp. and in 
particular the house mouse, M. musculus, are found both in anthropized environments and agriculture 
and often considered as pests. The epidemic dispersion of the house mouse is thought as responsible for 
the domestication of cats (38). Apodemus spp. resemble the house mouse in terms of morphology and 
habitat, with slight differences according to the subspecies. Voles like Microtus arvalis and Microtus 
agrestis are smaller in size compared to Muridae and can be found in cities as well as in grassland, 
whereas M. glareolus prefers woodland (source: IUCN red list of threatened species and the mammal 
society	(48)). The species above have a lifespan of one to two years, longer for voles than mice, mostly 
depending on the presence of predators. Due to the ubiquitous presence of cats in Europe, these rodent 
species and one of their major predators are sympatric. A recent study held in Berlin by Krucken et al. 
showed that indeed all mentioned species are present in the urban and suburban environment and are 
infected with T. gondii (49). 
Voles as M. glareolus and Microtus spp. are reservoir of numerous zoonotic diseases as viruses like 
tick-borne encephalitis virus and cowpox virus, bacteria such as Leptospira spp., Bartonella spp., 
Rickettsia spp., Borrelia spp. and unicellular eukaryotic parasites like Giardia spp., Cryptosporidium 
spp. and Babesia microti (50-55). In the last years M. glareolus attracted increased attention for being 
the main host for Puumala orthohantavirus (PUUV) whom infection provokes increasing cases of 
hemorrhagic fever with renal syndrome (HFRS) in humans, occasionally with lethal outcome	 (56). 
However, studies focussing on these natural reservoirs are largely underrepresented. Nevertheless, non-
murine rodents of the mentioned species are gaining increased interest in the field of wild- or eco-
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immunology because of their role as natural reservoirs and carriers of the genetic variability lost in 
inbred mouse colonies (57). 
 
Fig. 2. Taxonomic tree of rodent species (a) A taxonomic species tree based on phylogenetic 
relationship between the rodent species mentioned in this work (tree computed at 
https://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi). Image as part of Fig. 4 from the 
published manuscript Ehret et al. (58) (b) From top left clockwise: M. glareolus (credits Roger 
Butterfield), A. sylvaticus and M. agrestis (credits Rudmer Zwerver). 
3.2.2 T. gondii infection in European rodents 
Another factor contributing to the likelihood of T. gondii genotypes maintenance in nature is the 
frequency of cat’s preys infection. The prevalence of infection of most preyed species mentioned in the 
previous chapter ranges between 0.0 and 34.9 % in Europe (Table 2). Despite a general low prevalence 
of T. gondii in the considered species, data suggest that M. glareolus, Microtus spp. and Apodemus spp. 
are more often infected than Mus spp. Of notice are the high prevalence values for M. musculus and 
Apodemus spp. registered in UK. Authors of these studies found constant high prevalence in rodents at 
different ages, even in the absence of cats in the environment (59), and conserved genotypes in rodent 
populations (60, 61), suggesting high levels of vertical transmission.  
It is crucial to consider that only rodents resistant to infection will be identified in these studies, since 
susceptible hosts will die of acute toxoplasmosis. Several studies indicate that not only different 
susceptibility to T. gondii exists within inbred laboratory mouse strains (23) and between different Mus 
musculus subspecies (7, 62), but also between different rodent species. For example a study performing 
in vivo infection of wild animals of all the mentioned rodent species with a fresh virulent clinical isolate 
concluded that these more preyed species are also more resistant to infection compared to Mus spp.	(63). 
19	
	
In particular M. glareolus is by far the most resistant, followed by Microtus arvalis and Apodemus 
flavicollis, then Microtus agrestis and Apodemus agrarius. Importantly, and differently from other in 
vivo studies, Mus rodents were also trapped from the wild; therefore the result was not influenced by 
confounders linked to laboratory animal models (58). Furthermore, results were independent of the 
infection route of choice. In agreement with this study, in vivo experiments on Microtus arvalis (64) and 
corean Apodemus agrarius (65) confirmed their less susceptibility to virulent T. gondii than C57BL/6 
inbred mice via all tested infection routes. Interestingly a fully genotyped isolate from naturally infected 
rodents reports the formation of virulent parasite brain cysts in a living vole, highlighting the resistance 
of the latter to infection and its potential as intermediate host (66, 67). 
Taken together these data support the hypothesis that M. glareolus, Microtus spp. and Apodemus spp. 
might be reservoir of virulent T. gondii, given both their higher infection rate and their lower 
susceptibility to virulent parasite infection compared to Mus spp. 
Table 2. T. gondii infection in rodent species in Europe. Na = not assessed. PCR = polymerase chain 
reaction; WB = Western Blot; SF = Sabin-Feldman dye test. 
Reference Location Diagnostic method 
Prevalence [%] 







PCR na 4.3 31.0 0.0 
(18) Germany PCR, WB 0.0 0.0 0.0 0.0 
(68) Czech 
Republic 
SF 0.7 8.3 3.5 1.0 
(69) France and 
Portugal 
SF 0.7 0.8 0.0 0.0 
(70) Netherlands PCR 9.0 0.0 4.2 0.0 
(61) UK PCR na 34.9 na na 
(71) UK SF na 20.0 na 17.6 






3.3 Host immune response during T. gondii infection 
Mechanisms of host immune responses during T. gondii infection have been widely studied in many 
host species. The initial phase of infection corresponds to the ingestion of infective oocysts or 
bradyzoites and their differentiation in actively dividing tachyzoites within the host intestine. This phase 
is still the least known stage and surely deserve to be more addressed in the near future (reviewed in 
(72)). The host response to tachyzoite infection is the most commonly studied and well-known stage. 
Conserved feature between different host species is the pivotal role of the IFN-γ cytokine. Indeed, mice 
deficient of IFN-γ or its receptor, or when the cytokine binding is blocked via antibody neutralization, 
display higher susceptibility to infection (73-75). Similarly, the cytokine promotes parasite clearance in 
human cells (76). 
IFN-γ is secreted by natural killer (NK) cells first and CD4+ and CD8+ lymphocytes later, following 
stimulation with the interleukine 12 (IL-12) (reviewed by Hunter and Sibley (77)). Major triggers for 
IL-12 release from macrophages and dendritic cells differ between mice and humans. Murine phagocytic 
cells can directly recognize the main T. gondii antigen profilin via Toll-Like Receptors (TLR) 11 and 
12, as well as phagocytise infected cells or opsonized parasites. Human cells rely on the latter 
mechanisms, since they do not have functional TLR11 and TLR12. Only recently, a novel mechanism 
of human immune response mediated by the release of an alarmin from infected cells was identified 
(78). In both human and murine cells, IFN-γ pathway activation induces several mechanisms to promote 
parasite clearance, like production of reactive oxygen species (ROS) and nitric oxyde (NO). Humans 
have IFN-γ-mediated control mechanisms of T. gondii infection that have not been identified in the 
mouse model so far, e.g. limitation of iron and tryptophane supply and induction of an inflammasome-
mediated death (77). The main resistance mechanism in mice, mediated by the Immunity Related 
GTPase family of proteins (IRG, further discussed in section 3.3.3) is also unique of this host family 
and induced by IFN-γ. 
3.3.1 The IFN-γ pathway  
IFN-γ binds as a homodimer to its cell surface receptor –composed of subunits IFN-γR1 and IFN-γR2– 
leading to subsequent activation of the Janus Kinase (JAK)-mediated signal transduction pathway (79). 
Signal transducer and activator of transcription 1 (STAT1) is the main transcription factor that is 
activated by engagement of the IFN-γ receptor. Phosphorylation on tyrosine 701 (Tyr701) and serine 
727 (Ser727) and subsequent dimerization of STAT1 leads to its nuclear translocation where it induces 
the expression of several target genes via binding to the γ-interferon-Activation Sites (GAS) and 
Interferon-Stimulated Response Elements (ISRE) in their promoter region (80, 81).  
Following IFN-γ treatment more than 4,000 genes varying 2 folds or more have been identified in the 
mouse model to date, and more than the double in human cells	(82). This cytokine’s main function is to 
activate cellular immune responses to the invading pathogen, including bacteria, viruses and parasites. 
The two main families of proteins induced by IFN-γ treatment are Immunity-Related GTPases (IRG) 
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and Guanylate Binding Proteins (GBP) (83), both part of the defense mechanism proper of each 
nucleated cell named cell-autonomous immunity (84). When a pathogen succeeds in invading the host 
cell, the cell-autonomous response represents the last line of defense against the pathogen. Indication of 
the importance of IFN-γ-regulated cell-autonomous genes is their expansion within genome clusters and 
tight regulation, both costly processes for the host cell. These two families of genes are broadly 
conserved between plants and vertebrate mammals and they are expressed in hematopoietic as well as 
non-hematopoietic cells (85). 
The importance of the IFN-γ-mediated immune response in T. gondii infection is evident from the 
evolution of parasite mechanisms specifically inhibiting this cytokine pathway and the downstream 
transcriptional factor STAT1-mediated gene expression. The mechanism is conserved in all three clonal 
lineages and results in the transcriptional repression of almost half of the interferome (86). Interestingly 
the expression of crucial Irg genes like Irga6 and Irgb6 was reduced by at least 2-fold following 
infection with all the tested strains. Mediator of STAT1 transcriptional repression is TgIST (T. gondii 
inhibitor of STAT1 transcriptional activity), a protein secreted by the parasite into the host cytoplasm 
(87, 88). TgIST reaches the host nucleus where it sequesters the phosphorylated form of STAT1 in 
chromatin-bound repressor complexes (89). The blocked recycling of STAT1 leads to a decreased 
expression of IFN-γ-induced genes and confers the parasite a crucial advantage during infection (90). 
TgIST is just one example of the numerous parasite tools to alter host signalling and immune response, 
recently reviewed by Hakimi et al (32). 
3.3.2 Immunity Related GTPases  
Immunity Related GTPases are conserved in many vertebrate genomes but with species differences 
regarding copy number and chromosome loci. For example, they are present in fish but absent in birds, 
and within mammals present in dogs but not cats. Primates lost IRGs with the exception of IRGC, locally 
expressed in the testis, and IRGM (91, 92). Rodents have the biggest Irg diversity described so far, 
counting 23 Irg genes in C57BL/6 mice encoded in large gene clusters located on chromosomes 7, 11 
and 18 ((91) Fig. 6b). Their tight regulation via IFN-γ is highlighted by the presence of GAS and ISRE 
elements in the promoter regions regulating their expression (91). IRGs play key roles in murine 
resistance against a wide variety of intracellular pathogens such as parasites like Toxoplasma gondii, 
bacteria as Chlamydia trachomatis, Mycobacteria tubercolosis, Salmonella typhimurium and Listeria 
monocytogenes, and fungi like the microsporidia Encephalitozoon cuniculi (93-99). IRGs seem also 
involved during bacterial infection in lower vertebrate (100). 
IRGs are 21-47 kDa proteins that have been recently classified in three main categories based on their 
described functions: effector, regulatory and decoy IRGs ((7) Fig. 3).  
Effector IRGs, as IRGa6 and IRGb6, are recruited on the PVM of invading pathogens and mediate its 
disruption via still unclear mechanisms. As GTPases they hydrolyze GTP which is paramount for protein 
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dimerization and membrane loading (101). IRGa6 is the only crystalized protein of the family, and 
sequence comparison predicts that its structure well represents the IRG 47 kDa protein family (101). 
Regulatory IRGs, as IrgM1-3 in mice and IRGM in humans, are necessary to regulate the activity of 
effector IRGs. Interestingly, large genome-wide association studies linked specific human IRGM alleles 
with the development of inflammatory disorders like Crohn’s disease, possibly via a lack of IRGM-
mediated regulation of the inflammasome assembly (102). Murine IRGm1 and IRGm3 localize at 
different intracellular organelles’ membranes and display a regulatory function by keeping effector IRGs 
in a GDP-bound inactive state (103). IRGm3 is necessary for PVM disruption and for host resistance to 
avirulent strains infection (104), and mediates the PVM stripping and blebbing into the cytoplasm of 
murine astrocytes (105). 
Decoy IRGs count at the moment only IRGb2-b1, whose activity is described thoroughly in section 
3.3.4. However, Irgb2-b1 gene structure, two single classic Irg exons separated by a long 6 kb intron 
and translated as 2.5 kb long mRNA, is analogous to other three genes, i.e. Irgb5-b4, Irgb9-b8 and the 
pseudogene Irgb5-b3. Their function has not been documented yet, thus redundancy of decoy IRG 
cannot be excluded at the moment.  
Overall it seems that, at least in the mouse model, the IRG system covers the role of powerful immune 
Swiss Army knife, with many functions identified and still mysterious tools to figure out. 
 
Fig. 3. Immunity Related GTPases (Irgs) of M. musculus. Unrooted tree (p-distance based on 
neighbour-joining method) of nucleotide sequences of the G-domains of the 23 Irg GTPases in the 
mouse BL6 genome (genome ID 52). Highligthed the three categories of Irg genes: regulatory, effector 
and decoy Irgs. The image was modified from Bekpen et al (91). 
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3.3.3 Effector IRG role during T. gondii infection 
During T. gondii infection of IFN-γ-primed cells, effector IRGs like IRGa6 and IRGb6 are relocated 
from different organelles, as the endoplasmic reticulum and the Golgi apparatus respectively, on the 
parasite membrane in a GTP-dependent fashion observed both in vitro and in vivo (106, 107). These 
IRGs mediate vacuole rupture and are necessary to limit T. gondii avirulent growth. Effector IRG 
loading is hierarchical, with pioneers IRGb10 and IRGb6 followed by IRGa6 (108). Loading of parasite 
vacuoles starts as soon as few minutes after infection and increases progressively up to 2 hpi covering 
almost the totality of type II and III PVM, whereas type I parasite PVM are scarcely coated (108). First, 
loading of avirulent parasites’ PVM results in morphological changes of the vacuole and the parasite 
within, both of them rounding up. Then, the parasitophorous vacuole membrane permeabilizes, followed 
by the parasite membrane itself few minutes later (105, 109). Given the change in shape of the vacuole, 
it has been hypothesized that the trigger for PVM rupture is the mechanical pressure caused by 
oligomerization of IRGs and GBPs. By electronic microscopy, it was observed that vacuole rupture 
happens by opening of the PVM and formation of vesicles which protrude in the host cytoplasm (105). 
IRGs display a dynamin-like phenotype despite the fact that they do not share sequence similarities and 
that their vesicle coating might regulate trafficking for intracellular degradation. Afterwards, GBP2 
directly binds the plasma membrane of free intracellular parasites, likely contributing to its killing, 
recently showed by high-resolution live-cell imaging (110). 
Following PVM rupture and along with the parasite killing, the cell starts a process of programmed cell 
death with features of pyronecrosis, meaning loss in cell membrane integrity and release of the pro-
inflammatory chromatine remodelling protein HMBG1, observed both in murine macrophages and 
fibroblasts (109). Despite a not clear association of the autophagosome marker LC3 with the PVM (106) 
and no exposure of the autophagy-associated phosphatidyl serine on the plasma membrane (109), 
members of the autophagy pathway like Atg5 are necessary to mediate IRGs loading (108) and parasite 
killing (111).  
This host mechanism protects only against infection with avirulent but not with virulent strains. As 
already anticipated in chapter 3.1.3, virulent parasites express ROP5 proteins (27, 28) which bind to 
IRGa6, and to a lesser extent to IRGb6 and IRGb10, to prevent their GTP-hydrolysis and protein 
oligomerization on the PVM (112, 113). ROP5 binding induces a conformational change that exposes 
IRGa6 Thr102 and Thr108 to be target of phosphorylation from ROP17 and ROP18 respectively (30, 
114). Eventually, the synergistic activity of the virulent ROP triad succeeds in hijacking the host cell-
autonomous response thus allowing parasite replication. 
3.3.4 The role of IRGb2-b1 in mediating resistance to virulent T. gondii 
Intraperitoneal injection of virulent T. gondii strains always have a lethal effect on inbred laboratory M. 
musculus strains (24). In 2013 Lilue et al. showed that the wild-derived M. musculus castaneus Indian 
strain CIM survives infection with the virulent GT1 strain whereas, as expected, all inbred NMRI mice 
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die within 15 days (7). A genetic backcross between resistant and susceptible strains identified the Irg 
locus on chromosome 11 to be associated with the resistant phenotype. Interestingly, Irg genes are 
conserved in laboratory mice due to breeding, whereas high diversity was observed in wild-derived mice 
(7). Furthermore, cloning of one of the most diverse genes, the tandem Irgb2-b1CIM, in susceptible 
fibroblasts resulted in the ROP5-mediated phosphorylation of the transfected protein instead of the key 
immune mediator IRGa6. Phosphorylation of Irga6 implies loss of function of the protein, therefore the 
“decoy” activity of IRGb2-b1 allows the host cell to still mount an IRG-mediated response to infection. 
Structural mimicry of IRGb2-b1 to IRGa6 is suggested by the fact that the first was crystalized as dimer 
and the latter is only found as tandem protein of subunits with the same size (101). CIM-derived Irgb2-
b1 KO cells lose their resistance to infection, supporting the hypothesis of a protective role of the protein 
during virulent T. gondii infection (115). More recently, it has been showed that resistance to virulent 
strain infection is not only dependant on the genetic variability of wild-derived mice, but is also linked 
to M. musculus subspecies (62). In particular, M. musculus domesticus shows susceptibility to infection 
regardless of inbred or outbred strain choice. On the contrary M. musculus castaneus strains, including 
the CIM strain already investigated by Lilue et al., as well as M. musculus musculus PWK/Ph strains are 
resistant to infection regardless of breeding. In agreement with the work of Lilue et al., resistance is 
associated with the region of chromosome 11 encompassing the Irg genes. This work further highlights 
the critical protective role of IRG proteins during T. gondii infection in a major host as M. musculus.  
Phylogenetic analyses revealed positive pressure in rhoptry proteins’ residues involved in binding to 
IRGs as well as in the target threonine on IRGa6 (30, 116). Furthermore, the whole region at the interface 
with ROP5 is under selective pressure and is enriched with nonsynonymous versus synonymous 
substitutions, both in Irga6 and Irgb2 genes (7, 116). This suggests co-evolution mechanisms between 
the T. gondii main virulence factor and the murine target IRGa6, resulting in virulent parasites success 
in infection. Similarly, IRGb2-b1 was suggested as the host response to virulent parasite evolution, 
which evolved only in certain host species. Overall the ROP5-IRG system is an example of the 
evolutionary arms race between the host immune responses and pathogen virulence (117). Analysis of 
further host species’ Irg might lead to the identification of virulent parasites reservoirs, similarly to what 
described for Mus spp.     
The T. gondii infection events described in the last sections are graphically shown in Fig. 4. The table 
includes both the host response to virulent and avirulent T. gondii in murine inbred cell systems, and the 




Fig. 4. Scheme of early events during in vitro T. gondii infection in inbred laboratory mice and 
wild-derived M. musculus castaneus (CIM). Data reported in the scheme are from the following 
studies (7, 30, 105, 108-110, 114-116). “Prylates” stands for phosphorylates.	  
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3.4 Aims of the study 
Rodents surely constitute a crucial intermediate host for T. gondii, because of their ubiquitous presence, 
their ability to develop chronic infections and their central role in the diet of the parasite’s main definite 
host, the domestic cat. Most of the research on protozoan parasites is carried on in laboratory inbred M. 
musculus, and T. gondii is not an exception (58). All T. gondii strains require a suitable host that is 
tolerant to infection and develops chronic infection in order to reach the definitive host and avoid 
extinction. However, the definition of T. gondii virulence in laboratory inbred mice does not provide an 
explanation for virulent strains persistence in nature, since they all lead to lethal infections.  
Two independent groups identified specific wild-derived M. musculus musculus and M. musculus 
castaneus strains which survive infection with virulent T. gondii strains and develop brain cysts (7, 62). 
Their resistance is correlated with specific alleles of the extremely polymorphic host Immunity-Related 
GTPase Irgb2-b1. Resistance-associated IRGb2-b1 has been shown to bind and inhibit the parasite main 
virulence factor ROP5 (7, 115). Irg sequences in laboratory mice strains are highly conserved due to the 
extensive inbreeding process, which makes these models not suitable systems to mimic natural infection. 
On the contrary, the identified wild-derived M. musculus subspecies surviving infection with virulent T. 
gondii genotypes and carrying high Irg diversity can potentially act as reservoir and allow further 
transmission to cats. 
However, M. musculus might not be the most relevant intermediate host for T. gondii. Several studies 
conducted in Europe showed that the diet of feral domestic and wild cats consist mostly of M. glareolus, 
Microtus spp. and Apodemus spp. rather than Mus spp. The same species have also a higher prevalence 
of T. gondii infection compared to the previously examined Mus spp. Furthermore, there is evidence 
that these non-murine rodents are less susceptible to virulent T. gondii strains which eventually form 
brain cysts. As already speculated by Afonso et al., dietary habits of cats have a direct impact on their 
infection with T. gondii and this warrants further investigation (118).  Therefore, the main aim of this 
study was to evaluate the potential for M. glareolus, Microtus spp. and Apodemus spp. to act as 
intermediate hosts for virulent T. gondii genotypes by resistance mechanisms involving IRGb2-b1-like 
proteins.  
Different approaches are possible to unravel the link between Irgb2-b1-like genotypes present in nature 
and the T. gondii virulence phenotype. One strategy relies on genotyping naturally infected rodents in 
the wild as well as their pathogens. Whereas this might represent the ideal approach, it also presents 
drawbacks. First, many confounders in nature influence the outcome of infection, as for example 
concomitant infections, age and immune status of the host. Knowing the impact of each of these 
variables for developing a reliable model requires a deep knowledge of the studied population, a highly 
prevalent pathogen and a large sample size. Examples are given by the correlation between Tnf-α and 
Mx2 expression and infection with helminths/hantaviruses (119, 120), or cytokines’ genetic diversity 
and infection with several pathogens (121), both studies performed in a extensively studied population 
of M. agrestis in UK. The outcome of these studies is the likelihood that a certain factor is either directly 
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or indirectly involved in infection with the pathogen. In a second approach the natural variability is 
transferred in an in vitro setting, by cloning the gene of interest from different wild individuals in a 
homogeneous host system. This approach allows a reduction in the sample size needed and causes an 
observable effect of the introduced gene, and has been used previously, for example to study the species 
specificity of Canine Distemper Virus (122). Both approaches can also be combined to formally assess 
the impact of a putative target emerged from an explorative analysis. In the specific case of IRG-
mediated host resistance, pathogen infection is not only influenced by sequence diversity but expression 
levels play an equally crucial role. For example resistance-associated Irgb2-b1 alleles were also more 
expressed than susceptibility-associated ones (7). Further, polymorphisms in the promoter region of 
Irgb10 result in higher expression levels in a mouse laboratory strain, and is directly related to resistance 
to C. trachomatis (123). Therefore, in order to evaluate the effect of solely Irg polymorphisms, we need 
to control their expression levels. Overall these considerations convinced us in adopting the second 
approach, with cloning of Irgb2-b1-like genes from several wild rodents into Mus musculus Flp-In-3T3 
fibroblasts. Since the latter were generated from inbred mice we expected these cells to encode for the 
T. gondii susceptibility-associated Irgb2-b1 genotype, consequently to allow virulent parasite 
proliferation. Cloning of a resistance-conferring Irgb2-b1-like gene should mediate rupture of the 
parasitophorous vacuole membrane and cause parasite death. Flp-In-3T3 cells also allow a site-specific 
integration of transfected genes which results in comparable expression levels. This established cell 
culture-based system will allow me to evaluate the infection phenotype associated with Irgb2-b1-like 
genes from wild rodents. 
In Chapter 1 I assessed the diversity of Irgb2-b1-like genes in samples across Germany from wild 
rodents of M. glareolus, Microtus spp. and Apodemus spp. Similarly to Lilue et al. in their study on 
wild-derived M. musculus, I expected a high diversity between and within these rodent species 
sequences. Selected Irgb2-b1-like genes were stably transfected into Flp-In-3T3 fibroblasts, starting 
from the positive control Irgb2-b1CIM with the resistance-associated CIM allele and the negative control 
Irgb2-b1Bl6 with the susceptible allele from inbred mice. The created cell lines were observed in the 
context of virulent and avirulent T. gondii infection. 
In Chapter 2 I produced and characterized a recombinant vole IFN-γ (124). Working with non-model 
organisms poses special challenges as the lack of reliable genomic references and reagents, like the 
crucial cytokine IFN-γ. Because of our interest in IFN-γ-induced genes and the availability of vole-
derived cell systems, access to this cytokine was a prerequisite for the project. Due to the phylogenetic 
distance between voles and Muridae indicated in Fig. 2, we expected and initially proved lack of cross-
reactivity of the murine IFN-γ on vole-derived cells. Thus, the vole cytokine was produced by 
recombinant expression in E. coli and its activity validated by several means.  
In Chapter 3 I studied the IFN-γ-mediated resistance of different M. glareolus-derived systems to 
infection with virulent and avirulent T. gondii strains. Given M. glareolus less susceptibility to virulent 
parasite infection from in vivo studies compared to Mus spp., we expected vole cells to display a resistant 
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phenotype. Similarly, resistant phenotype was expected against avirulent strains which do not cause 
acute toxoplasmosis in these rodent species. For this purpose, I established novel hematopoietic and 
non-hematopoietic cell cultures from M. glareolus, like Bone Marrow-Derived Macrophages and 
primary fibroblasts cultures, which are frequently used cell types in T. gondii research. 
Taken together these results contribute to assess the ecological potential of rodent species as M. 
glareolus, Microtus spp. and Apodemus spp. as intermediate hosts for virulent T. gondii in Europe and 
their subsequent transmission to cats. 
4. Materials 
4.1 Media and agar 
Tab. 3. Media and agar 
Name Composition 
DMEM cell culture medium DMEM high glucose (4.5 g/l) with sodium pyruvate and stable 
glutamine added with 1 or 10 % heat-inactivated FCS and 
100 µg/ml Pen/Strep (1x) 
Cell freezing medium 90 % (v/v) of either complete DMEM cell culture medium or FCS 
added with 10 % DMSO 
Hogness freezing medium (10x) 36 mM K2HPO4; 13 mM KH2PO4; 20 mM Na-citrate; 10 mM 
MgSO4; 40 % (v/v) glycerol (pH 7.5) 
LB medium 10 g/l Bacto Tryptone; 5 g/l yeast extract; 10 g/l NaCl (pH 7.0) 
2xYT medium 16 g/l Bacto Tryptone; 10 g/l yeast extract; 5 g/l NaCl (pH 7.0) 
SOB medium 20 g/l Bacto Tryptone; 5 g/l yeast extract; 0.5 g/l NaCl; 2.5 mM 
KCl; 10 mM MgCl2 (pH 7.0) 
SOC medium SOB-medium added with 20 mM glucose 
DMEM medium for LDH assay DMEM high glucose (4.5 g/l) and stable L-glutamine without 
sodium pyruvate and phenol red added with 1 % of heat-
inactivated FCS and 100 µg/ml Pen/Strep (1x) 
 
4.2 Buffers and solutions 
Tab. 4. Buffers and solutions 
Name Composition 
Inoue transformation buffer 55 mM MnCl2*4H2O; 15 mM CaCl2·2H2O; 250 mM KCl; 10 mM 
PIPES (pH 6.7) 
Crystal violet dye solution 0.2 % (w/v) in 2 % (v/v) ethanol 
PBS 13.7 mM NaCl; 8.0 mM Na2HPO4; 2.7 mM KCl; 1.5 mM KH2PO4 
(pH 7.4) 
TBS  150mM Tris; 20mM NaCl (pH 7.6) 
TAE electrophoresis buffer 40 mM Tris; 20 mM acetic acid; 1 mM EDTA 
Permeabilization buffer 100 mM glycine und 0.25 % (v/v) Triton X-100 in PBS (pH 7.2) 
Fixing solution 4 % (v/v) formaldehyde; 250 mM NaCl in PBS 
Phosphoprotein lysis 
solution 
10 mM Tris, 150 mM NaCl, 1 % TX-100, 1 % Na-DOC (pH 7.2) 
Laemmli solution 250 mM Tris, 25 % (v/v) glycerol. 7.5 % (w/v) SDS, 0.25 mg/ml 
bromphenol blue, 12.5 % (v/v) ß-mercaptoethanol in ddH2O 
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Intracellular (IC) buffer 
(10x) 
5 mM NaCl; 142 mM KCl; 2mM EGTA; 1 mM MgCl2; 5.6 mM 
glucose; 25 mM HEPES-KOH (pH 7.2) 
Direct Blue 71 (DB71) 
whole protein staining  
8 % (v/v) of 0.1 % DB71 stock solution in 40 % ethanol / 10% acetic 
acid solution 
DB71 destaining solution 50 % (v/v) absolute ethanol, 15 % (v/v) 1M NaHCO3, in ddH2O 
Bacteria lysis buffer  25 mM Tris; 500 mM NaCl; 10 mM imidazole (pH 7.5) 
Lysis buffer for luciferase 
assay (5x) 
125 mM H3PO4, 10 mM DTT, 10 mM CDTA, 50 % glycerol, 5 % TX-
100, in ddH2O (pH 7.8) 
Luciferase assay reagent 
stock solution 
20 mM Tricine, 1.07 mM (MgCO3)4Mg(OH)2*5H20, 2.67 mM 
MgSO4*7 H2O, 0.1 mM EDTA, in ddH2O (pH 7.8) 
 
Tab. 5. Antibiotics and their used concentration  
All antibiotics were diluted in ddH2O. 





Hygromycin B	 50	 200	
Amphotericin B	 25	 0.25	
 
4.3 Enzymes, proteins and antibodies 
4.3.1 Enzymes and proteins 
All enzymes used in this work (Q5® High-Fidelity DNA Polymerase, restriction enzymes, T4 DNA 
ligase, Antarctic Phosphatase) were bought from New England Biolabs GmbH (Frankfurt am Main, D). 
Exception were: the DreamTaq DNA polymerase and Exonuclease I (Thermo Fisher Scientific Inc., 
Karlsruhe, D); Shrimp Alkaline Phosphatase (SAP) from (Amersham, Freiburg, D);  
The recombinant mouse IFN-γ was reconstituted in 1 ml sterile ddH2O supplemented with 0.1 % bovine 
serum albumin (BSA) and stored in aliquots at -20°C (100 U = 20 ng).  
The produced recMgIFN-γ protein solution was supplemented with 0.1% BSA and antibiotics (P/S) and 





Tab. 6. Antibodies and their used concentrations. WB: Western Blot; IF: Immunofluorescence assay; 
Cyt: Flow cytometry. 
Antibody (origin) Manufacturer Dilution 
anti-phopshoTyr701-STAT1 
(rabbit mAb) 




Cell Signaling Technology Inc., MA,USA IF 1:100 
anti-STAT1 (rabbit pAb) Cell Signaling Technology Inc., MA,USA WB 1:1,000 
anti-ß-actin (rabbit) Cell Signaling Technology Inc., MA,USA WB 1:3,000 
anti-6His-tag (mouse mAb) Linaris GmbH, Dossenheim, D WB 1:2,000 
anti-HA-tag (rat) Roche Diagnostics GmbH, Berlin, D IF 1:400 
WB 1:500 
anti-rabbit IgG (H+L) PO (goat) Jackson ImmunoResearch Europe Ltd., UK WB 1:3,000 
anti-mouse IgG (H+L) PO (goat) Dianova GmbH, Hamburg, D WB 1: 
2,000 
anti-rat IgG (H+L) PO (donkey) Jackson ImmunoResearch Europe Ltd., UK WB 1:4,000 
anti-rabbit Alexa Fluor® 488 
(goat) 
Thermo Fisher Scientific Inc., Karlsruhe, D IF 1:1,000 
anti-rat Cy5 (goat) Dianova GmbH, Hamburg, D IF/Cyt 
1:500 
anti-SAG1 (llama serum) Preclinics Postdam IF 1:500 
anti-llama IgG Dylight 594 (goat) Antibodies-online GmbH, Aachen, D IF 1:300 
anti-IRGB1 954/3 (rabbit serum) Jonathan Howard, Instituto Gulbenkian de 
Ciência, Oeiras, P 
IF 1:4,000 
anti-IRGa6 165/3 (rabbit serum) Jonathan Howard, Instituto Gulbenkian de 
Ciência, Oeiras, P 
IF 1:8,000 
anti-IRGb6 141/3 (rabbit serum) Jonathan Howard, Instituto Gulbenkian de 
Ciência, Oeiras, P 
IF 1:4,000 
anti-IRGb6 TGTP A-20 (goat 
pAb) 
Santa Cruz Biotechnology Inc., TX, USA IF 1:50 
anti-GRA7 (rabbit) David Sibley, Washington University St. Louis, 
WA, USA 
IF 1:1,000 
anti-CD68/SR-D1 (mouse) Novus Biologicals, Centennial, CO, USA Cyt 1:10 
anti-F4/80 (rat) Santa Cruz Biotechnology Inc., TX, USA Cyt 1:50 




4.4 Plasmids and oligonucleotides 
4.4.1 Plasmids 
Tab. 7. Plasmids 
Plasmid (length) Source and characteristics  AB-resistance 
pASG-IBA33 (3,181 bp) IBA Göttingen, Germany. Used for cloning of 
MgIFN-γ. 
Amp 
pQE90S-LEA (4,426 bp) GenExpress GmbH (Berlin, Germany). Contains the 
TGME49_076870 T. gondii sequence in frame with a 
C-terminal 6His-tag used for production of LEA870 
negative control. 
Amp 
pcDNA™ 6/TR (6,662 bp) Invitrogen™ Corporation, Carlsbad, CA, USA. Used 
for cloning of BsdR gene in pGAS-Luc plasmid. 
Bsd 
pGAS-Luc (5,744 bp) Stratagene. It expresses the firefly luciferase gene 
under the control of a promoter encoding a human γ-




Jonathan Howard, Instituto Gulbenkian de Ciência, 




Flag-CIM (7,653 bp) 
Jonathan Howard, Instituto Gulbenkian de Ciência, 
Oeiras, P. Used to clone the Irgb2-b1CIM gene into 
pFS-1 vector. 
Amp 
pUC19 (2,686 bp) Standard cloning vector with multiple cloning site, 
LacZα. 
Amp 
pmaxGFP® (3,486 bp) Lonza GmbH, Basel (CH). Expression of a GFP 
protein under the CMV promoter. Used as control for 
transfection efficiency. 
Kan 
pOG44 (5,785 bp) Flp recombinase expression vector designed for use 
with the Flp-In™ System. When cotransfected with the 
pcDNA5/FRT plasmid into a Flp-In mammalian host 
cell line, like Flp-In™-3T3, the expressed Flp 
recombinase under a CMV promoter mediates 
integration of the pcDNA5/FRT vector containing the 
gene of interest into the genome via Flp 
Recombination Target (FRT) sites. Invitrogen™ 








Tab. 8. Oligonucleotides 
Oligonucleotides  Sequence (5’ -> 3’) 
Bsd Fw TCATGATAATAATGGTTTCTTAGACCAGACATGATAAGATACATTG 
Bsd Rev ATTTCCCCGAAAAGTGCCACCTGACGAATGTGTGTCAGTTAGGG 
B2-3’ Fw AAAGAAGAGCTTYTCACAG  
B1-5’ Rev TCAGAGAGGATTTTRCTTTC 
L-Ywhaz GATGAAGCCATTGCTGAACTTGA 
R-Ywhaz GCCGGTTAATTTTCCCCTCCT 
Cyt B Fw TCATCMTGATGAAAYTTYGG 
Cyt B Rev ACTGGYTGDCCBCCRATTCA 
Irgb2 Fw ATGGGTCAGWCYTCCTCTTCTAC 
Irgb2 Rev CTGTGARAAGCTCTTCTTT 
Irgb1 Fw GAAAGYAAAATCCTCTCTGA 
Irgb1 Rev CATYSCTGYTTCCCAGTATTC 
Irgb2 Slice Fw TTTCTAGAGGCAAGGAAGCTCTTCGATGGGTCAGWCYTCCTCTTCTAC 
Irgb2 Slice Rev TTAAGCTTGCTTTCCTTGCTCTTCGTGTGARAAGTTCTTCTTT 
b1f4 Slice Rev TTAAGCTTGCTTTCCTTGCTCTTCGTCCCATYSCTGYTTCCCAGTATTC 





B2-3’ Fw AAAGAAGAGCTTYTCACAG 
B1-5’ Rev TCAGAGAGGATTTTRCTTTC 
 
4.5 Commercial kits 
Tab. 9. Commercial kits 
Name	 Manufacturer 
BigDye® Terminator v3.1 Cycle Sequencing Kit Applied Biosystems, Carlsbad, CA, USA 
DNA Clean & Concentrator™ Zymo Research Europe, Freiburg, D 
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Zyppy™ Plasmid Miniprep Kit Zymo Research Europe 
PureLink® HiPure Plasmid Midiprep Kit Life Technologies GmbH, Darmstadt, D 
Pierce™ 660nm Protein Assay Reagent  ThermoFisher Scientific GmbH, Schwerte, D 
PrimeScript™ RT-PCR Kit Takara Bio Inc., Kusatsu, JAP 
PrimeSTAR® GXL DNA Polymerase Takara Bio Inc., Kusatsu, JAP 
Maxima SYBR Green/ROX qPCR Master Kit (2x)  ThermoFisher Scientific GmbH, Schwerte, D 
RNeasy Plus Mini Kit Qiagen, Hilden, D 
QIAshredder spin column Qiagen, Hilden, D 
DNeasy Blood & Tissue Kit Qiagen, Hilden, D 
NucleoSpin® Tissue DNA extraction Kit Macherey-Nagel GmbH, Düren, D 
Zero Blunt® TOPO® PCR cloning Kit Invitrogen™ Corporation 
Dual-Luciferase® Reporter Assay System Promega GmbH, Madison, WI, USA 
Amaxa® Cell Line Nucleofector Kit R Lonza GmbH 
Agilent RNA 6000 Pico Kit Agilent Technologies Inc., Santa Clara, CA, 
USA 
QuantiFluor® dsDNA Dye System and 
QuantiFluor® RNA System 
Promega GmbH, Madison, WI, USA 
 
4.6 Bacterial, eukaryotic and Toxoplasma gondii strains 
4.6.1 Bacterial strains 
Tab. 10. Bacterial strains 
Bacterial strain Genotype and source AB-resistance 
DB3.1  Contains ccdB-CAT as insert; released upon SapI-digest which 
was used for SLiCE cloning. 
Kan, CAM 
JM109(DE3) Contains plasmid pKD46 (Coli Genetic Stock Center #64672). 
Used to prepare SLiCE extract. Grows at 30°C. Promega 




Sensitive to ccdB toxin, used for positive selection of cloned 









4.6.2 Eukaryotic cell lines 
Tab. 11. Eukaryotic cell lines 
Eukaryotic cell lines  
(catalog number) 
Species Description and source 
BJ-5ta  
(ATCC® CRL-4001™) 
Homo sapiens HFF cells for maintenance of T. gondii strains. 
Cells were immortalized after transfection with 
human telomerase reverse transcriptase (hTERT). 





Mouse Swiss NIH embryonic cells. From LGC 
Standards GmbH. 
Flp-In™-3T3 (R761-07) Mus musculus 
(domestic mouse) 
Cell line with FRT recombinase site for site-
specific gene insertion. More details in chapter 
6.1.5. From Invitrogen™ Corporation. 
BVK168 Myodes glareolus 
(bank vole) 
Derived from the kidney of a single animal. 
Description of BVK168 cell line establishment 
here (125). From Sandra Eßbauer, Institute of 





Derived from the kidneys of two common voles. 
Received from the Collection of Cell Lines in 
Veterinary Medicine (CCLV) of the Friedrich-







Derived from the lungs of a single animal. 
Received from the Collection of Cell Lines in 
Veterinary Medicine (CCLV) of the Friedrich-
Loeffler-Institut. 
 
4.6.3 Toxoplasma gondii strains 
Tab. 12. Toxoplasma gondii strains 
All parasite strains were cultered in DMEM cell culture medium added with 1 % FCS and p/s and frozen 
in freezing media with 90 % FCS and 10 % DMSO (v/v).  
Toxoplasma gondii strain	 Genotype and source 
RhßGFPmt Express a green fluorescence protein in the mitochondria and the β-
galactosidase enzyme. 
Pru tdTomato From Jonathan Howard, Instituto Gulbenkian de Ciência, Oeiras, P. 
36	
	
PruΔku80Δhxgprt LDH2 promoter-driven GFP. Pru-Δhxgprt-GFP was initially 
established (126) and ku80 subsequently deleted (127). From Martin 
Blume (Robert Koch-Institut). 
 
4.7 Softwares and databanks 
4.7.1 Softwares 
Tab. 13. Softwares 
Softwares	 Manufacturer 
AxioVision Rel. 4.8. 	 Carl Zeiss Microscopy GmbH, Göttingen, D 
Geneious® 11.1.5	 Biomatters Ltd., Auckland, New Zealand 
GraphPad Prism 7.4	 GraphPad Software Inc., La Jolla, CA, USA 
i-control 1.10 	 Tecan Group Ltd., Männedorf, Switzerland 
ImageJ 1.51g 	 Wayne Rasband, National Institutes of Health, USA; used Macros: 
Count_Plaques_Toolbox_7 (written by Prof. Seeber) 
PS Remote	 Breeze Systems, Camberley, Surrey, UK 
ZEN 2012 (blue and black)	 Carl Zeiss Microscopy GmbH, Göttingen, D 
CytExpert 2.1	 Beckman Coulter Inc., Brea, CA, USA 
7500 Software v2.3	 Applied Biosystems Inc., Foster City, CA, USA 
 
4.7.2 Databanks 
Tab. 14. Databanks 
Databanks	 Manufacturer 
Basic Local Alignment Search Tool 	
(BLAST) (128)	
http://blast.ncbi.nlm.nih.gov/Blast.cgi 
E. coli genotypes	 http://openwetware.org/wiki/E._coli_genotypes 
National Center for Biotechnology 	
Information (NCBI)	
Literature research 




5.1 Molecular Biology 
5.1.1 Nucleic acid extraction from mammalian cells and wild rodent tissue samples 
5.1.1.1 Wild rodent samples collection and genomic DNA isolation 
Wild rodent samples from Germany were collected and kindly provided to us from Dr. Rainer Ulrich 
(Friedrich-Loeffler Institute, Insel Riems, Greifswald, D). Rodents were killed shortly after caught and 
the entire small intestine was cut from each rodent. Tissues were preserved in 15 mL falcon tubes filled 
with PBS, and stored at -70°C. 
Two DNA extraction kits and several protocols for genomic DNA (gDNA) extraction were evaluated: 
the NucleoSpin® Tissue DNA extraction Kit and the NucleoSpin® Soil DNA extraction Kit. Each sample 
was thawed at RT, 25 mg tissue cut out with a sterile disposable scalpel and weighted, washed 
extensively with sterile PBS buffer, then gDNA isolation was performed according to manufacturer 
conditions with a pre-lysis step of 2 h at 56°C. gDNA was eluted in 30 µl sterile ddH20 and stored at -
20°C until use. gDNA amount was assessed at the Quantus™Fluorometer with the QuantiFluor® dsDNA 
Dye System according to manufacturer instruction and its quality in terms of 260/280 and 260/230 ratios 
with the NanoQuant Plate™ at the Tecan reader. A sample was considered of good quality when the 
260/280 ratio was around 1.8 and the 260/230 ratio 2.0-2.2. 
Murine tandem Irg sequences as reference were kindly provided by Jingtao Lilue (Wellcome Sanger 
Institute, Cambridge, UK). 
5.1.1.2 Nucleic acid extraction from mammalian cells 
gDNA 
Cell pellets were resuspended in 200 µl PBS supplemented with 200 µg/ml Proteinase K and gDNA was 
extracted with the DNeasy Blood & Tissue Kit following the manufacturer’s instruction. Samples were 
eluted in 200 µl ddH2O, the gDNA amount assessed with the QuantiFluor® dsDNA Dye System and they 
were stored at -20°C until use.  
RNA 
Cell lines RNA for RT-qPCR was obtained with the RNeasy Plus Mini Kit from direct lysis in either 6 
or 24 well plates. The cell layer was washed once with cold PBS, then covered with 350 µl of RLT Plus 
buffer added with 2-mercaptoethanol and the plate left for gentle shaking on a rocking plate for 5 min, 
then extraction was performed as protocol. Samples were eluted in 30 µl ddH2O, the RNA amount was 





RNAseq samples preparation and assembly 
AAL-R, FMN-R and BVK168 cells were grown in two T75 culture flasks each and, when at 70-80 % 
confluency, treated with murine IFN-γ (200 U/ml) and recMgIFN-γ (200 ng/ml) respectively or left 
untreated as control. 24 h after treatment cells were detached from the flask with either trypsin (AAL-
R) or Accutase (FMN-R and BVK168). Whole cell RNA was extracted with the RNeasy Plus Mini Kit. 
Each cell pellet was resuspended in 350 µl of RLT Plus buffer added with 2-mercaptoethanol as 
manufacturer’s instruction and first homogenized with a pestel cleaned in a solution of 3 % H2O2 in 
ddH2O, then passed through a QIAshredder spin column to increase the RNA yield. After, the flow 
through was passed through a gDNA removal column provided by the kit and the rest of the protocol 
was followed as instructions. RNA samples were eluted with 52 µl of RNAse-free water provided with 
the kit in individually packed RNAse and DNAse -free vessels and immediately stored at -80°C. A first 
assessment of RNA quantity and quality at the NanoDrop® ND-1000 spectrophotometer confirmed a 
yield of 50-100 µg per sample and optimal 260/280 and 260/230 ratios. Furthermore, quality was 
assessed by electrophoresis (Bioanalyzer with the Agilent RNA Pico Kit) to confirm integrity of extracted 
RNA. All samples presented the maximum Rna Integrity (RIN) value of 10 and clearly visible bands of 
5.8S, 18S and 28S rRNA. Finally samples were shipped on dry ice to the Beijing Genomics Institute 
(BGI, Schenzen, China) for RNAseq. All surfaces prior RNA extraction and the Bioanalyzer before use 
were cleaned with the RNaseZap™ RNase Decontamination Solution.  
RNAseq was performed for the 6 samples using Illumina-HiSeq2500/4000. 42.5 million reads were 
obtained on average per sample (minimum: 38 million; maximum: 56.5 million). RNAseq analysis is 
currently being performed by Alice Balard (Heitlinger group, Humboldt-Universität zu Berlin, Berlin). 
Erroneous k-mers were detected prior to the assembly using rcorrector (129) and read pairs for which 
one of the reads was deemed unfixable removed 
(https://github.com/harvardinformatics/TranscriptomeAssemblyTools/blob/master/FilterUncorrectable
dPEfastq.py). Adapters and low quality bases were trimmed from fastq files using TrimGalore! 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore) with a minimum read length 
threshold set as 36 bp.  Transcriptomes were assembled de novo for each rodent species using Trinity 
version 2.6.6 (130). Quality of the assemblies was estimated using three methods. First, N50 (define as 
follow: at least half of all assembled bases are in transcript contigs of at least the N50 length value) was 
calculated was calculated for all samples. Then, bowtie2 version 2.3.0 (131) and samtools version 0.1.18 
(132) were used to align the trimmed reads back to their corresponding transcriptome. Finally, 
transcriptomes completeness was quantified using BUSCO (Benchmarking Universal Single-Copy 
Orthologs) version 3.0.2 (133) with the mamalia_odb9 database. In a total of 4104 BUSCOs, the number 
of "complete"/"fragmented"/"missing" genes for our three transcriptomes were 74.9% / 5.6% / 19.5% 
for AAL transcriptome, 75.2% / 5.3% / 19.5% for BVK transcriptome, and 74.0% / 4.8% / 21.2% for 
FMN transcriptome. Moreover, transcriptomes for FMN-R cells (Microtus arvalis) and BVK168 cells 
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(M. glareolus) are currently analyzed by guided assembly on the available Microtus ochrogaster 
genome (genome ID 10848). This part of the analysis is still ongoing. 
5.1.2 Reverse Transcriptase 
Reverse transcription of mRNA to cDNA for use in PCR or RT-qPCR was performed with the 
PrimeScript™ RT-PCR Kit according to manufacturer’s instruction. Up to 1 µg RNA was processed per 
reaction. A positive control provided with the kit and a negative control without template were included 
in each experiment. 
 PCR – Polymerase Chain Reaction 
The PCR technique to amplify target genes has been extensively used for different purposes all 
throughout the project. Depending on the application, different Taq polymerases, PCR approaches or 
programs have been used. These are described in more detail below. In order to determine possible 
contaminations of the components used, each experiment always carried a control in which no DNA 
was present. The verification of a successful PCR was carried out by means of a gel electrophoretic 
separation or sequencing.  
Analytical PCR 
The analytical PCR was used to check for the presence of certain DNA segments in a DNA template. 
This may be the detection of an insertion into a plasmid after cloning or else the integration of gene 
segments into a genome. By default, the DreamTaq™ polymerase was used using a 50 µl PCR mix 1x 
DreamTaq™ buffer (10x), 0.2 mM each dNTP, 1.25 U DreamTaq™ polymerase, circa100 ng DNA and 
0.2 µM of each oligonucleotide Fw and Rev contained in ddH2O. Unless otherwise described below, 
the following PCR program was used: 94°C 300 s; 35 × (94°C 30 s; Tm - 5°C 45 s; 72°C 90 s); 72°C 
300 s; 4°C, where Tm is the annealing temperature of the primers. 
When high sequence accuracy was crucial, e.g. for subsequent cloning of PCR fragments, the Q5® Hot 
Start High-Fidelity DNA polymerase with proofreading activity was used. 25 µl PCR mix were prepared 
with 1x Q5® buffer (5x), 0.2 mM each dNTP, 0.5 U Q5® polymerase, circa 100 ng DNA and 0.4 µM of 
each oligonucleotide Fw and Rev contained in ddH2O. The following PCR program was used: 98°C 30 
s; 35× (98°C 10 s; Tm - 5°C 15 s; 72°C 30 s); 72°C 120 s; 4°C, where Tm is the annealing temperature 
of the primers. 
For long amplicons (>8Kb) the PrimeSTAR® GXL DNA Polymerase was used. 50 µl PCR mix were 
prepared with 1x PrimeSTAR® GXL buffer (5x), 0.2 mM each dNTP, 1.25 U PrimeSTAR® GXL 
polymerase, circa 250 ng DNA and 0.2 µM of each oligonucleotide Fw and Rev contained in ddH2O. 
The following PCR program was used: 94°C 300 s; 35× (98°C 30 s; Tm - 5°C 30 s; 72°C 150 s); 72°C 






The identification of successfully cloned recombinant plasmid DNA from the E. coli strains was carried 
out by means of a colony PCR based on the use of intact cells as DNA template. For this purpose, 
bacterial cell material of a colony was transferred with a sterile 200 µl pipette tip into a PCR reaction 
vessel with 50 µl PCR reaction (see above "Analytical PCR") and suspended by pipetting up and down. 
Subsequently the same tip was used to smear the colony in a new LB agar plate with the required AB 
selection.  
 RT-qPCR – Reverse Transcriptase quantitative PCR 
The relative amount of mRNA abundance of Irgb2-b1 compared to the reference gene tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene (YWhaz) was performed via 
RT-qPCR. Cells were seeded into 24-well or 6-well plates and when at 70 % confluency treated for 24 
h with different dilutions of recMgIFN-γ, mouse IFN-γ, negative control recTgLEA protein or left 
untreated as control. Then medium was aspirated and cells were washed once with PBS, and total RNA 
was extracted and reverse transcribed to cDNA. PCR primers to amplify Irgb2-b1, B2-3’-Fw and B1-
5’-Rev, were designed on available Microtus ochrogaster and M. musculus sequences. PCR primers to 
amplify the reference gene Ywhaz, L-Ywhaz and R-Ywhaz, were based on the homologous M. agrestis 
sequence reported previously	(134). The amplicon extends over intron 4 with 1764 bp in M. ochrogaster, 
whereas the mRNA-derived product is 155 bp. These primers also bind to the respective M. musculus 
sequence. Real-Time PCR was performed with the Maxima SYBR Green/ROX qPCR Master Kit (2x) on 
an Applied Biosystem ABI 7500 Real-Time PCR system. All reactions were run in duplicate with a no-
template control to check for contaminations. Each tube contained 1 µl of cDNA template (equivalent 
to 5 ng), 12.5 µl SYBR Green mix solution, 0.75 µl primer (75 µM each) and 10 µl H2O for a total 
reaction volume of 25 µl. The PCR conditions were 2 min at 50°C, 10 min at 95°C and 40 cycles of 
each 95° for 15 s and 60°C for 1 min. Melting curve analysis was performed from 60° to 95°C at 1 % 
ramp rate with each step lasting 30 s to confirm presence of a single product and absence of primer 
dimers.  
 Agarose gel electrophoresis  
The products of PCR amplification were mixed with 1:10 Midori Green Direct DNA dye and applied 
to 1-3% agarose gel in 1x TAE buffer. The electrophoretic separation was then carried out after applying 
a voltage of 100 V in a horizontal gel chamber until desired separation of the bands of interest was 
reached. Separation of the DNA bands was visualized using a UV transilluminator. Midori Green Direct 
interacts with the DNA and can be detected by its absorption at ~500 nm as a green fluorescent nucleic 
acid dye. The size of the bands obtained was determined by comparison with the DNA size standard 
GeneRuler™ 1 kb Plus DNA Ladder. If, after identification of a desired DNA fragment, the band is 
isolated by excision for downstream applications, it is called a preparative agarose gel. In that case the 
agarose gel was visualized at 470 nm using a blue light LED illuminator to avoid UV-induced DNA 
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damage. To extract the DNA from the agarose gel, the Zymoclean™ Gel DNA Recovery Kit was used 
and then the concentration of DNA assessed at the Quantus™ Fluorometer. 
 Cloning 
There are a variety of methods available to generate plasmids. In addition to the classical cloning variant, 
the ligating of DNA fragments after restriction enzyme digestion, two further methods were used in this 
work: Seamless Ligation Cloning Extract (SLiCE) and Golden Gate cloning methods. SLiCE is based 
on cloning via homologous recombination and the second relies on type II restriction enzymes. They 
are described in more detail below. The plasmid maps of selected plasmids are reported in the thesis.  
Seamless Ligation Cloning Extract (SLiCE) cloning method  
SLiCE cloning methods allows cloning in a single step reaction without need ad additional ligation step. 
It relies on the amplification of a gene of interest (GOI) with primers encoding for recombinase sites in 
overhangs. The same recombinase sites are present in the recipient vector. When the vector, the 
recombinase and the amplified gene are incubated together, the gene gets easily inserted in the vector. 
A complete description of the method is reported here (135). Buffer and extract were prepared following 
published protocol, aliquoted and stored at -80°C until use. This cloning method was used thoroughly 
along the project for cloning of Irg-like genes from wild rodents into the pES51-bl vector, but also to 
create the pGAS-Luc-Bsd plasmid for the establishment of BVK-LucA reporter cell line. Before 
cloning, the vector was digested for linearization for 1 h at 37°C, followed by 20 min 65°C restriction 
enzyme inactivation step. Dephosphorylation was performed with the Antarctic Phosphatase following 
the manufacturer’s instructions. I used an insert:vector molar ratio of 6:1 for 1.2 Kb inserts (as single 
Irg exons and BsdR), 2:1 for 2.5 Kb long inserts (as tandem Irg) and 1:1 for longer inserts. Each tube 
contained the calculated amount of insert, 1.5 µl of vector (equivalent to 100 ng), 1 µl of SLiCE extract, 
1 µl SLiCE buffer for a total reaction volume of 10 µl. The vessel was incubated for 1 h at 37°C, then 
transformed in OmniMAX 2T1R bacteria. Omnimax cells allow positive selection via CcdB (136). 
Golden Gate assembly  
The Golden Gate Assembly method is based on Type IIS endonucleases which cut out of the recognized 
sequence and leave sticky overhangs (137). This renders the method particularly useful for cloning 
purposes. This cloning method was used to clone Irg-like genes from the plasmid pES51-bl to pFS-1. 
We use restriction with the SapI enzyme which recognizes the GCTCTTC1/4 site. This RE site was 
introduced at the extremities of Irg-like genes via during the cloning in pES51-bl. I used an insert:vector 
molar ratio of 1:1. Each tube contained the calculated amount of insert cloned into pES51-bl vector, 
0.38 µl of uncut pFS-1vector (equivalent to 89 ng), 1.5 µl Cutsmart buffer, 1 µl SapI enzyme, 0.75 µl 
ATP 20 mM, 1 µl T4 Ligase HC for a total reaction volume of 15 µl. The vessel was incubated for 1 h 
at 37°C, then transformed in OmniMAX 2T1R bacteria and selected via CcdB as previously explained. 
I observed that incubation at 25 °C, suboptimal temperature for digestion, allowed me to obtain more 
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full-length tandem Irg-like genes. As explained in section 6.1.5.4, these genes contained SapI RE sites 
and a suboptimal digestion increased the chances to clone the full sequence.  
 Sequencing 
Generated plasmid DNA or PCR products were checked for correctness by sequencing. First a 
purification step using either the DNA Clean & Concentrator™ kit or a 2:1 mix of Exonuclease I and 
Shrimp Alkaline Phosphatase (SAP) used according to manufacturer’s instruction was performed. 
Sequencing with the BigDye™ Terminator 3.1 Cycle Sequencing Kit was used, which is based on the 
Sanger method. After carrying out a PCR reaction of the DNA to be sequenced with in each case one 
oligonucleotide, the sequencing was carried out in the in-house facility. A 10 µl sequencing reaction 
contained 1x ABI buffer (5x), 1 µl BigDye 3.1, DNA and 0.5 mM of the oligonucleotide in ddH2O. The 
DNA amount varied according to the template length following the facility’s guidelines, i.e. 10-20 ng 
for 500-1000 bp long PCR products, 150-300 ng for plasmids. The following PCR program was used: 
96°C 120 s; 25× (96°C 10 s; Tm -5°C 240 s); 4°C, where Tm is the annealing temperature of the primers. 
The oligonucleotides used for sequencing the respective plasmids are listed in Tab. 8. The sequencing 
results were evaluated using the program Geneious® 11.1.5.
5.2 Microbiology 
 Culturing and freezing E. coli strains 
The cultivation of the different E. coli strains was mostly carried out at 37°C (exceptions are reported 
in Tab. 10) and 250 rpm in LB medium (liquid culture) or on LB agar plates with addition of the 
corresponding antibiotics in the reported concentrations (see Tab. 5). For the permanent storage of the 
strains, 900 µl of an o/n liquid culture were mixed with 100 µl Hogness freezing medium and stored at 
-80°C. 
 Production of chemocompetent cells and heat shock transformation 
For the amplification of generated plasmids or for the reintroduction of already existing plasmid DNA 
in bacteria, a transformation was carried out. For bacteria to be able to take up external (plasmid) DNA, 
they must be brought into a state of competence, which can be obtained by different means. All 
throughout this project chemically competent E. coli strains were created and heat shock transformation 
performed, allowing the DNA to pass through the heat shock created membrane pores and thus enter the 
cell. 
According to the protocol of Inoue et al. (138), a colony of either OmniMAX2T1 or DB3.1 E. coli strain 
was transferred to a 25 ml SOB or LB liquid culture with appropriate antibiotic and incubated at 37°C 
and 250 rpm for 6-8 h in a shaking incubator. Three 1 L flasks filled with 250 ml each of LB medium 
(+ AB) were inoculated with 2, 4 or 10 ml of this culture. The subsequent o/n incubation at 18°C, also 
in a shaking incubator, ended after one of the three cultures assayed reached an OD 600 of 0.55. The 
respective culture was chilled on ice for 10 min before centrifuging the cells at 4°C for 10 min at 2500 
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g. The supernatant was discarded and the cells gently resuspended in 40 ml of ice-cold Inoue 
transformation buffer, which was then centrifuged as before. The buffer was removed and the resulting 
pellet was resuspended again in 10 ml of ice-cold Inoue transformation buffer, mixed with 750 µl of 
DMSO and, after mixing, incubated again on ice for 10 min. The suspension was rapidly pipetted in 100 
µl aliquots into 2 ml reaction tubes and, after sealing, placed in liquid nitrogen. The prepared competent 
cells were directly stored at -70°C.  
For the transformation an aliquot was thawed on ice, added with 10-50 ng of plasmid DNA or with the 
cloning reaction and cooled for 30 min on ice. Subsequently the heat shock of the mixture took place 
for 30 s at 42°C in a water bath. Cells were immediately cooled on ice then regenerated without selection 
by adding 500 µl SOC medium for 60 min in a rotary shaker at 37°C 250 rpm. For the selection of 
recombinant clones, each mixture was plated on LB agar plates (+ AB) and incubated at 37°C o/n. To 
identify the recombinant bacterial colonies after transformation, a colony PCR was performed. After 
transformation of plasmid DNA, the bacterial strain was frozen or the plasmid DNA was recovered. As 
a control, an aliquot of competent cells was always transformed with the same protocol without DNA 
to test the effect of the antibiotic solutions used. After the preparation of competent cells, the 
transformation efficiency was always determined. For this, 5 ng of pUC19 plasmid DNA were 
transformed, 1:10 dilutions of the transformed cell suspension were plated and the colonies counted in 
a suitable dilution. The transformation efficiency was determined according to the following formula: 
𝑇𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑎𝑛𝑡𝑠	𝑝𝑒𝑟	µ𝑔𝐷𝑁𝐴 =
𝑐𝑜𝑙𝑜𝑛𝑖𝑒𝑠 × 𝑡𝑜𝑡𝑎𝑙𝑉(µ𝑙)
𝑝𝑙𝑎𝑡𝑒𝑑𝑉(µ𝑙) × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛𝑓𝑎𝑐𝑡𝑜𝑟 × µ𝑔𝐷𝑁𝐴	
5.3 Cell culture  
5.3.1 Cultivation of eukaryotic host cell lines 
Adherently growing cells were cultured in DMEM (1 % or 10 % FCS) under 5 % CO2 at 37°C and 
subcultured when confluency was reached. For this purpose, the medium contained in the cell culture 
flasks (T75) was aspirated with a plastic straw and cells were washed twice with 10 ml of PBS. Cells 
were detached either by adding 1 ml of trypsin / EDTA solution (1x) or 500 µl Accutase detaching 
solution, followed by a ~5 min incubation at 37°C. After 10 ml of DMEM were added to the bottle, the 
cell suspension transferred to a 15 ml centrifuge tube and either transferred immediately in a new flask 
in case of Accutase or centrifuged for 4 min at 300 g for trypsin / EDTA. After discarding the 
supernatant, the cell pellet was resuspended with 5-10 ml DMEM (10 % FCS) by gently pipetting up 
and down. Depending on the desired application, the cell suspension was diluted in DMEM (10 % FCS) 
and distributed in T25 / 75 cell culture flasks or 6 / 12 / 24 / 48 / 96 -well plates. If a 24-well plate should 
be prepared for an Immunofluorescence assay (IFA), the plate wells were prepared with Ø 10 or 12 mm 
coverslips before adding the cell suspension. For all cell lines reported in Tab. 11 DMEM cell culture 




5.3.2 Establishment of Mus musculus and M. glareolus primary cell cultures 
Bone Marrow Derived Macrophages (BMDM) and primary fibroblast cultures were derived from both 
M. musculus inbred laboratory mice and from a colony of outbred M. glareolus, the latter property of 
Prof. Dr. Umberto Agrimi (Istituto Superiore di Sanità, Rome, I) and kept at the in-house animal facility 
of the institute under the supervision of Dr. Michael Beekes. Mice were anesthetized in a chamber 
containing isoflurane and sacrificed by cervical dislocation. Rear legs, ears, tail, brain, blood and 
intestine collected for different purposes. 
Monocytes were extracted from both femors according to established protocols in the lab. The M. 
musculus inbred strain C57BL/6 was used for BMDM extraction. The general monocytes yield was 
around 3*106 per M. glareolus, at least 10 fold less compared to C57BL/6 monocytes, which might be 
due to the smaller dimension of vole bones compared to mice ones. Monocytes were put in Petri dishes 
and differentiated into BMDM for 5-7 d according to the established protocols (139, 140) with complete 
DMEM added with 15 % L929 conditioned media (containing the murine macrophage colony 
stimulating factor (mM-CSF), (141)) and additionally 20 ng/ml recombinant human M-CSF for M. 
glareolus cells, then frozen in 90 % FCS / 10 % DMSO until use. After thawing, complete DMEM with 
both growth factors was used for vole BMDMs and replaced with 1.5 % mM-CSF only during 
experiments, whereas murine BMDMs suffice the latter. 
Primary fibroblasts were obtained from either ears or tail of the animals and processed following the 
protocol of Khan et al. (142). For this purpose the M. musculus inbred strain B6.Cg-Tg(Vil1-
cre)997Gum/J (stock 008546, The Jackson Laboratory, Bar Harbor, ME, USA) was used. The optimal 
medium condition resulted DMEM added with 10 % FCS and P/S, and incubation at 3 % O2 in the 
hypoxia chamber conferred a slight growth advantage over normal 5 % O2 other than the resulting higher 
number of passages in cultures already reported in literature (143). Further freezing in freezing medium 
composed of 90 % FCS / 10 % DMSO granted higher viability than 90 % complete DMEM / 10 % 
DMSO. 
5.3.3 Antiviral activity assay 
The viral infection with VSV*ΔG(FLuc) and MHV68 whatever viruses were performed by Georg 
Kochs (University of Freiburg, Germany). M. glareolus BVK168 cells were seeded into 24-well plates 
and 6 h later treated with either recMgIFN-γ (1:200 and 1:1,000 dilutions, equivalent to 1 ng/ml and 0.2 
ng/ml, respectively), with the control protein LEA (in concentration analogous to recMgIFN-γ) or left 
untreated for 16 h before infection. In addition, recombinant human IFN-αB/D known to be active on 
M. glareolus cell line was used as positive control (5 ng/ml) (144). Next, the medium was aspirated and 
cells were inoculated with 0.5 MOI of VSV*ΔG(FLuc), a VSV glycoprotein-pseudotyped, propagation-
incompetent VSV replicon, expressing firefly luciferase (145). At 24 h post inoculation cells were lysed 
in 80 µl passive lysis buffer per well and luciferase activity determined in duplicates in a luminometer 
via the Dual-Luciferase Reporter Assay System.  
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5.3.4 Mammalian cells transfection 
Transient transfection 
Both reagent-based and physical transfection methods were used on different mammalian cell lines. All 
reagents listed in Table 15 were tested according to manufacturer’s instruction and conditions optimized 
for each experiment. 
Tab. 15. Tested transfection reagents 
Reagent	 Method Manufacturer Reference 
25 KDa linear 
Polyethylenimine 
(PEI)	
Cationic polymer-based Polysciences Inc., 




Magnetofection™ Chemicell GmbH, Berlin 
(D) 
 
TransIT-X2®,   
TransIT-LT1® and 
TransIT-2020® 
Polymer-based Mirus Bio LLC, 
Wisconsin (USA) 
 
jetPRIME® Polymer-based Polyplus transfection®, 
Illkirch (France) 
(148)  
Lipofectamine™ 3000  Lipid-based ThermoFisher Scientific  
 
Other than these reagents, also the physical transfection method electroporation was tested for Flp-In-
3T3 cells. For this purpose, the Amaxa® Cell Line Nucleofector Kit R specifically suggested for NIH/3T3 
cells was used. 106 cells and 5 µg of plasmid (corresponding to 0.78 pmol) were mixed in the supplied 
cuvettes in serum-free Opti-MEM™ medium, electroporated with the U-030 program in the Amaxa®	
Nucleofector®	 II	Device, then plated after 10 min recovery time in 4 wells of a 24 well plate with 
complete DMEM. Not electroporated cells as well as electroporated cells without plasmid DNA served 
as controls.  
Transfection efficiency was tested by means of transient transfection with the pmaxGFP® vector and 
with pFS-CIM both expressing green fluorescent proteins. 24 h post transfection all cells nuclei were 
stained for 20 min in the dark at RT with 1:500 Hoechst 33342 and 1:500 Propidium Iodide to stain dead 
cells, then cells were immediately analyzed at the fluorescent microscope. The transfection efficiency 
was estimated by the proportion of green cells on the total living cells and expressed as percentage. The 
transfection methods that resulted successful for pmaxGFP® transfection in Flp-In-3T3 cells were also 
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used for transfected with pFS-CIM and cells were tested for expression of HA-tagged IRGb2-b1 via 
immunofluorescence assay. 
Stable transfection 
Since Lipofectamine™ 3000 was the only successful reagent for transient transfection of pFS-CIM, stable 
transfection was attempted only with this reagent. Protocol was optimized on manufacturer’s instruction 
as follow. Flp-In-3T3 cells were seeded in a 24-well plate and when at 70 % confluency transfected with 
pFS-derived and pOG44 plasmids in a molar ratio 1:5. pFS-derived plasmid concentration was always 
1 µg/ml (corresponding to around 0.16 pmol), 1.5 µl/well Lipofectamine™ 3000 was used and all 
reagents were diluted in transfection-optimized Opti-MEM™ medium. At least four wells of cells were 
transfected per condition and each experiment included a positive control with pmaxGFP® for successful 
transfection and a negative control without DNA. The following day cells were analyzed at the Observer 
fluorescence microscope for successfully transfected cells expressing a green fluorescent protein, then 
left growing further in the incubator. Two days after transfection medium was exchanged with fresh one 
supplemented with 200 µg/ml Hygromycin B to select for positive clones, and exchanged every three 
days (+AB) to remove dead cells and debris. Cells were expanded for two weeks under constant AB 
selection. 
5.3.5 Maintenance of T. gondii tachyzoites 
T. gondii tachyzoites were cultured with HFF cells (Human Foreskin Fibroblasts, BJ-5ta ATCC® CRL-
4001™) as host cells in DMEM (1 % FCS) under 5 % CO2 and at 37°C. Every second to third day ~ 0.5 
ml of a freshly lysed tachyzoite suspension was transferred to a T25 cell culture flask with confluent 
HFF cells with a Pasteur pipette. In order to determine the T. gondii cell number, infected HFF cells just 
prior lysis were used. Cells were scraped off T25 or T75 cell culture flask, passed through a 25 G needle 
mounted on a syringe two to three times for lysis, then transferred into a 15 or 50 ml centrifuge tube and 
centrifuged at 100 g for 5 min. The supernatant was then transferred to a new centrifuge tube and again 
centrifuged at 300 g for 10 min. The supernatant was aspirated with a plastic pipette and the pellet 
resuspended in 500 µl DMEM (1 % FCS) and transferred in a 1.5 ml vessel. A serial 1:10 dilution in 
DMEM (1 % FCS) was prepared and parasites from a 102 or 103 dilution were counted using the C-chip 
counting chamber according to the manufacturer's instructions. For infection experiments appropriate 
amount of parasites were diluted in cell culture complete medium and applied of the cell monolayer, 
then 2 hpi medium was changed to remove parasites that did not invade host cells.  
5.3.6 Immunofluorescence Assay 
For immunofluorescence assays (IFA) 24-well plates were always prepared with coverslips (Ø 10 or 12 
mm) and seeded with eukaryotic cells with or without T. gondii infection according to protocol. After 
the desired period, the medium was aspirated and the cell layer washed with 1 ml of PBS or TBS buffer 
(according to the Ab protocol) before the cells were fixed by adding 200 µl of 4 % PFA solution in PBS 
or TBS for 20 min at RT. After washing again with 1 ml of PBS, the cells were incubated with 200 µl 
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of permeabilization buffer for 20 min at RT before adding 200 µl of 3 % BSA solution in PBS or TBS 
to the wells for 1 h at RT or o/n at 4°C. Then, using a curved cannula and forceps, coverslips were 
transferred upside down on parafilm on 50 µl of the appropriate first antibody dilution in 3 % BSA 
solution in PBS or TBS and incubated for 1 h at RT. Coverslips were then transferred back to the plate 
for three washing steps with 1 ml PBS or TBS 10 min each. Staining with the secondary antibody 
dilution in 3% BSA solution in PBS or TBS was performed similarly to the primary antibody for 1 h at 
RT in the dark. Again, coverslips were transferred back to the plate and 200 µl of a 1 ng/µl DAPI solution 
in PBS or TBS were pipetted into the wells for DNA staining and incubated at RT for 10 min. After 
three washing steps with 1 ml PBS or TBS 10 min each, coverslips were placed on slides on 7 µl 
Fluoromount™ and lightly pressed. After hardening, images were taken on the Zeiss Axio Imager Z1 / 
Apotome or at the confocal microscope Zeiss LSM780. Image editing was performed with the programs 
AxioVision Rel. 4.8. and ImageJ 1.51g. The antibodies used and the dilutions used can be found in Tab. 
6. 
For T. gondii intracellular parasite growth, parasites were stained with an-anti-SAG1 antibody and a 
minimum of 100 vacuoles per condition were counted. 
5.3.7 Detection of IFN-γ-mediated cell death  
Cytotoxicity assay  
Necrosis is accompanied by lactate dehydrogenase (LDH) release whose detection is part of the 
cytotoxicity (or LDH) assay and is a proxy for necrotic cell death. NIH/3T3 and BVK168 cells were 
seeded in a 24-well plate, treated with the murine IFN-γ (200 U/ml) and recMgIFN-γ (200 ng/ml) 
respectively or left untreated as control. The day after cells were infected with a MOI 2 of syringe-lysed 
Pru tdTomato or RHβGFPmt parasites or left uninfected as control and DMEM medium for LDH assay 
was used to reduce interference with the measurement. 24 hpi the plate was gently spin down at 1,500 
rpm for 5 min, 100 µl of supernatant transferred in a 96-well plate and the LDH amount quantified with 
either a commercial Cytotoxicity Detection Kit or homemade reagents according to the protocol of Ka-
Ming et al.	(149). A control well of medium only was inclueded to measure the background signal which 
was subtracted to all values. The assay sensitivity was assessed via titration of fully lysed cells with 1 
% TX-100 treatment for 45 min as suggested by the Pierce LDH Cytotoxicity Assay Kit manual (Thermo 
Scientific). Samples were incubated 30 min RT in the dark, then absorbance at 490 nm with reference 
at 680 nm was measured at the Tecan reader. Each condition was done in triplicate per experiment. 
Values were normalized to the signal from fully lysed cells.  
Sensitivity was assessed via titration of TX-100-killed cells, leading to a detectable signal with 5 % of 
cell death in both set-up (Fig 5). This result indicates that homemade reagents represent a cheap and 
equally sensitive alternative to the more expensive kit. Considering that the expected impact of murine 
cell death 24 hpi with avirulent T. gondii is around 25 %	(7), we concluded that the assay was suitable 




Fig. 5. Homemade and commercial LDH-detection protocols are comparable. NIH/3T3 and 
BVK168 cells were used to test the sensitivity of LDH detection comparing the protocol of Ka-Ming et 
al.	(149) and the Pierce LDH Cytotoxicity Assay Kit. Cells were fully lysed with TX-100 and lysates 
were titrated to assess the sensitivity of the two protocols.  
Propidium Iodide assay 
Cells were either seeded in a 24-well plate or when available in a limited amount, i.e. M. glareolus 
primary fibroblasts and BMDM, in 96-well plate. After one day adaptation in culture, cells were treated 
with the respective murine IFN-γ (200 U/ml) –for Flp-In-3T3 and derived cell lines–, recMgIFN-γ (200 
ng/ml) –for M. glareolus cell cultures– or left untreated as control. 24 h post treatment cells were 
infected with a MOI 2 of syringe lysed PruΔku80Δhxgprt or RHβGFPmt parasites filtered throught a 3 
mm millipore filter to remove debris similarly to Niedelmann et al (150), or left uninfected. Medium 
was replaced with fresh one 2 h later to remove not invasive parasites. The proportion of dying cells 24 
hpi was determined via a double staining with both a nuclear impermeable dye, Propidium Iodide (PI, 
final concentration 2 ng/ml), and a permeable one, Hoechst 33342 1:500 for 20 min RT in the dark. 
Images of around 500 cells per condition were taken at the Observer fluorescence microscope and the 
ratio PI+/Hoechst 33342+ assessed as proxy for cell death. 
Cytometry-based assay 
1x106 M. glareolus BMDMs were seeded in 6-well plates and the day after treated with recMgIFN-γ 
(200 ng/ml) or left untreated as control. The following day cells were infected with a MOI 3 of syringe-
lysed Pru tdTomato or RHβGFPmt parasites or left uninfected. Medium was replaced with fresh one 2 
h later to remove not invasive parasites. 24 hpi the supernatant was transferred in a deep well 96-well 
plate and the cell layer washed with potassium (K+)-rich IC buffer (see Tab. 4) to avoid parasite 
premature egress due to osmotic stress (151). Cells were gently detached from the plate with 200 µl 
Accutase for 5 min 37°C and transferred in 96-well deep plates with the corresponding supernatant. 
Cells were spinned down at 500 g for 5 min and resuspended in 500 µl PBS added with 1 µl/well Violet 
LIVE/DEAD fixable dye (ThermoFisher Scientific GmbH, Schwerte, D) reconstituted on the moment 
and incubated for 30 min RT in the dark. Cells were spinned down at 500 g for 5 min and washed twice 
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with 1 ml IC buffer, then fixed with 1 % PFA in IC buffer for 20 min RT. Cells were washed once and 
immediatly analyzed at the flow cytometer. A positive control of cells killed at 65°C for 5 min was 
always included, as well as a not stained well to remove background signal. 20,000 BMDMs were 
acquired, with gating performed on physical parameters.  
5.4 Biochemistry 
 SDS-PAGE and immunoblotting 
Cells were directly lysed in the plate for 30 min on ice with the lysis solution added with both proteases 
and phosphatases inhibitors. After centrifugation at the maximum speed for 5 min, soluble proteins were 
separated from the precipitate and collected in low binding vessels, and lysates quantified with the 
Pierce™ 660nm Protein Assay Reagent. Equal amount of protein samples were first added with loading 
Laemmli 5x solution added with inhibitors, then separated by standard SDS-PAGE and transferred to 
nitrocellulose by semidry blotting. A control for equal protein loading via the reversible Direct Blue 71 
(DB71) staining according to the protocol of Hong et al. (152) was performed. After, non-specific 
binding sites were blocked for 1 hour with either 5 % dry milk or 3 % BSA in 0.1 % Tween-20 PBS 
solution. Membranes were incubated o/n at 4°C with the first antibody dilution in the blocking solution. 
After three washing steps with 0.1 % Tween-20 PBS solution, the membrane was incubated with 
horseradish peroxidase (HRP)-conjugated secondary antibody dilution in the blocking solution. Finally, 
after two washing steps with 0.1 % Tween-20 PBS solution and a single washing step with PBS, 
enhanced chemiluminescence reagent substrate of peroxidase was added and the signal detected using 
a luminescent image analyzer. The antibodies and dilutions used can be found in Tab. 6. 
 Luciferase assay 
The BVK-LucA cell line was established as bank vole reporter for IFN-γ activity. For this purpose, 
BVK168 M. glareolus cells were transfected with PEI-transfection method (section 5.3.4 for details) 
with the plasmid pGAS-Luc-Bsd. The plasmid encodes for a firefly luciferase enzyme under the control 
of a promoter with GAS sites for STAT1 binding. The antibiotic Blasticidin was chosen for selection of 
transfected cells, thus the Blasticidin resistance gene (BsdR) encoding for Blasticidin-S deaminase was 
cloned from pcDNA6/TR into the final vector pGAS-Luc via SLiCE cloning. Transfected cells were 
selected with Blasticidin for two weeks before use. 
For the luciferase assay BVK-LucA cells were seeded into a 48-well plate. After 24 h either serial 
dilutions of recMgIFN-γ or mouse IFN-γ and LEA or DMEM as controls were added and incubation 
was continued for 330 min or 18 h at 37°C as described previously REF. For infection experiment (Fig. 
29) cells were infected with MOI 10 of RhßGFPmt or Pru tdTomato 3 h prior IFN-γ-treatment, or left 
untreated as control. The supernatant was removed, cells were washed once with PBS and 65 µl of lysis 
reagent was added to each well. The lysates were assayed using the Dual-Luciferase Reporter Assay 
System. 20 µl of the cell lysate was mixed with 100 µl of reconstituted luciferase assay reagent in a 96-
well plate and the emitted light was measured in a Tristar LB 941 luminometer (Berthold). 
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For experiments in Fig. 29, a cost-effective and equally sensitive homemade luciferase assay reagent 
solution was used (already used in published work	(153)). According to this protocol the luciferase assay 
reagent stock solution (Tab. 4) was added just before use with 33.3 mM DTT, 270 µM Coenzym A, 470 
µM Luciferin and 530 µM ATP. The bioluminescence signal was detected as previously described.  
5.5 Statystical analysis 
Statistical analyses were performed using Prism 7 (GraphPad). Data were tested for normal distribution 




6.1 Irgb2-b1-like sequence diversity in wild rodents in Germany  
In the first part of this project I explored Irgb2-b1-like genes’ diversity in M. glareolus, Microtus spp. 
and Apodemus spp. across Germany. To this end I developed a cell culture-based system to study host 
cell phenotypes during T. gondii infection. The source of genomic DNA (gDNA) were intestinal tissue 
samples from wild rodents. Additionally, I had fortuitous access to different and rare wild rodents-
derived immortalized cell lines established from rodents collected in Germany. In particular, I had two 
vole kidney cell lines, the M. glareolus BVK168 cell line (125) and the M. arvalis FMN-R cell line, as 
well as the striped field mouse A. agrarius lung AAL-R cell line. In addition, I used the commercially 
available NIH/3T3 embryonic fibroblasts cell line and, for stable cloning of Irg genes, the derived Flp-
In-3T3 cell line, both derived from laboratory inbred M. musculus. All the mentioned cell lines are 
described in detail in Table 16. 
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Derived from NIH/3T3 cell 
line. FRT recombinase site for 
site-specific gene insertion. 
More details in chapter 6.1.5. 
From Invitrogen™ Corporation. 
BVK168 Myodes glareolus 
(bank vole) 
Kidney epithelial  
cell line 
Derived from the kidney of a 
single animal. Description of 
BVK168 cell line 
establishment here (125). From 
Sandra Eßbauer, Institute of 







Kidney epithelial  
cell line 
Derived from the kidneys of 
two common voles. Received 
from the Collection of Cell 
Lines in Veterinary Medicine 
(CCLV) of the Friedrich-








Lung epithelial  
cell line 
Derived from the lungs of a 
single animal. From the 
Collection of Cell Lines in 
Veterinary Medicine (CCLV - 
FLI)  
 
6.1.1 Establishing the M. ochrogaster reference for Irg-like genes  
One of the factors hampering research on non-model organisms is the lack of reliable genomic 
references (57). Despite continuous progresses, not much genomic and transcriptomic data are currently 
available and when available, they are not complete or badly annotated (58). If the situation is already 
complex for conserved genes, Irg genes which are among the most divergent ones in the mouse genome 
(154), pose further challenges. With the exception of Irgc on chromosome 7, Irg loci cover 3 240 Mb 
and 40 Mb long regions characterized by highly repetitive sequences that went through many duplication 
events and divergence cycles on murine chromosomes 11 and 18 (91). Characterization of this gene 
family was not trivial and, after a first pivotal work in 2005, its description is still ongoing (7, 91, 154). 
To approach the complexity of Irg genes, we first analyzed the best available vole transcriptome, which 
is of M. ochrogaster (genome ID 10848), to identify the putative Irg loci and sequences and to design 
suitable primers for wild rodents’ Irg-like genes amplification. When performing a Basic Local 
Alignment Search Tool (BLAST) of the M. musculus C57BL/6J (herein named BL6) Irgb2-b1 sequence 
(Irgb2-b1BL6, genome ID 52) against M. ochrogaster genome, we identified two Irg-like tandem genes 
(indicated by red arrow-heads in Fig. 6). The two tandems – named tandem 1 Irg (LOC101989451) and 
tandem 2 Irg (LOC101990019) – belong to two distinct loci and share higher similarity with the Irgb5-
b3 murine gene than with Irgb2-b1. The Mus spp Irgb2-b1 tandems are encoded on chromosome 11. In 
M. ochrogaster, the Irgb2-b1-like tandems are encoded on chromosome 7. The conserved disposition 
of Irg-like genes in neighbouring loci and the presence of >6 kb long introns between single exons of 
the tandem make us confident in considering them putative Irgb2-b1 genes (Fig. 6). Furthermore, the 
cDNA sequence, reported in full length in Fig. 9, has conserved residues typical of tandem Irg genes 
and important to develop their functions. The overall putative disposition of Irg-like genes in the M. 
ochrogaster genome on chromosomes 7 and 18 resembles the one on Mus spp.. Important genes 
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involved in resistance to T. gondii, like Irga6 and Irgb6, are also found similarly in this vole genome 
and transcriptome, as well as Irg genes with regulatory functions such as Irgm. BLAST of BL6 Irg genes 
against M. ochrogaster genome identified in total 21 putative Irg-like genes. 
 
Fig. 6. Irg genes are conserved in clusters in both M. ochrogaster and Mus spp. genomes. (a) 
Schematic representation of putative Irg-like genes disposition on chromosomes 7 and 18 of M. 
ochrogaster (genome ID 10848). Red harrow-heads indicate the Irg-like tandem genes. (b) Disposition 
of Irg on chromosomes 11 and 18 of laboratory BL6 mouse genome. Figure from Lilue et al. (7). 
Degenerated primers to amplify tandem Irg-like genes from wild rodents-derived samples were 
designed based on the consensus alignment between Irgb2-b1BL6 and the identified vole tandems as 
shown in Fig. 7. The Irgb2 Fw primer (“Irgb2 Fw”) starts with the start codon encoding for methionine, 
whereas the Irgb1 Rev primer (“Irgb1 Rev”) ends three amino acid (aa) upstream for reasons explained 
further in chapter 6.1.5.1. The big divergence around the splicing site in the middle of the sequence 
limited our possibilities for primer design. Thus, between the Irgb2 Rev primer (“Irgb2 Rev”) and the 
Irgb1 Fw (“Irgb1 Fw”) primer there are 117 bp which are not amplified by PCR of the single exons. 
The sequences are depicted in full length in Fig. 9 and primer sequences are reported in Tab. 8. 
 
Fig. 7. Degenerated primers for Irg-like genes amplification were designed based on Mus musculus 
and M. ochrogaster sequences. The alignment between M. musculus BL6 Irgb2-b1 and M. ochrogaster 
putative Irg tandem genes (genome ID 10848) was used to design primers. Red boxes highlight 
alignment and relative consensus used to design degenerated primers, with primer names reported above 
the boxes. Conserved residues are represented by dots and divergent ones are highlighted. The black 
arrow-head indicates the splicing site between Irgb2 and Irgb1. Positions of the nucleotides relative to 




6.1.2 Irg-like sequences from wild rodents-derived cell lines 
Even though the best quality vole genome available is from M. ochrogaster, it is an American and not 
a European rodent species. Availability of the cell lines from Germany and of the recombinant vole IFN-
γ (recMgIFN-γ, results in chapter 6.2 and Tab. 16 above), allowed us to obtain IFN-γ-induced tandem 
Irgb2-b1-like genes from German specimens of the considered M. glareolus, Microtus spp. and 
Apodemus spp.. The identified sequences can be used as better reference for tissue-derived sequences 
than Mus spp. and M. ochrogaster. 
First, I amplified the whole genomic locus by PCR in all cell lines. Since both murine and vole references 
have tandem genes with different intronic sizes, resulting in ~9 kb and ~11 kb long gDNA, amplification 
of tandem Irg-like genes from wild rodents-derived cell lines was performed with the PrimeSTAR® GXL 
DNA Polymerase suitable for long amplicons. Two bands of the expected size were identified for inbred 
mouse-derived Flp-In-3T3 cell (lower and higher bands indicated by a black and red asterisk 
respectively on Fig. 8a). Similarly, FMN-R and AAL-R cells displayed two bands of analogous size, 
and BVK168 cells a single band of ~8 bb. 
Following this, vole cells (FMN-R and BVK168) and murine cells (AAL-R and Flp-In-3T3) were 
treated for 24 h with 200 ng/ml recMgIFN-γ and with 200 U/ml mouse IFN-γ respectively, according to 
results presented in chapter 6.2 and as published (7, 91). Full length tandem Irg-like genes were PCR 
amplified with the same primer pair from mRNA reverse transcribed into cDNA. For all cell lines a 2.5 
Kb long band was observed in treated cells but not in untreated controls (Fig. 8b, untreated controls not 
shown), confirming the IFN-γ induction of tandem Irg-like genes expression also in these species. These 
results confirmed the likely presence of similar Irg loci in M. glareolus, M. arvalis and A. agrarius. 
Direct sequencing of the 2.5 kb PCR products revealed mixed bases in certain positions, indicating the 
presence of different products with the same size (example of FMN-R tandem Irg-like gene in Fig. 8c). 
These mixed nucleotides were observed for all tandem Irg-like sequences from wild rodents-derived 
cell lines, even for BVK168 cells which had a single band amplified from the gDNA, and sometimes 
resulted in amino acid differences (Fig. 8c). Mixed bases were observed from sequencing not only with 
primers designed on the amino (N-) and carboxy (C-) terminal, but also with primers designed within 
the sequences. These results indicate conservation of primer binding sites both within and at the exon 
extremities of Irg-like genes. To obtain single Irg-like sequences possible solutions were: 1) design of 
sequence-specific primers for each of these species’ Irg-like gene 2) clone of the single amplified genes 
into a vector prior to sequencing. Given the lack of good quality genomic references for the rodent 
species in study, and considering that eventually the genes would have been cloned in mammalian cells, 





Fig. 8. M. glareolus, Microtus arvalis and Apodemus agrarius have more than one tandem Irg-like 
gene. (a) 0.5 % Agarose gel loaded with PCR amplified Irg and Irg-like tandem genes from gDNA of 
murine Flp-In-3T3, M. glareolus BVK168, M. arvalis FMN-R and A. agrarius AAL-R cells. Black and 
red asterisks indicate the smaller and larger band sizes respectively. (b) 1 % Agarose gel loaded with 
PCR amplified Irg-like tandem genes from cDNA of the same cell lines after 24 h IFN-γ stimulation. 
Untreated controls are not shown. Vole cells (BVK168 and FMN-R) were treated with 200 ng/ml 
recMgIFN-γ and murine cells (NIH/3T3 and AAL-R) with 200 U/ml mouse IFN-γ. First and last lanes 
with DNA marker (with sizes in kb given on the side). (c) Example of direct sequencing of Irg-like 
tandem genes’ PCR products from FMN-R cells. Ambiguous bases are highlighted with red arrow-heads 
and indicate the presence of either heterozygotes or different genes with the same size amplified. The 
same PCR product was sequenced with two different primer pairs (“Irgb2 Fw” and “Irqb2qF1”) twice 
as indicated on the left. Positions of nucleotides relative to the start codon are indicated above the 
sequences. 
 
I cloned Irgb2-b1-like genes in the plasmid pES51-bl prior sequencing. I adopted the convenient 
Seamless Ligation Cloning Extract (SLiCE) method, which allows cloning of genes of interest in a 
single-step reaction. Requirement for the SLiCE cloning is amplification of the gene of interest with 
primers with overhangs encoding for recombination sites, to allow insertion of the gene in the vector via 
homologous recombination. Two tandems were successfully cloned from AAL-R cells, and a single one 
from BVK168 and FMN-R cells. However, sequencing data indicate the presence of more tandem Irg-
like genes in the cell lines. Sequences of the cloned genes and alignment of these sequences are reported 
in Fig. 9. 
Cloning was attempted also for the tandem Irg-like genes amplified from gDNA. However, cloning of 
these only yielded a few positive clones, i.e. from the band indicated with the black asterisk in Fig. 8a 
of Flp-In-3T3, FMN-R and AAL-R cell lines. The cloned FMN-R-derived sequence shared a higher 
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similarity with M. ochrogaster tandem 1 Irg (LOC101989451) which also corresponds to the smaller 
genomic sequence. This and the cloned tandem from cDNA shared a deletion around 420 bp, which 
characterizes tandem 2 Irg (LOC101990019), although they diverge at many residues (not shown). The 
cloned AAL-R gDNA-derived sequence was identical to the cloned tandem 1 from cDNA (AAL-R 
tandem 1 in Fig. 9).   
Cloned tandem Irg-like sequences from wild rodents-derived cell lines and published murine tandem 
Irg genes (Irgb2-b1BL6, Irgb2-b1CIM and Irgb2-b1PWD/EiJ) are reported in Fig. 9. The susceptible 
phenotype-associated Irgb2-b1BL6 was used as reference in the alignment. All cloned sequences 
terminate with a methionine, two aa before the stop codon, for reasons explained in chapter 6.1.5.1. The 
Irgb1-like sequence of AAL-R tandem 2 gene is characterized by many stop codons, which may hint to 
the presence of a pseudogene. However, I cannot exclude that the presence of several adenine residues 
in a row (Fig. 37 in the appendix) induced a mistake in the polymerase activity and caused a frame-shift. 
Cloned Irg-like sequences have conserved GTPase motifs at the amino-terminal, like the α-phosphate-
binding loop G(X4)GKS and the DXXG motif (highlighted in red boxes in Fig. 9, (83)). The latter is not 
present in Irgb2-b1BL6 and Irgb2-b1CIM, and murine Irgb2-b1 sequences also lack the nine aa-long 
insertion at the utmost amino-terminal. More deletions characterize vole sequences, like the one of four 
aa around the residue 830 as well as a smaller one of two aa right after the splicing site indicated with a 
black arrow-head in Fig. 9. All tandem sequences have a conserved histidine as first amino acid of the 
IRGb1 exon. I observed variability between these sequences, especially in the αD and H4 domains which 
interact with T. gondii virulence factor ROP5 in Mus spp., as well as in residues in position 245-318 and 
after the splicing site. In general, a higher diversity in the Irgb2 exong compared to Irgb1 was previously 
observed within murine genes and is through my work confirmed in other wild rodent species. 
Fig. 9 (following page). High variability between murine and vole Irg tandem genes. Alignment of 
Mus spp. tandem Irg genes and tandem Irg-like genes cloned from wild rodents-derived cell lines. Irgb2-
b1BL6 was used as reference. Important domains and motifs are indicated in red boxes, and the splicing 
site by a black arrow-head. Conserved amino acids are represented by dots and divergent ones are 








6.1.3 RNAseq data of M. glareolus, Microtus arvalis and Apodemus agrarius cell lines 
Analysis based on binding of designed degenerated primer pairs skews the results towards sequences 
more similar to the reference sequence. In order to make an unbiased identification of Irg-like genes in 
the available wild rodents-derived cell lines, we performed an RNAseq analysis of the same, treated and 
not treated with IFN-γ. A complete list of prepared RNA samples is presented in Tab. 17. RNA samples 
with high yield (50-100 µg per sample) and good quality evaluated at the Bioanalyzer were obtained. 
Finally, samples were sent for RNAseq and results are currently being analyzed in collaboration with 
Alice Balard (Heitlinger group, Humboldt Universität, Berlin). Preliminary results of the de novo 
assembly explained in section 5.1.1.2 are reported. First, at least half of all assembled bases in each 
transcript are more than 2500 bases-long and more than 97 % of fragments were aligned as proper pairs 
in all three transcriptomes. Moreover, for each prepared sample more than 74 % of assemblies is 
recognized as full-length genes compared to a mammalia database (see section 5.1.1.2 for details), 
around 5 % as fragmented and 20 % missing. Overall, first indications point out to a good and uniform 
quality of the RNAseq data, which is a prerequisite for future transcriptomic analysis. 
Tab. 17 List of samples prepared for RNAseq. RecMgIFN-γ was used in a concentration 200 ng/ml 
and mouse IFN-γ 200 U/ml; both treatments were performed for 24 h.  
Sample #	 Species Cell line Condition 
1	 A. agrarius AAL-R untreated control 
2	 A. agrarius AAL-R mouse IFN-γ 
3 M. glareolus BVK168 untreated control 
4 M. glareolus BVK168 recMgIFN-γ 
5 M. arvalis FMN-R untreated control 
6 M. arvalis FMN-R recMgIFN-γ 
 
6.1.4 Irg-like sequences from wild rodents-derived tissue samples 
6.1.4.1 Extraction of genomic DNA and rodent species determination 
A subset of tissue samples from the collection available to us was selected for gDNA extraction. Two 
DNA extraction kits and several protocols for gDNA extraction were evaluated. The NucleoSpin® Tissue 
DNA extraction Kit allowed us to obtain high yield of gDNA with a less laborious protocol than the 
NucleoSpin® Soil DNA extraction Kit, therefore was the kit of choice for the processing of wild rodents 
tissue samples. gDNA yield and quality varied widely, supposedly due to contaminants in the intestinal 
tissue used. Many samples displayed almost undetectable gDNA amount and high impurity (in terms of 
260/280 ratio measured at the NanoQuant Plate™). The part of samples considered suitable (260/280 
ratio so-so) were stored for subsequent PCR reactions. First, the rodent species hypothesized by 
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morphometric analysis at the moment of capture was confirmed by PCR amplification and sequencing 
of CytB, according to the protocol of Schlegel et al. (155). The latter is based on degenerated primers 
designed to amplify numerous small mammals’ CytB sequences and allowed us to classify them at the 
species level. Initially PCR amplification lacked reproducibility, with the PCR products not always 
present despite applying the same DNA template and reaction protocol. The reason likely lies in the 
presence of phenol compounds in fecal materials, which potentially inhibits the reaction (156). The 
addition of Bovine Serum Albumin (BSA) greatly improved the PCR amplification yield (Fig. 10a) and 
was then applied to all PCR reactions with gDNA derived from tissue samples. 
6.1.4.2 Irg-like sequences from wild rodents-derived tissue samples 
I then proceeded to PCR-amplify and sequence Irg-like genes from the same tissue-derived gDNA used 
for CytB amplification. Irgb2-like and Irgb1-like genes were amplified with the degenerated primers 
designed based on both Mus spp. and M. ochrogaster genomes as described previously. Despite the 
addition of BSA and several steps of optimization of the protocol, only approximately half the samples 
generated a PCR product ~1.2 kb long (Fig. 10b). I thus cloned Irgb2-like and Irgb1-like genes in the 
plasmid pES51-bl via SLiCE cloning method previously explained. Amplification was most efficient 
for the primer pair designed to amplify the Irgb1-like gene and provided few Irgb2-like sequences. In 
an attempt to enlarge our repertoire of Irgb2-like sequences, I thus used the Zero Blunt® TOPO® PCR 
cloning Kit, which allows cloning of blunt end PCR products in a single-reaction step, to clone Irgb2-
like sequences that were successfully amplified without SLiCE primers. These different cloning 
methods confirmed the presence of different alleles or genes amplified by the same primer pair, since 
the same PCR product produced up to four different sequences (e.g. 050_Aag in Fig. 11). However, the 
yield in terms of number of colonies was low with less than 20 colonies per amplicon. This is despite 
transformation of all the cloning reaction, plating of all the transformation solutions, and use of high 
transformation efficiency commercial bacteria). Considering the high cost of this approach, it cannot be 
considered optimal to explore Irg-like genes diversity. Amplification of the whole Irgb2-b1-like locus 





Fig. 10. The poor gDNA quality and diversity at the primers’ binding sites might account for low 
PCR amplification yield. PCR amplification from wild rodents-derived gDNA of CytB and Irg-like 
genes. (a) 1 % Agarose gel loaded with PCR amplified CytB gene for rodent species determination. The 
red box highlights two lanes where the reaction was performed with the same gDNA template (sample 
#1) with and without addition of BSA 1µg/µl. (b) 1 % agarose gel of PCR-amplified Irgb2-like and 
Irgb1-like genes (with BSA). Midori Direct was used to visualize the ladder and the PCR products. First 
and last lanes are DNA markers (with sizes in kb given to the left). 
 
Recently the group of Tobias Steinfeldt (University of Freiburg, Germany) showed that the IRGb2 
subunit of IRGb2-b1 is responsible for mediating the resistant phenotype in M. musculus castaneus CIM 
cells and that the mechanism is based on binding of T. gondii virulent ROP5 protein (115). Therefore, 
it is reasonable to assume that resistance is accomplished by the 43 amino acids which are different 
between susceptible IRGb2BL6 and resistant IRGb2CIM. An alignment of 33 out of the 43 differential 
amino acids are displayed in Fig. 11 and compared to collected IRGb2-like sequences from wild rodents. 
We observed diversity between IRGb2BL6 and approximately half of the residues in wild rodents-derived 
sequences. Some residues are conserved in all non-Mus spp. sequences, whereas others display a higher 
diversity, e.g. in positions 99, 151 and 180. Interestingly, the diverging residues in positions highlighted 
by red boxes are enriched at the putative interface with ROP5, as shown in the structural model of M. 
ochrogaster IRGb2-like binding to ROP5 (Fig. 12). 
These results indicate that there is variability between and within rodent species’ Irg-like genes, 
similarly to the differences in wild Mus spp.-derived sequences. Different residues are enriched at the 





Fig. 11. Wild rodents-derived Irg-like proteins have high diversity in residues that vary between 
resistant and susceptible murine sequences. Amino acid alignment of IRGb2 and IRGb2-like proteins 
from susceptible inbred BL6, resistant Mus musculus castaneus CIM (CIM) and wild rodents of M. 
glareolus, Microtus spp. and Apodemus spp. Afl = A. flavicollis; Aag = A. agrarius; Asy = A. sylvaticus; 
Mgl = M. glareolus; Mag = M. agrestis; Mar = M. arvalis; Mochro = M. ochrogaster. Positions of the 
amino acid relative to murine references are indicated above the sequences. Residues conserved between 
the analyzed sequenced and BL6 are indicated in yellow boxes. Varying amino acids in the same 
position where CIM varies are highlighted in orange. The positions indicated by red boxes under the 
alignment refer to residues highlighted in the following Fig. 12. Missing residues due to inconsistent 





Fig. 12. Wild rodents-derived IRG-like proteins have high diversity in residues at the putative 
interface with ROP5. M. ochrogaster IRGb2-like residue (LOC101989451, genome ID 10848) was 
modeled onto mouse IRGa6 (PMID: 29788355) bound to Toxoplasma ROP5B (PDB: 4LV5). Residues 
in the positions highlighted in red in the alignment in Fig. 11 are indicated with the same color in the 
structure. The model was created using Swiss-Model (157) and the resulting model visualized with 
UCSF Chimera 1.1.3. (158). The structural model was created by Frank Seeber (Robert Koch-Institut). 
 
6.1.5 Establishment of an in vitro system to study wild-derived Irg genes 
I established a cell culture-based system to explore the effect of wild rodents-derived Irg-like genes 
during T. gondii infection. For convenience, most xenogenous genes are expressed transiently. However, 
stable transfection is for several reasons preferred over transient transfection when a uniform population 
of host cells with a single copy of the introduced gene is desired. In transient transfection, the number 
of plasmid copies that enter the host cell could vary greatly, which creates noise and might lead to wrong 
interpretations of readouts. Additionally, the short recovery time between transient transfection of cells 
and their use in experiments might lead to cell stress influencing the phenotype (159). Thus, despite 
being a more tedious procedure, stable transfection is to be preferred when possible. We opted for the 
Flp-In cell system as the recipient for wild rodents-derived Irg-like genes. These cells allow stable 
expression of transgenic sequences in a reproducible manner (159). Commercially available parental 
strains contain a Flp Recombination Target (FRT) sequence which is recognized by a flipase (Flp) 
recombinase allowing a site-specific integration of genes of interest. The latter requires a cloning step 
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in a plasmid containing a FRT site, to allow insertion of the gene. Parental cells are isogenic, meaning 
they have the same genetic background. This feature allows a streamlined creation of clonal cell lines 
avoiding the time-consuming single cell expansion step. However, despite being genetically identical, 
single cells within the isogenic population might have slightly different growth characteristics (148), 
thus single cell expansion might still be necessary. Within the possible Flp-In systems, Flp-In-3T3 was 
the cell line of choice since it is the only M. musculus cell line available. Furthermore, NIH/3T3 
fibroblasts, which are the parental cells of Flp-In-3T3, are referred to as highly transfectable cells, which 
is a crucial aspect for molecular cloning. As for T. gondii infection, fibroblasts are one the most studied 
cell types for in vitro studies and their cell-autonomous immune response is believed to be crucial for 
limiting parasite burden. 
Flp-In-3T3 cells were confirmed to be of M. musculus species via sequencing of the CytB gene. NIH/3T3 
are derived from embryonic fibroblasts of the inbred NIH Swiss strain and the Irgb2-b1 genotype was 
confirmed to be identical to the published inbred sequences from Lilue et al. as expected (reported in 
Fig. 9, (7)). This is crucial since the introduced gene will be present in addition to the endogenous Irgb2-
b1. We assume that since inbred M. musculus-derived cells are not able to control virulent parasite 
infection, an observed parasite control by Flp-In-3T3 cells transfected with a wild rodent Irg-like gene 
can be attributed to the introduced gene. 
6.1.5.1 Establishment of suitable vectors for the cloning strategy  
The expression system of choice requires the use of suitable vectors, for example containing a FRT site 
to mediate site-specific insertion of the gene. Additional features facilitate the identification of 
successfully transfected cells as well as the intracellular localization of the expressed xenogenous 
protein. For this reason, establishment of suitable vectors was a prerequisite for the setup. 
For the introduction of Irg-like genes in Flp-In-3T3 cells we developed a cloning strategy with two 
different plasmids: pES51-bl and pFS-1 (Fig. 13). Irg-like genes were first introduced in the pES51-bl 
plasmid using the SLiCE cloning method. Amplification of Irg-like genes with SLiCE-adapted primers 
with overhangs encoding for recombinase sites allows cloning of the gene of interest in a single-step 
reaction (Fig. 13a). After confirmation of successful cloning by colony PCR and sequencing of the gene, 
the latter was transferred to the pFS-1 vector. This insertion was performed via Golden Gate Assembly 
system, which is a non classical cloning method ((137), and explained further in chapter 5.1.6). This 
cloning method is convenient for recombining genes of interest and has e.g. already been used to study 
pathogenicity-conferring components in bacteria (160). This system allows us for example to explore 
the resistance activity of different Irgb2-like genes, by combining different exons to identify the ones 
responsible for the resistant phenotype. The Golden Gate Assembly system is based on Type IIS 
endonucleases which cut out of the recognized sequence and leave sticky overhangs. This renders the 
method particularly useful for cloning purposes. We integrated the restriction SapI site (GCTCTTC1/4) 
in the SLiCE primers’ overhangs for Irg-like amplification, which allowed us to clone genes in pFS-1 
with the methionine as start codon and in frame with an HA-Tag at the carboxy-terminal. However, the 
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adaptation of SapI sites at the C-terminal implied the loss of the last two amino acids before the stop 
codon of IRGb1-like proteins, visible in the alignment in Fig. 9. Both SLiCE and Golden Gate cloning 
methods were successful and always led to a majority of positive clones. However, Golden Gate 
recombination was complicated by the presence of a possible SapI site within the sequence, which 
indeed happened for cloning of tandem Irg-like sequences in chapter 6.1.5.4. Identification of full length 
sequences required a change in the assembly protocol by using suboptimal digestion parameters for 
temperature and time, as explained in Material and Methods in chapter 5.1.6. Successfully cloned 
plasmids were positively selected via CcdB protein toxicity (136).  
Once wild rodents-derived sequences were cloned in the final vector pFS-1, they were introduced into 
the Flp-In-3T3 cell system, i.e. transfected. Transfected cells can be identified by the green fluorescent 
nucleus, since pFS-1 carries EGFP expressed with a nuclear localization signal (3xNLS, Fig. 13b). 
Expression of the cloned gene is regulated by the human elongation factor 1α (EF-1α) promoter which 
induces a strong and constitutive expression. Also, as anticipated the gene is in frame with a C-terminal 
HA-Tag, thus expression and intracellular localization of the protein can be determined. Co-transfection 
with the pOG44 plasmid encoding for the yeast-derived Flp recombinase allowed site-specific 
integration of the gene of interest via FRT sites present on both pFS-1 and in the Flp-In-3T3 genome 
(Fig. 13c). Stably integrated cells were selected via Hygromycin B treatment. 
 
Fig. 13. Cloning strategy of Irg-like genes in Flp-In-3T3. In sequential order: (a) Cloning of Irg-like 
genes into pES51-bl via SLiCE cloning method. (b) pFS-1 vector where Irg-like genes are cloned from 
pES51-bl via Golden Gate assembly method. (c) Stable transfection of Flp-In-3T3 with pFS-1 carrying 
Irg-like genes. The last figure was modified from Niewiadomski and Rohatgi (148). 
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6.1.5.2 Establishment of the optimal transfection protocol for Flp-In-3T3 cells  
Transfection in Flp-In-3T3 cells posed higher challenges than expected because of the size of pFS-1 
(9,081 bp). The plasmid size increases further when a tandem Irgb2-b1 gene is cloned in the vector, as 
for the positive control Irgb2-b1CIM sequence creating a final pFS-CIM plasmid 9,741bp-long. Here, the 
aim was to identify the protocol leading to the highest possible transient transfection rate in order to 
increase the probability to obtain stable transfected cells. For this purpose, different not viral-
transfection methods and reagents were tested with both a commercially available pmaxGFP® and the 
pFS-CIM plasmids. More details about the reagents are reported in chapter 5.3.4. 
Despite the reputation of NIH/3T3 cells to be highly suitable for transfection, not more than 20 % of the 
derived Flp-In-3T3 cells got transfected in my hands (Tab. 18). A higher transfection rate was observed 
when using small dimension plasmids, as the commercially available pmaxGFP® (3,486 bp) used to 
determine transfection efficiency, but decreased drastically when using pFS-CIM (Tab. 18). 
Transfection efficiency was estimated by the number of green fluorescent cells on the total of Hoechst 
33342 stained nuclei on living cells 24 h after transfection. Unfortunately, despite many rounds of 
optimization and the use of a NIH/3T3-specific kit (Amaxa® Cell Line Nucleofector Kit R), the cost-
efficient electroporation was not successful for pFS-CIM transfection. Combined with an extremely 
high mortality rate (> 95 %), positive clones were never identified (Tab. 18). The highest proportion of 
pmaxGFP®-transfected cells was observed when using Lipofectamine™3000 and jetPRIME®, 15 and 20 
% respectively. The reported values are only slightly lower than published transfection rates on NIH/3T3 
with Lipofectamine™2000 (161)  and a similar lipid-based Attractene reagent (162). Interestingly, 
immunofluorescence assays of pFS-CIM-transfected Flp-In-3T3 cells with Lipofectamine™3000 
detected a specific HA-tagged IRGb2-b1 signal in cells where the EGFP nuclear signal was weak or not 
detectable (Tab. 18 and visible in Fig. 14b). This resulted in a higher percentage of transfected cells by 
this staining than by sole detection of green fluorescent nuclei. However, Lipofectamine™3000 was the 
only transfection reagent which led to the identification of pFS-CIM-transfected cells. 
Lipofectamine™ 3000 was then the transfection reagent of choice to clone the gene of interest in Flp-In-
3T3 cells via pFS-1, and integration was possible via co-transfection with pOG44. The consequently 
higher amount of DNA used for stable transfection did not negatively interfere with the transfection 
rate, however we observed the formation of aggregates in solution (data not shown). The optimized 
protocol (described in details in chapter 5.3.4) leads reliably to the establishment of Flp-In-3T3 stable 






Tab. 18. Transfection methods and reagents tested on Flp-In-3T3 cells and the estimated 
transfection efficiency with either the control plasmid pmaxGFP® or pFS-CIM. Each 
reagent/protocol was tried at least twice. na = not assessed. 
Reagent	
Transfection efficiency (pmaxGFP®) 
[%] 






PolyMag™ 	 na 0 
TransIT-X2®,   
TransIT-LT1® and  
TransIT-2020® 
0 0 
jetPRIME® 20 0 (0 % by HA-staining) 
Amaxa® Cell Line 
Nucleofector Kit R 
< 1 0  
Lipofectamine™3000  15 1 (10 % by HA-staining 
Fig.14b) 
 
6.1.5.3 Establishment of positive and negative control Flp-In-3T3 cell lines 
At first I needed to validate the results of Lilue et al. in our expression system. I thus established positive 
and negative control cell lines by stably transfecting Flp-In-3T3 with the murine inbred Irgb2-b1BL6 
sequence, cloned in pFS-BL6, and the M. musculus castaneus Irgb2-b1CIM sequence, cloned in pFS-CIM, 
associated with susceptibility and resistance to virulent T. gondii respectively. After the establishment 
of a reliable protocol, the production of the two cell lines, named Flp-BL6 and Flp-CIM, was 
straightforward. Cell lines were confirmed to express the cloned Irgb2-b1 genes via Western Blot of 
cell lysates with an anti-HA-tag antibody. As expected from the expression system, the amount of 
constitutively-expressed protein is equal in the created cell lines (Fig. 14a). Furthermore, I performed 
an immunofluorescence assay to investigate the intracellular localization of the protein. In uninfected 
cells IRGb2-b1 accumulates in reticular structures, similarly to what observed by Lilue et. al (Fig. 14b, 
(163)). During T. gondii infection of Flp-CIM cells, IRGb2-b1 relocates on the parasitophorous vacuole 
membrane (PVM) colocalizing with the parasite protein GRA7 (Fig. 14 b and c). GRA7 mediates ROP 
binding and phosphorylation of IRG proteins (164), is a useful staining for the PVM and differentiates 
between parasite’s active invasion, where GRA7 is secreted and loaded on the PVM, from phagocytosis. 
These results also highlight that we underestimated the pFS-CIM transfection efficiency, since the EGFP 
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nuclear signal is not always visible from cells that express the HA-tagged IRGb2-b1, thus obviously 
transfected (Fig. 14b). Importantly IRGb2-b1 loading is independent of IFN-γ treatment, also in 
accordance to what previously observed in resistant cell lines (163). These results confirm that in our 
expression system the positive and negative control proteins are equally expressed and behave similarly 
to what previously published. 
 
Fig. 14. The Flp-In-3T3-based system leads to comparable expression levels of transfected IRGb2-
b1, which localizes on the PVM of virulent parasites. Flp-In-3T3 (Flp) parental strain was stably 
transfected with the negative (-BL6) and positive (-CIM) control Irgb2-b1 gene, which is expressed in 
frame with an HA-tag. (a) DB71 total protein staining (left) and Western Blot with an anti-HA-tag 
antibody on the same membrane (right) of lysates from the three cell lines. First lane of the total protein 
staining with molecular weight marker (with sizes in kDa given to the left). A representative experiment 
of two replicates is shown. (b, c) Immunofluorescence assay of Flp-CIM cell line expressing an HA-
tagged IRGb2-b1. Flp-CIM cells were infected for 1 h with a virulent T. gondii strain expressing a green 
fluorescent protein in the mitochondria, RHβGFPmt. In uninfected cells IRGb2-b1 accumulates in 
intracellular structures, whereas on T. gondii infected cells it relocates on the PVM (b) as shown by 
colocalizing with GRA7 (c). Following staining is shown: IRGb2-b1 (red), GRA7 (yellow), DAPI 
staining for nuclei (blue). A representative image is shown. The scale bar represents 20 µm. 
 
6.1.5.4 Establishment of stable Flp-In-3T3 cell lines with wild rodents-derived Irg-like genes 
Given the efficient and successful establishment of cell lines with the murine control sequences, I then 
proceeded with wild rodents-derived Irg-like sequences. I first transfected tandem Irg-like genes from 
the available wild rodents-derived cell lines, and in particular the identified tandem from M. glareolus 
BVK168 cells and tandem 1 from A. agrarius AAL-R cells (visible in Fig. 9). The cloning strategy used 
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for Irgb2-b1BL6 and Irgb2-b1CIM and explained in previous chapters was used to clone these wild rodents’ 
sequences in pFS-1, resulting in pFS-BVK and pFS-AAL transfected in Flp-In-3T3 cells. Surprisingly, 
I observed an HA-tagged protein of 50 kDa instead of the expected 100 kDa, via Western Blot of cellular 
lysates from the created Flp-BVK and Flp-AAL cell lines (Fig. 15a). Nevertheless, these smaller IRG-
like proteins loaded on the PVM of virulent parasites, as seen via immunofluorescent detection with an 
anti-HA-tag antibody (Fig 15b). I then PCR-amplified the full lenght genes from the plasmids used for 
cloning, to investigate the reason behind the detected smaller proteins. Full lenght genes were observed 
in pES51 cloned plasmids. However, pFS-BVK and pFS-AAL had a shorter inserted gene compared to 
positive control cells (Fig. 15c). A closer look to the full lenght sequences identified two additional SapI 
sites in both tandem Irg-like genes, the first exactly at the end of the Irgb2-like exon and the second 50 
bp prior Irgb1-like C-terminal (Fig. 15d). Sequencing of both pFS-BVK and pFS-AAL plasmids 
confirmed sequence digestion at these sites during Golden Gate Assembly and ligation of the two 
fragments creating a shorter version of the gene with a gap of 1,256 bp in the Irgb1-like exon. The use 
of a reverse primer binding the Irgb2-like exon for colony PCR on cloned pFS plasmids did not allow 
identification of these truncated Irg-like sequences before establishment of the cell lines. However, this 
mistake allowed me to observe that the IRGb2-subunit only –together with the last residues of IRGb1– 
is sufficient for binding to the PVM of virulent parasites.  
 
Fig. 15. The IRGb2 subunit is sufficient for binding to virulent parasites vacuole membranes. (a) 
DB71 total protein staining (left) and Western Blot (right) with an anti-HA-tag antibody. First lane with 
molecular weight marker (with sizes in kDa given to the left). A representative experiment of two 
replicates is shown. (b) Immunofluorescence assay of Flp-AAL-IRGb2-like cell line (left) and Flp-
BVK-IRGb2-like cell line (right) expressing an HA-tagged IRGb2-b1. Cells were infected for 1 h with 
a virulent T. gondii strain expressing a green fluorescent protein in the mitochondria, RHβGFPmt. 
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Following staining is shown: IRGb2-b1 (red), T. gondii mitochondria (green), DAPI staining for nuclei 
(blue). A representative image is shown. The scale bar represents 20 µm. (c) 1 % agarose gels loaded 
with PCR-amplified Irg aand Irg-like tandem genes cloned in the pES51- bl plasmid (upper gel) and in 
the pFS-1 plasmid (lower gel). Red boxes highlight full length BVK and AAL sequences cloned in 
pES51- bl and truncated BVK and AAL sequences cloned in pFS-1. Positive and negative control 
sequences (-CIM and –BL6) and empty plasmids are indicated for comparison. First lane with DNA 
ladder (with sizes in kb given to the left). (d) Alignment of the full (pES-BVK) and truncated (pFS-
BVK) versions of BVK Irg-like tandem genes. Red boxes highlight SapI sites within the sequence. 
Nucleotides positions relative to the full lenght sequence are reported above the sequences. Nucleotide 
sequences are reported, and for the full lenght pES-BVK also the translated sequence. 
6.1.5.5 T. gondii infection phenotype in established positive and negative control cell lines 
Host-mediated T. gondii killing is followed by programmed death of the cell itself (109). An association 
between this phenotype and host resistance was suggested, since the parasite niche gets disrupted (7, 
150). On the contrary, susceptible cells allow parasite proliferation until active egress of the same around 
48 hpi. Resistant M. musculus castaneus CIM cells display an IFN-γ-dependent increase in necrotic cell 
death for both type I and type II infection, whereas susceptible BL6 cells display this phenotype only 
following avirulent infection (7). I will then refer to the IFN-γ-mediated cell death as the resistance 
phenotype.  
Necrotic death results in permeabilization of both plasma and nuclear membranes. I thus performed a 
double staining with both a nuclear impermeable dye, Propidium Iodide (PI), and a permeable one, 
Hoechst 33342, to quantify the ratio of necrotic cells during T. gondii infection and IFN-γ stimulation, 
similarly to published protocols (150). As shown in Fig. 16, an increase in necrotic murine Flp-In-3T3 
cells was observed during type II infection following stimulation with IFN-γ, however not to the extent 
expected from literature (7). A similar increase in PI+ cells increase was observed following type I 
infection of IFN-γ-treated cells, suggesting that cells are not completely susceptible to infection. 
We expected Flp-CIM positive cells to show an increase in necrotic cell death following IFN-γ treatment 
and T. gondii infection. Surprisingly, a rather decreased amount of necrotic cells was observed for both 
Flp-CIM and Flp-BL6 compared to the wild-type (wt) cell line (Fig. 16). No obvious control of parasite 
proliferation was observed at the microscope in positive control Flp-CIM cells compared to other cell 
lines. Indeed, preliminary experiments confirmed that IFN-γ treated Flp-CIM cells did not display a 
reduced number of parasites per vacuole compared to Flp-BL6 cells (Appendix Fig. 38). 
Results suggest that our cell culture-based system does not reproduce results published in literature. 
Despite the identical Irgb2-b1 genotype, Flp-In-3T3 cells display a different phenotype during T. gondii 
infection compared to other inbred mouse cells. A difference between the derived positive Flp-CIM and 





Fig. 16. The positive control cell line Flp-CIM does not display the host resistance phenotype. Flp-
In-3T3 (Flp) parental strain, negative control Flp-BL6 and positive control Flp-CIM cell lines were 
treated with 200 U/ml mouse IFN- γ or left untreated 24 h prior infection with avirulent (type II) and 
virulent (type I) T. gondii. 24 hpi a double staining with Propidium Iodide (PI) and Hoechst 33342 on 
living cells was performed. Double stained nuclei were quantified at the fluorescent microscope. Mean 
± sd (n = 3 experiments, each with 2 replicates). 
 
6.1.5.6 Flp-In-3T3 cells express higher levels of endogenous Irgb2-b1 compared to primary 
fibroblasts 
The resistant phenotype described in CIM cells is influenced by polymorphisms in Irg sequences, but 
also by expression levels of the same (163). Surprisingly, the amount of endogenous IRGb2-b1 protein 
(indicated with a black arrow-head in Fig. 17a) in Flp-In-3T3 cells was higher than the introduced one 
(indicated with a red arrow-head), as observed via Western Blot with the anti-IRGb2-b1 serum. The 
observed IRGb2-b1 protein levels in Flp-In-3T3 cells were higher than in primary murine fibroblasts in 
literature (7). Thus, I established a primary murine fibroblasts culture to confirm its lower amount of 
IRGb2-b1 protein compared to immortalized murine Flp-In-3T3 cells.  
Primary fibroblasts cultures were easily established from tails of inbred mice as explained in chapter 
5.3.2. As expected, cells were susceptible to treatment with mouse IFN-γ, as shown by phosphorylation 
and nuclear translocation of STAT1 following treatment (Fig. 17b). Confirming our hypothesis, a 
strikingly lower IFN-γ-induced expression of IRGb2-b1 in primary fibroblasts than in Flp-In-3T3 cells 
was observed by Western Blot (Fig. 17c, (7)). However, the transcript abundance was only slightly 
lower in primary cells compared immortalized murine cells available to us (Fig. 17d). My results 
indicate a higher amount of endogenous IFN-γ-induced IRGb2-b1 in immortalized fibroblast cell lines 




Fig. 17. Flp-In-3T3 cells express high level of endogenous IRGb2-b1 compared to primary murine 
fibroblasts. (a) DB71 total protein staining (left) and Western Blot with anti-IRGb2-b1 serum on the 
same membrane (right) of lysates from Flp-In-3T3 and Flp-BL6 cells. Cells were treated for 24 h with 
mouse IFN-γ (200 U/ml) or left untreated as control. The black arrow-head indicates the endogenous 
IRGb2-b1 protein in Flp-In-3T3 parental cells, and the red arrow-head the xenogenous IRGb2-b1BL6 in 
Flp-BL6 cells. First lane with molecular weight marker (with sizes in kDa given to the left). A 
representative experiment of three replicates is shown. (b) Established primary murine fibroblast cell 
cultures are responsive to mouse IFN-γ (200 U/ml). In each panel the following stainings are shown 
from left to right: phospho-Tyr701-STAT1 staining (green), DAPI staining (white) and overlay of the 
two signals. Activated phospho-STAT1 is indicated by nuclear translocation. A representative 
experiment of two replicates is shown. The scale bar represents 50 µm. (c) DB71 total protein staining 
(left) and Western Blot with anti-IRGb2-b1 serum on the same membrane (right) of lysates from Flp-
In-3T3 and primary murine fibroblasts. Cells were treated for 24 h with mouse IFN-γ (200 U/ml) or left 
untreated as control. First lane with molecular weight marker (with sizes in kDa given to the left). A 
representative experiment of two replicates is shown. (d) Irgb2-b1 mRNA abundance in primary murine 
fibroblasts is lower than in NIH/3T3 cells and almost equal to Flp-In-3T3 cells. Cells were treated for 
24 h with either treated with mouse IFN-γ (200 ng/ml) or left untreated as control. The reported mRNA 
fold induction is relative to untreated cells (set as 1; not shown) and normalised to Ywhaz for reference. 







6.1.5.7 The endogenous Irgb2-b1 does not interfere with the transfected gene in Flp-In-3T3 cells 
Results indicate that Flp-In-3T3 cells express a higher amount of endogenous IRGb2-b1 compared to 
the introduced protein and to primary cell lines susceptible to T. gondii infection. We speculated that 
loading on the PVM of an eccessive amount of a not susceptible protein might interfere with the 
infection phenotype in our Flp-based system. To validate this hypothesis, we knock-out (KO) the 
endogenous Irgb2-b1 from Flp-In-3T3 cells. The resulting Flp Δb2b1 line was used to establish new 
stable positive and negative control cell lines, i.e. Flp Δb2b1-CIM and Flp Δb2b1-BL6.  
The KO was performed by Tobias Steinfeldt (University of Freiburg, Germany) via CRISPR-Cas9 with 
a recently published protocol (115). I clonally amplified several clones from the resulting pool of KO 
cells to identify a clonal cell line lacking both copies of the allele. I identified one suitable clone, named 
Flp Δb2b1 and indicated in the red box in Fig. 18a, by Western Blot with the anti-IRGb2-b1 serum. The 
correspondent lane lacks the band at ~100 KDa, similarly to the negative control CIM Irgb2-b1 KO cells 
(CIM Δb2b1, (115)). KO of Irgb2-b1 from Flp-In-3T3 cells was further confirmed via RT-qPCR (data 
not shown). The faint band with similar size present in all lanes, and particularly visible for KO cells, is 
likely another IRG tandem protein recognized by the anti-IRGb2-b1 serum. Indeed, the peptide sequence 
at the protein C-terminal used to develop the serum is conserved amongs tandem IRGs (7).  
Flp Δb2b1 was used for cloning of Irgb2-b1BL6 and Irgb2-b1CIM, as already performed with the wt cell 
line, resulting in positive Flp Δb2b1-CIM and negative Flp Δb2b1-BL6 control cell lines. I performed a 
PI-assay to evaluate the phenotype of the newly established cell lines to infection with T. gondii. The 
three cell lines – i.e. Flp Δb2b1, Flp Δb2b1-CIM and Flp Δb2b1-BL6 – display the same phenotype to 
infection with type I and II T. gondii, with and without IFN-γ treatment (Fig. 18b). Notably, I did not 
observe an increase of necrotic cell death in IFN-γ-treated Flp Δb2b1-CIM cells following parasite 
infection. Data rather suggest an opposite trend, similarly to what observed for wt Flp-In-3T3 clones 
(Fig. 16). Furthermore, cells did not exhibit striking differences in parasite burden as observed at the 
microscope (data not shown).  
The developed cell culture-based system does not replicate results from literature despite Flp-In-3T3 
cells carry the Irgb2-b1 susceptible allele. The gene is more expressed compared to other murine 
fibroblast cultures. However, we showed here that the higher amount of endogenous IRGb2-b1 is not 
responsible for the lack of reproducibilty of published phenotypes in the Flp-based system. Taken 
together, our results indicate that the Flp-In-3T3 cells cannot be used to study the Irg-like-mediated 




Fig. 18. The endogenous IRGb2-b1 protein in Flp-In-3T3 cells does not interfere with the 
resistance phenotype of IRGb2-b1CIM. Irgb2-b1 was knock-out from Flp-In-3T3 cells via CRISPR-
Cas9 and resulting clonal cell line was stably transfected with resistance-associated Irgb2-b1CIM and 
susceptibility-associated Irgb2-b1BL6. (a) DB71 total protein staining (left) and Western Blot (right) with 
an anti-IRGb2-b1 serum. Flp-In-3T3 wt (Flp wt), the negative control CIM Irgb2-b1 KO cells (CIM 
Δb2b1) and different clonal cell lines established from Flp-In-3T3 Irgb2-b1 KO cells were treated for 
24 h with mouse IFN-γ (200 U/ml). Identified Irgb2-b1 KO cell line (Flp Δb2b1) is highlighted by the 
red box. First lane with molecular weight marker (with sizes in kDa given to the left). A representative 
experiment of two replicates is shown. (b) Established Flp ΔIrgb2b1, Flp ΔIrgb2b1-CIM and Flp 
ΔIrgb2b1-BL6 cell lines were treated with 200 U/ml mouse IFN-γ or left untreated 24 h prior infection 
with avirulent (type II) and virulent (type I) T. gondii. 24 hpi a double staining with Propidium Iodide 
(PI) and Hoechst 33342 on living cells was performed and double stained nuclei were quantified at the 




6.2 Production of recombinant M. glareolus IFN-γ 
Results from the following chapter have been published on my first author paper Torelli et al. (124). 
Figures and a limited number of sentences in this result section (chapter 6.2) as well as the relative 
discussion (chapter 7.3.1) have been left unchanged from the published manuscript. 
6.2.1 Limited sequence conservation of IFN-γ between different rodent species  
The availability of M. glareolus-derived cell systems allowed us to study vole cells’ susceptibility to T. 
gondii infection. Because of our interest in IFN-γ-induced Irg genes and the central role of the cytokine 
during infection, access to an active type II interferon on M. glareolus cells was a prerequisite for the 
project. Diversity in the protein sequence of IFN-γ results in species-specific activity of the cytokine 
(165). We compared available IFN-γ genomic sequences of various rodents to predict cross-reactivity 
of the commercially available murine cytokine on vole-derives cell cultures. Peromyscus maniculatus 
and H. sapiens were used as more distant species for comparison (Fig. 19a).   
Amino acid sequences within the Arvicolinae cluster species – i.e. Microtus ochrogaster, M. agrestis, 
Ellobius lutescens and M. glareolus – and within the Murinae cluster species – i.e. M. musculus, A. 
sylvaticus and R. norvegicus – share more than 83 % sequence identity over the entire sequence (Fig. 
19a). In contrast, there is a high divergence between murid and arvicoline clusters, with M. musculus 
and M. glareolus sharing only 57.3 % amino acid sequence identity. 
Core regions of the protein (underlined areas in Fig. 19b) have a high sequence conservation between 
species, whereas the rest of the IFN-γ sequence is less conserved out of the same phylogenetic clade. In 
particular, certain residues previously implicated in the binding of IFN-γ with the receptor (IFN-γR1) 
(165) have a high degree of sequence divergence between murid and cricetid rodents (red boxes in Fig. 
19b). The basic lysine and arginine-rich stretch, located at the C-terminal end of murine IFN-γ (Fig. 
19b; “basic stretch”), is highly conserved in all IFN-γ sequences and has also been implicated in receptor 
binding (165, 166). After the basic stretch, a C-terminal extension of the IFN-γ sequence is present in 
cricetid rodents but not in murine species, whereas present but divergent in the human homologue gene 
(Fig. 19b). Taken together, there is low sequence conservation between murid and cricetid sequences 
and we anticipated that the commercial mouse IFN-γ would not be active on vole cells.  
Fig. 19 (following page). Protein sequence diversity of IFN-γ within rodent species. (a) Amino acid 
sequence similarity (in percentage) of IFN-γ proteins. On the left, a dendrogram based on IFN-γ 
sequence similarity is shown, whereby Peromyscus maniculatus and H. sapiens served as more distant 
species for comparison. The Arvicolinae (red branches) and the Murinae species (blue branches) are 
indicated. (b) IFN-γ amino acid sequence comparison between different rodent species and H. sapiens. 
Light blue indicates lower percentage of identity than dark blue. Arrow head indicates the M. musculus 
signal peptide cleavage site. Residues involved in the binding to the receptor subunit IFN-γR1 are 
highlighted by red boxes. Functionally important regions and the C-terminal basic domain are indicated 





 Production of recombinant M. glareolus IFN-γ in E. coli 
Given the expected lack of activity of the murine IFN-γ on vole cells, heterologous expression of M. 
glareolus recombinant IFN-γ (recMgIFN-γ) was performed in Escherichia coli OmniMax 2T1R cells. 
The deposited MgIFN-γ sequence (GenBank HQ650825) was cloned in frame with a C-terminal 6His-
tag into a tetracycline-regulated expression vector, resulting in the created plasmid pASG33-MgIFN-γ. 
RecMgIFN-γ expression was robust, yielding generally >3 mg/l of soluble protein after a single round 
of purification by immobilised metal affinity chromatography. SDS-PAGE analysis of the purified 
protein showed three major bands (20, 42 and 65 kDa; inferred from a standard curve based on the 
molecular weight (MW) markers) and two minor bands (15 and >100 kDa; Fig. 20a). The four largest 
proteins reacted with an anti-6His antibody and are interpreted as monomer, dimer, trimer and higher 
order aggregates. Their molecular masses are in good agreement with the calculated MW of monomeric 
recMgIFN-γ containing a 6His-tag (18.3 kDa). RecMgIFN-γ production in E. coli and its analysis via 
Western Blot were performed by Florian Müller (Robert Koch Institut). I tested the cross-reactivity of 
a commercial anti-human IFN-γ antibody on recMgIFN-γ by Western Blot. However, given the great 
diversity of IFN-γ sequences, especially of the tagged epitope in position 31-80 (Fig. 19b), the antibody 
did not cross-react as expected (data not shown).  
Since IFN-γ needs to be in a homodimeric form to activate its receptor, the purified recMgIFN-γ was 
analysed by gel filtration by Frank Seeber (Robert Koch-Institut). This analysis determines the 
proportion of different protein aggregates in the preparations. As shown in Fig. 20b, the vast majority 
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of the applied protein eluted at a column volume which is consistent with the dimeric form (36.4 kDa 
observed vs. 36.6 kDa calculated).  
Since lipopolysaccharide (LPS) of bacterial origin can induce Irg expression in murine macrophages 
(167), another recombinant protein was produced in the same E. coli strain to exclude an aspecific 
activity of bacteria fragments in the recMgIFN-γ preparation. Therefore, T. gondii Late Embryogenesis 
Abundant (LEA) 870 protein (Gene ID TGME49_076870) was cloned in plasmid pQE90S in frame 
with a 6His-tag, and expressed similarly to recMgIFN-γ in OmniMax 2T1R. Recombinant RecTgLEA 
production was performed by Sandra Klein (Robert Koch-Institut). As expected, RecTgLEA was 
expressed as monomeric protein of 17.9 KDa, similar in mass to recMgIFN-γ (personal communication 
from Benedikt Fabian, Robert Koch-Institut). 	
Collectively, these results show that a single affinity chromatography purification of recMgIFN-γ 
resulted in a large proportion of soluble, dimeric and thus presumably correctly folded and active 
protein. Another recombinant protein produced in the same bacteria strain allows us to test for the 
specific activity of recMgIFN-γ, especially in the context of Irg genes induction. 
 
Fig. 20. recMgIFN-γ purified by immobilised metal affinity chromatograph is mostly in a dimeric 
form. (a) SDS-PAGE followed by Coomassie staining for total protein detection (left) and detection of 
6His-tagged proteins by Western Blot with an anti-6His monoclonal antibody (right). Lane 1: molecular 
weight marker (with sizes in kDa given to the left - sizes greater than 100 kDa were unreliable when 
constructing a standard curve); lane 2: flow-through (unbound proteins); lane 3: purified protein(s). 
SDS-PAGE and Western Blot performed by Florian Müller (Robert Koch-Institut). (b) Size 
determination of purified recMgIFN-γ by analytical gel filtration analysis on a pre-calibrated Superdex 
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75 column. Protein peaks were detected at 230 nm (red) and 260 nm (blue), respectively. The gel 
filtration analysis was performed by Frank Seeber (Robert Koch-Institut). 
 recMgIFN-γ activates STAT1 signaling in vole cell lines 
When IFN-γ activates its signaling pathway, phosphorylation of cytosolic STAT1 at the residues Tyr701 
and Ser727 and its subsequent nuclear translocation is observed. STAT1 is divergent between taxa; it 
shares the highest degree of homology within the DNA binding site and the lowest in the transactivation 
domain (168). The latter implies species-specific differences in interaction with cofactors involved in 
the IFN-γ pathway activation (169). However, STAT1 sequences from different species share conserved 
residues around the activating Tyr701 and Ser727. Thus, we anticipated that antibodies raised against 
the phosphorylated murine Tyr701-STAT1 and Tyr727-STAT1 proteins will cross-react on other rodent 
species.  
I tested recMgIFN-γ activity on the already introduced vole-derived cell lines, the M. glareolus BVK168 
and the M. arvalis FMN-R cell lines. Mouse IFN-γ cross-reactivity was instead tested on A. agrestis 
AAL-R cells and used as positive control on M. musculus NIH/3T3 embryonic fibroblasts cell line. I 
therefore assessed co-localization of phosphorylated STAT1 with cell nuclei of treated cells by 
immunofluorescent assay (IFA) with an anti-phospho Tyr701-STAT1 antibody (similar to a previous 
study on bank vole cells (170)) and an anti-phospho Tyr727-STAT1 antibody on the mentioned cell 
lines.  
M. musculus NIH/3T3 cells treated with the homologous mouse IFN-γ showed nuclear-localised and 
phosphorylated Tyr701-STAT1 (middle panel in Fig. 21). No signal was detected in either untreated 
NIH/3T3 cells or cells treated with recMgIFN-γ. As expected from the low IFN-γ sequence similarity 
between murine and vole species, following treatment of the M. glareolus BVK168 cell line with mouse 
IFN-γ we observed no nuclear signal, similarly in untreated cells (middle panel in Fig. 21). In contrast, 
a clear co-localization of phosphorylated Tyr701-STAT1 and cell nuclei was detected in BVK168 cells 
following recMgIFN-γ treatment (upper panel in Fig. 21). Furthermore, recMgIFN-γ but not mouse IFN-
γ was active on a M. arvalis FMN-R cell line (upper panel in Fig. 21). Moreover, in the AAL-R cell line 
from A. agrarius mouse IFN-γ activated phosphorylation and nuclear translocation of STAT1 in this 
related murine species, confirming our predictions from sequence analysis (middle panel in Fig. 21). 
The results gave us a first confirmation of the species-specific activity of recMgIFN-γ on bank vole 
cells, which are not responsive to the mouse IFN-γ as predicted. RecMgIFN-γ shows also activity on the 






Fig. 21 (following page). Species-specific activity of recMgIFN-γ and mouse IFN-γ on different 
rodent cell lines. NIH/3T3, BVK168, FMN-R and AAL-R cells were tested and either left untreated as 
control (lower panel), stimulated for 1h with recMgIFN-γ (200 ng/ml, upper panel) or mouse IFN-γ (200 
U/ml, central panel). In each panel the following stainings are shown from left to right: phospho-Tyr701-
STAT1 staining (green), DAPI staining (white) and overlay of the two signals. Activated Phospho-
STAT1 is indicated by nuclear translocation. A representative experiment of three replicates is shown. 







STAT1 activation persists longer than in other STAT isoforms (171). I confirmed that the IFN-γ-induced 
phosphorylation of STAT1 is not only detected 1 h post treatment (Fig. 21), but also at 24 h (Fig. 22) 
which is the time point of choice for the infection experiments in this project. Both STAT1 isoforms –
i.e. STAT1a of 91 kDa and the C-terminal truncated version STAT1b of 84 kDa – are recognized by the 
anti-murine phospho-Tyr701-STAT1 antibody in both the murine Flp-In-3T3 cell line and in bank vole 
BVK168 cells 24 h after treatment with the respective IFN-γ (higher panel Fig. 22). Results suggest a 
higher phosphorylation level of the more transcriptionally active STAT1a isoform in the vole cell line 
compared to the murine one. The not phosphorylated form of STAT1 is highly induced following IFN-
γ treatment in both cell lines as expected (Interferome REF, middle panel Fig. 22), in a higher degree in 
the murine cells compared to voles. However, the not phosphorylated form of STAT1 expected in 
untreated and LEA-treated controls was surprisingly not or barely detected at this time point (middle 
panel Fig. 22). 
 
Fig. 22. STAT1 pathway is activated in BVK168 cells 24 h post treatment. Western Blot with anti-
murine antibodies against phospho-Tyr701-STAT1 (upper panel), STAT1 (central panel) and β-actin 
(lower panel). Cells were treated for 24 h with either the negative control protein recTgLEA (LEA, 200 
ng/ml), mouse IFN-γ (for Flp-In-3T3, 200 U/ml) or recMgIFN-γ (for BVK168, 200 ng/ml), or left 
untreated as control (untreat ctrl). A representative experiment of two replicates is shown. First lane 
with molecular weight marker (with sizes in kDa given to the left).  
 
Since full transcriptional activity of STAT1a also requires Ser727 being phosphorylated (80), I assessed 
its phosphorylation status by an anti-mouse phospho-Ser727-STAT1 antibody in NIH/3T3, BVK168 
and AAL-R cell lines. Via immunofluorescence assays I detected basal phosphorylation levels of Ser727 
in all three cell lines, which reflects results already reported in literature (86). However, a clear increase 
in the nuclear signal correspondent to phospho-Ser727-STAT1 is obvious following treatment of 
BVK168 with recMgIFN-γ and AAL-R with the murine IFN-γ compared to untreated control cells (Fig. 
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23). These results mirror what observed for the residue Tyr701 and confirmed Ser727 of STAT1 being 
also phosphorylated.  
Taken together, these results confirmed via different assays the species-specific activity of the produced 
recMgIFN-γ on M. glareolus BVK168 cells and M. arvalis FMN-R cells. Pathway activation induces 
the phosphorylation at the STAT1 activating residues Tyr701 and Tyr727. Furthermore, results show 
activity of the murine IFN-γ on A. agrarius AAL-R cells, confirming the prediction based on sequence 
identity with the murine cytokine. The IFN-γ pathway is activated not only one hour following 
treatment, but also 24 h later, which corresponds to the time point for T. gondii infection experiments.  
 
Fig. 23 (following page). Ser727-STAT1 phosphorylation confirms the activity of recMgIFN-γ on 
BVK168 cell line and of mouse IFN-γ on AAL-R cell line. NIH/3T3, BVK168 and AAL-R were either 
stimulated for 1 h with recMgIFN-γ (200 ng/ml, upper panel), with mouse IFN-γ (200 U/ml, central 
panel) or left untreated as control (lower panel). In each panel the following staining is shown from left 
to right: phospho-Ser727-STAT1 staining (green), DAPI staining for nuclei (white) and overlay of the 
two signals. Activated Phospho-STAT1 is indicated by nuclear translocation. A representative 







 recMgIFN-γ induces expression of Irgb2-b1 
IFN-γ pathway activation leads to STAT1-mediated expression of numerous target genes, such as the 
Irg gene family in rodents. Due to our interest in this innate immune response gene family during 
infection with T. gondii, I measured the increase of mRNA of one of its members and our main focus, 
Irgb2-b1, by real-time quantitative Reverse Transcription PCR (qRT-PCR) as a further proof of 
recMgIFN-γ activity. At the same time I could assess the relative expression of this gene in the vole-
derived cell lines BVK168 and FMN-R. I compared Irgb2-b1 expression in cells treated with either 
recMgIFN-γ, murine IFN-γ, recTgLEA, or left untreated as control. As reference gene for normalization 
I used the tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta gene 
(Ywhaz), which was previously shown to be a reliable gene for this purpose in the closely related field 
vole M. agrestis (134). Following recMgIFN-γ treatment, a dose-dependent relative increase in Irgb2-
b1 mRNA levels in both vole cell lines was observed, which reached 8-fold when 200 ng/ml protein 
was used, compared to untreated cells or cells treated with the control protein recTgLEA (Fig. 24). The 
latter confirmed a recMgIFN-γ-specific effect on this target gene rather than a non-specific cellular 
stimulation by bacterial contaminants. Taken together, these data demonstrated that recMgIFN-γ was 
capable of activating IFN-γ-dependent cellular responses in two cell lines of the two related vole species. 




Fig. 24. Dose-dependent induction of the expression of the target gene Irgb2-b1 by recMgIFN-γ in 
BVK168 and FMN-R cells. Bank vole BVK168 and common vole FMN-R cells were treated for 24 h 
with either the negative control protein LEA (200 ng/ml), mouse IFN-γ (200 U/ml) or recMgIFN-γ (10-
fold dilution from 200 to 0.2 ng/ml). The reported mRNA fold induction is relative to untreated cells 
(set as 1; not shown) and normalised to Ywhaz for reference. Mean ± SEM (n = 3 experiments, each 
with 2 replicates) are shown. Statistical analysis: One-way Anova followed by Dunnett's multiple 
comparisons test (all against the LEA control protein). BVK168 (F(5,12) = 3.75, p=0.0282) * p=0.0322, 
FMN-R (F(5,12) = 21.34, p<0.0001) **** p= 0.0001, *** p=0.0004. Note that only statistically 
significant (p≤0.05) differences were depicted in the figure. 
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 recMgIFN-γ limits replication of vesicular stomatitis virus in bank vole cells  
Testing for antiviral activity is a standard procedure for reporting biological activity of IFN-γ. BVK168 
cells were previously shown to be permissive for a number of viruses including vesicular stomatitis 
virus (VSV) (125) known to be highly susceptible to IFN-γ treatment in murine cells (172, 173). Bank 
voles are known reservoir of murid herpesvirus (174, 175) also responding to the type II interferon 
response (176). Georg Kochs (University Freiburg, Germany) performed viral infections of BVK168 
cells treated or not with recMgIFN-γ to test its antiviral activity. He used two luciferase expressing viral 
strains, as the VSV replicon VSV*ΔG(FLuc) (145) and a murine gammaherpesvirus 68 (MHV68), as 
an easy to follow reporter via bioluminescence readout for measuring the IFN-γ effect on virus 
replication. As positive control he used a human hybrid type I interferon, IFN-αB/D, shown previously 
to be active on a wide variety of mammalian species and to inhibit VSV virus replication (144), and as 
negative control recTgLEA to assess specificity of recMgIFN-γ. As shown in Fig. 25, we observed a 
drastic reduction of virus replication in VSV-infected BVK168 cells treated with 1 ng/ml recMgIFN-γ 
and to a lesser extent with a lower concentration (0.2 ng/ml). No obvious antiviral effect was seen in 
cells treated with the control protein LEA. These results demonstrate that recMgIFN-γ possesses 
antiviral activity using this host-virus system. However, recMgIFN-γ antiviral potency led to 
inconsistent results on MHV68-infected BVK168 cells (Fig. 25).  
Vole BVK168 cells also proved to be susceptible to infection with cowpox virus (CXPV) isolates from 
both a Brazilian rodent (125) and from the closely related M. arvalis (177). In collaboration with Heinz 
Ellerbrok (Robert Koch-Institut), we infected BVK168 cells with a cowpox virus (CXPV) Brighton Red 
strain expressing a green fluorescent protein to further prove recMgIFN-γ antiviral capacity, given the 
dependancy of the virus on this pathway (178). Fluorescence detection is a convenient read-out for viral 
growth and equally sensitive to virus-related bioluminescence signal (173). Unfortunately, results on 
recMgIFN-γ-mediated control of CXPV Brighton Red strain replication in BVK168 cells were 





Fig. 25. recMgIFN-γ limits replication of vesicular stomatitis virus, but not of murine 
gammaherpesvirus 68, in BVK168 cells. Cells infected with either (a) VSV*ΔG(FLuc) or (b) MHV68 
strains expressing firefly luciferase were treated with either IFN-αB/D (5 ng/ml) as a known positive 
effector; with two concentrations of recMgIFN-γ or the negative control protein LEA (1 and 0.2 ng/ml), 
or left untreated as control. The bioluminescence signal represents viral replication which is reported as 
percentage relative to untreated cells (not shown). Shown are mean ± SEM (n = 3 experiments, each 
with 2 or 3 replicates). Statistical analysis: One-way Anova (F(4, 10) = 37,24, p<0.0001) followed by 
Sidak's multiple comparisons test, ** p= 0.0003, *** p<0.0001.  
 
 Establishment of a bank vole reporter cell line responsive to recMgIFN-γ 
An IFN-γ-responsive, sensitive reporter cell line would be advantageous for different purposes, like 
studying the influence of pathogens on JAK-STAT signalling pathway. Moreover, it would provide an 
easy system to test for functional activity of recMgIFN-γ. To this end, I established a bank vole reporter 
cell line from BVK168 cells (named BVK-LucA) containing the stably integrated pGAS-Luc-Bsd 
plasmid expressing firefly luciferase under the control of a minimal promoter with GAS sites (see 
chapter 5.4.2 for details on the establishment of the cell line). pGAS-Luc-Bsd encodes for a Renilla 
luciferase gene under the control of a promoter with a human-derived GAS sequence. The resulting 
plasmid pGAS-Luc-Bsd was transfected in BVK168 cells. Stimulation of BVK-LucA with an active 
IFN-γ induces expression of the luciferase via STAT1 binding to the GAS site. Thus, recMgIFN-γ 
activity can be tested on BVK-LucA cells in a bioluminescence assay. 
Since this is the first stable transfection of bank vole cells to our knowledge, different transfection 
methods were tested. Methods included both polymer-based techniques, as home-produced 
polyethylenimine (PEI), and magnetic nanoparticles-conjugated reagents, as PolyMag™ and 
CombiMag™. All mentioned reagents are cationic polymers, or bound to cationic molecules, to bind 
the plasmid and introduce it in host cells (see 5.4.2 for details). BVK-LucA were transfected with the 
pmaxGFP plasmid to evaluate trasfection efficiency via expression of a green fluorescence protein. This 
bank vole cell line resulted easy to transfect with the highest efficiency reached with PolyMag™, 
followed by PEI and CombiMag™ (Fig. 26). Therefore, BVK168 cells were transfected with the created 
plasmid pGAS-Luc-Bsd independently with PolyMag™ and PEI methods, and selected for stable 
transfected clones. Cell growth and morphology were not affected, confirming Magnetofection™ and 
PEI-based methods suitable for transfection. The clonal BVK-LucA cell line established via PEI-




Fig. 26. Different transfection methods are suitable for the BVK168 bank vole cell line. BVK168 
cells are easy to transfect and the Magnetofection™-based transfection method with PolyMag™ provides 
a higher transfection efficiency compared to CombiMag™ and polyethylenimine (PEI). BVK168 cells 
were transfected with the pmaxGFP plasmid expressing a green fluorescent cytoplasmic protein to 
evaluate transfection efficiency. Representative images are shown. The scale bar represents 200 µm. 
 
The established BVK-LucA reporter cell line was treated with different concentrations of recMgIFN-γ 
in a bioluminescence assay to assess activity of the protein. Cells were treated with recTgLEA, mouse-
γ and left untreated as control. As illustrated in Fig. 27a, titration of recMgIFN-γ produced a sigmoidal 
dose-response in bioluminescence (6 to 8-fold) relative to control cells, which is typical for bio-indicator 
lines. Within the linear range of the assay (between 20 and 0.02 ng/ml) recMgIFN-γ showed a dose-
dependent decrease in signal strength, validating the BVK-LucA cell line as a useful tool to standardise 
recMgIFN-γ batches over a 100-fold concentration range.  
After, I tested recMgIFN-γ activity from two independently produced batches of protein, each of them 
aliquoted in three different aliquots. Bioluminescence signal intensity resulting from the BVK-LucA 
treatment with all preparations was comparable 5 h post treatment, whereas up to 10-fold of difference 
in signal was observed at 18 h (Fig. 27b). RecMgIFN-γ aliquots giving comparable results at both time 
points, corresponding to n° 1 and 4 in Fig. 27b, were used all throughout the project.  
I here for the first time established a stably transfected bank vole cell line. With the resulting BVK-
LucA cells I confirmed the reproducibility in the activity of different batches of recMgIFN-γ. Treatment 
with the recombinant cytokine induces a dose-dependent bioluminescent signal in BVK-LucA cells, 




Fig. 27. Dose-dependent firefly luciferase activity after recMgIFN-γ induction in a bank vole 
reporter cell line. Bioluminescence assay on the reporter cell line BVK-LucA expressing the firefly 
luciferase gene under the control of a GAS promoter element. The reported bioluminescence values are 
relative to untreated cells. (a) Cells were either left untreated (ctrl, not shown) or treated with the control 
protein LEA (200 ng/ml); mouse IFN-γ (200 ng/ml) or recMgIFN-γ (200 to 0.00002 ng/ml). Mean ± 
SEM (n = 4 experiments, each with 3 replicates). Statistical analysis: One-way Anova (F(9, 30) = 76,16, 
p= <0.0001) followed by Dunnett's multiple comparisons test (all against the LEA control protein). *** 
p=0.0002, **** p≤0.0001, relative to the control protein LEA. Note that only statistically significant 
(p≤0.05) differences were depicted in the figure. (b) RecMgIFN-γ activity in different produced batches 
is comparable. Cells were either left untreated (ctrl, not shown) or treated for 5 h and 18 h with two 
different batches of recMgIFN-γ (200 ng/ml), each aliquoted in three different vessels. Variance 
indicates ± sd of 2 independent experiments. 
 
6.3 T. gondii infection in M. glareolus-derived cell cultures  
6.3.1 Virulent T. gondii growth in the BVK168 bank vole cell line 
The number of established non-model cell lines is constantly increasing (57); however is still very 
limited compared to classical hosts like human and Mus spp.. Thus, the availability of an established M. 
glareolus kidney cell line (BVK168, (125)) represented a fortunate starting point to study parasite 
growth in this rodent species. Susceptibility to different virus infections has been already established in 
this cell line (125); however to our knowledge the work presented here is the first parasite infection 
performed in bank vole cells. 
To test the hypothesis that vole cells resist virulent T. gondii infection via an IFN-γ-dependent 
mechanism, we first observed parasite virulence in BVK168 cells in a so-called plaque assay. Parasite 
growth is assessed by quantifying the number of infection foci, or plaques. A host-induced limitation of 
parasite growth results in less such plaques (Fig. 28a). Surprisingly, BVK168 cells treated with 
recMgIFN-γ had an identical number of plaques to untreated controls, but of larger size (Fig. 28b). A 
direct comparison with murine fibroblasts was not possible since the latter outgrown the formed plaques 
(not shown), contrary to vole kidney cells which grow as a monolayer. Since BVK168 cells do not reach 
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full confluence, but rather leave small openings, the assay was only performed with RHβGFPmt parasite 
strain which expresses β-galactosidase and allows a distinction between spontaneous cavities and T. 
gondii induced plaques (see Fig 28a). 
 
Fig. 28. Virulent T. gondii infection leads to bigger plaques in recMgIFN-γ-treated BVK168 cells. 
M. glareolus BVK168 cells were treated with 200 ng/ml recMgIFN-γ or left untreated 24 h prior 
infection with type I T. gondii strain expressing β-galactosidase for plaque assay. (a) Vole BVK168 
cells are suitable for plaque assay since cells grow as monolayer. Parasites were stained with X-Gal/NBT 
staining (179). The scale bar represents 500 µm. (b) Mean ± sd of plaque number and area, normalized 
to untreated controls (n = 2 experiments, each with 2 or 3 replicates).  
 
6.3.2 T. gondii inhibits STAT1 pathway in bank vole cells 
Recently it was unveiled that T. gondii manipulation of the host acts also via inhibition of the IFN-γ 
pathway by blocking STAT1 transcriptional activity, observed in both human and murine cells. T. gondii 
TgIST sequesters STAT1 in an inactive form within the host nucleus, blocking its transcriptional activity 
(88, 89). The availability of the bank vole reporter cell line BVK-LucA allowed us to test whether the 
parasite’s ability is exclusive for mouse and human cells, or whether it is a conserved feature also in 
other rodents such as M. glareolus. With this assay, cells exhibit bioluminescence upon IFN-γ treatment 
due to STAT1 binding to the GAS sequences in the promoter region of the luciferase gene. Cells were 
infected prior to IFN-γ treatment similarly to published protocols (88). Parasite infection of both virulent 
and avirulent strains decreased the bioluminescence signal induced by recMgIFN-γ, indicating that 





Fig. 29. T. gondii inhibits STAT1 pathway in vole cells. Bioluminescence assay on the reporter cell 
line BVK-LucA at 5 h and 18 h post-treatment. Cells were either infected with type I (RhßGFPmt) or 
type II (Pru dtTomato) T. gondii strains or left uninfected. 2 h post infection, cells were either treated 
with recMgIFN-γ (400 ng/ml) or left untreated. The reported bioluminescence values are relative to 
untreated not infected cells. Variance indicates ± sd of 2 independent experiments, each with 3 technical 
replicates. 
 
6.3.3 Establishment of primary M. glareolus cell culture systems 
Although another kidney cell line is commonly used for T. gondii infection – i.e. the African green 
monkey VERO cell line – kidney cells are not likely to play a major role in vivo. The most used cell 
types for in vitro tachyzoite infection are immune cells such as macrophages (180) and nonhemopoietic 
cells as fibroblasts. Both hemopoietic and non hemopoietic cells are crucial for cellular immune 
response to T. gondii infection (74). The fortunate access in my institute to a living colony of M. 
glareolus gave us the chance to expand the repertoire of available relevant cell types. Notably, this is 
the first reported attempt of isolation of M. glareolus immune cells. 
Protocols for establishment of M. glareolus Bone Marrow-Derived Macrophages (BMDMs) and 
primary fibroblasts systems (explained in Chapter 5.3.2) required several steps of optimization. Final 
protocols reported here lead to BMDM cultures which phenotypically resemble murine BMDMs. To 
evaluate their phenotype, BMDMs were incubated with latex beads to test for phagocytic activity (181). 
I observed equal distribution of macrophages in four different categories according to their phagocytic 
capacity: a quarter had the cytoplasm full of beads, a quarter counted between three and ten beads, a 
quarter had only one or two beads per cell and the remaining quarter phagocytized no beads at all (Fig. 
30a). Additionally, phenotypic characterization of BMDMs by flow cytometry was attempted using 




As anticipated from results on BVK168 cells, both cell cultures were responsive to recMgIFN-γ, as 
indicated by the phosphorylation of the nuclear STAT1 in treated cells compared to untreated controls 
(Fig 30b, controls not shown). 
 
Fig. 30. M. glareolus Bone Marrow-Derived Macrophages (BMDMs) and primary fibroblasts 
cultures were established. (a) Phagocytic assay with BMDMs and latex beads. A representative image 
is shown. (b) Both cultures are responsive to recMgIFN-γ as indicated by phosphorylation and 
translocation to the nucleus of STAT1 following treatment (200 ng/ml) compared to untreated controls 
(not shown). In each panel, the following stainings are shown from left to right: phospho-Tyr701-
STAT1 staining (green), DAPI staining for nuclei (white) and overlay of the two signals. A 
representative experiment of three replicates is shown. The scale bar represents 50 µm. 
 
6.3.4 Virulent T. gondii growth in M. glareolus cell cultures 
T. gondii replicates synchronously in a binary logarithmic fashion, resulting in vacuoles with a single, 
two, four, or eight or more parasites, until they egress from the infected cell. First evidence of host 
resistance is represented by a decrease in the number of parasites per vacuole following immune 
activation (182). To test the hypothesis that primary and immortalized vole cells resist virulent parasites 
infection in an IFN-γ-dependent manner we monitored intracellular parasite growth at two times points 




RecMgIFN-γ treatment does not seem to impact parasite replication at 24 hpi in BMDMs and BVK168 
cells, but it results in bigger vacuoles in BMDM at 36 hpi (Fig. 31a and 31b). On the contrary, 
preliminary results on primary fibroblasts display the opposite trend, with parasites replicating faster 
following recMgIFN-γ treatment compared to untreated controls at 24 hpi. However, this difference in 
numbers is not observable twelve hours later (Fig. 31c). Notably, the majority of vacuoles with eight 
parasites or more observed in BMDM cultures were in big polynucleated cells (black arrow head in Fig. 
31d), whereas most of the smaller cells with a single nucleus had one parasite or none. These 
polynucleated cells, or giant cells, increased in number upon infection, suggesting an induction 
following infection. Taken together, in the M. glareolus host parasite intracellular growth is not strongly 
influenced by recMgIFN-γ treatment in any of the cell types investigated here, in spite of STAT1 
activation. 
 
Fig. 31. Virulent parasite intracellular growth is not decreased in M. glareolus cells following 
recMgIFN-γ treatment. I investigated three different M. glareolus cell cultures: (a) Bone Marrow-
Derived Macrophages (BMDMs), (b) an immortalized BVK168 kidney cell line, and (c) primary 
fibroblasts. Cells were treated with 200 ng/ml recMgIFN-γ or left untreated 24 h prior to infection with 
type I T. gondii expressing a green fluorescent protein in the mitochondria. 24 hpi and 36 hpi cells were 
fixed, parasites’ plasma membrane stained to facilitate counting parasites per vacuole. The number of 
parasites was counted in at least 100 parasitophorous vacuoles per sample. Mean ± sd (n = 2 
experiments) is shown. (d) shows a representative immunofluorescent assay of recMgIFN-γ-treated 
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BMDM 36 hpi. The black arrow-head indicates the vacuole containing more than eight parasites in a 
multinucleated cell. A Differential Interference Contrast (DIC) transmission light image with overlay of 
the following stainings is shown: parasite mitochondria marker (green), parasite membrane with anti-
SAG1 staining (red) and DAPI staining of nuclei (blue). The scale bar represents 50 µm. 
 
6.3.5 IFN-γ-mediated cell death during T. gondii infection 
Host-mediated parasite killing followed by death of the host cell itself was proposed as a host resistance 
mechanism. Because BVK168 cells infected with virulent parasites were observed rounding up and 
detaching from the plate bottom in recMgIFN-γ-treated but not in untreated control cells (not shown), I 
hypothesized that this phenomenon occurs in vole cells as well. I measured the magnitude of host cell 
death in several cell types during infection by means of two assays as described below. 
Propidium Iodide assay to detect host cell death during T. gondii infection 
We performed a double staining with Propidium Iodide (PI) and Hoechst 33342 to quantify the ratio of 
necrotic (PI+) cells during T. gondii infection and IFN-γ stimulation. All M. glareolus cells displayed 
an IFN-γ-dependant increase in cell death during virulent infection (Fig. 32 a and b). This phenotype is 
therefore conserved in all these species cells; however, to different degrees depending on cell type. 
Almost all type I infected primary fibroblasts died, more than half of BMDM cells died, and ~20 % 
kidney cells of the immortalized BVK168 cell line died as determined by the PI-assay. During avirulent 
infection only primary fibroblasts showed an increase in cell death in IFN-γ-treated cells compared to 
untreated controls. 
 
Fig. 32. M. glareolus cells undergo IFN-γ-mediated cell death following virulent T. gondii-
infection. (a) M. glareolus BVK168 kidney cell line, Bone Marrow-Derived Macrophages (BMDMs), 
and primary fibroblasts were treated with 200 ng/ml recMgIFN-γ or left untreated 24 h prior infection 
with avirulent (type II) and virulent (type I) T. gondii. 24 hpi a double staining with Propidium Iodide 
(PI) and Hoechst 33342 on living cells was performed and double stained nuclei were quantified at the 
fluorescent microscope. Variance indicate mean ± sd (n = 3 experiments, each with 2 technical 
replicates). (b) Representative image of BVK168 cells infected with RhßmGFP type I parasites 
expressing a green fluorescent protein in the mitochondria. 
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Flow cytometry-based assay to detect host cell death and T. gondii parasite burden  
The performed experiments informed us that IFN-γ-primed M. glareolus cells die following virulent 
parasite infection while the intracellular growth in surviving cells seems not to be affected. However, 
we did not have information regarding the overall T. gondii burden changes following treatment. We 
decided to develop an appropriate assay to assess this and further prove the IFN-γ-related cell death. A 
LIVE/DEAD fixable dye, staining exclusively dying cells, was used in a flow cytometry-based 
experiment as described in chapter 5.3.7 and showed in Fig. 33a. Infection with differently fluorescent 
parasite strains allowed their detection with appropriate lasers, whereas the cell population was 
recognized by its physical parameters.  
The performed experiments informed us that IFN-γ-primed M. glareolus cells die following virulent 
parasite infection whereas the intracellular growth in surviving cells does not seem to be affected. 
However, the PI-assay does not assess the overall T. gondii burden changes following treatment. I 
developed an assay to assess this and further investigate IFN-γ-related host cell death. A LIVE/DEAD 
fixable dye, staining exclusively dying cells, was used in a flow cytometry-based experiment as 
described in chapter 5.3.7 and shown in Fig. 33a. Infection with differently fluorescent parasite strains 
allowed detection with appropriate lasers, whereas the host cell population was recognized by its 
physical parameters. 
 
Fig. 33. Gating strategy for the flow cytometry-based assay. (a) A mixed population of living and 
heat-killed M. glareolus BMDMs stained with the LIVE/DEAD dye detected by the PB450-A filter. (b) 
Gating strategy of live infected, live uninfected and necrotic cells, the latter including both infected and 
uninfected populations. On the y axis either the FITC or the PE channel, according to the infection 
performed with either RHβGFPmt (type I) or Pru tdTomato (type II) parasites respectively. (c) An 
example of gating on recMgIFN-γ-treated M. glareolus BMDM 8 hpi with RHβGFPmt. 
The assay was performed in M. glareolus BMDMs since they displayed a more pronounced phenotype 
than kidney cells in the PI-assay and posed less challenges in cultures compared to primary fibroblasts. 
Confirming the PI-assay results, an IFN-γ-dependent increase in dying BMDMs of 50 % compared to 
untreated controls was observed during virulent parasite infection (Fig. 34a). At the same time, the 
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amount of living infected cells, which would further contribute to infection in a real setting, decreased 
drastically. Also, confirming the phenotype with avirulent parasite infection, an increase in cell death 
was not measured with type II parasite infection. However, IFN-γ-treated cells appear able to clear 
infection since the amount of infected cells was halved 24 hpi (Fig. 34a). In living infected cells the 
median fluorescence intensity relative to the parasite labels for type I and type II parasites, decreased by 
almost 40 % compared to untreated cells (Fig. 34b). The same trend was visible already at 8 hpi in two 
independently performed experiments (Fig. 34c). Taken together these results indicate that M. glareolus 
BMDM limit both virulent and avirulent parasites burden in a IFN-γ-dependent fashion. 
 
Fig. 34. IFN-γ treatment decreases parasite burden in M. glareolus Bone Marrow-Derived 
Macrophages. M. glareolus Bone Marrow-Derived Macrophages were treated with 200 ng/ml 
recMgIFN-γ or left untreated 24 h prior infection with type II and type I T. gondii strains. (a) 24 hpi 
cells were stained with a LIVE/DEAD dye, fixed and analyzed at the flow-cytometer. Mean ± sd (n = 2 
experiments, each with 2 replicates). (b) Decrease in the median fluorescence of live infected cells in 
recMgIFN-γ-treated cells indicates a decrease in parasite burden. (c) Same experiment performed at 8 
hpi. Mean ± sd (n = 2 experiments, each with 2 replicates). 
6.3.6 Investigating the role of M. glareolus Immunity Related GTPases in resistance to T. gondii 
Results support M. glareolus resistance to both virulent and avirulent T. gondii infection in a IFN-γ-
dependant fashion. This phenotype is related to IFN-γ-induced mediators. Since our main protein family 
of interest, IRG, is induced by the cytokine, we investigated the possible role of IRGs as mediators. 
Unfortunately, antibodies developed against the murine proteins do not cross-react with this vole species 
(Tab. 19), making it impossible to directly study IRGs in M. glareolus-derived cells without developing 
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species-specific antibodies. As for the main target, IRGb2-b1, a small band is visible in a Western Blot 
with lysates from IFN-γ treated BVK168 cells. However, this faint band is not comparable with the one 
visible for the positive control murine cells, and could even be another recognized tandem, similarly to 
what I observed in Flp Δb2b1 in Fig. 18a. 
 
Tab. 19 List of murine antibodies and serum anti-murine Irg proteins tested on M. musculus and 
M. glareolus cell lines. The type of parasite used during infection in IFA, either I or II, is reported in 
parenthesis. When not specified, the experiment performed was an IFA. * This experiment was 
performed by Tobias Steinfeldt (183). Na = not assessed. Detailes on antibodies sources are indicated 
in Tab. 6. § indicates the commercial anti-IRGb6 antibody.  
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Fig. 35. There is no cross-reactivity of murine anti-IRG antibodies with vole cell lines. (a) DB71 
total protein staining (left) and Western Blot with anti-IRGb2-b1 serum on the same membrane (right) 
of lysates from Flp-In-3T3 and BVK168 cells. Cells were treated for 24 h with IFN-γ (mouse IFN-γ 200 
U/ml for Flp-In-3T3 cells and recMgIFN-γ 200 ng/ml for BVK168 cells), with the negative control 
protein recTgLEA (LEA, 200 ng/ml) or left untreated as control (ctrl). The first lane is the molecular 
weight marker (with sizes in kDa given to the left). (b) IFA of NIH/3T3 cells infected with type II T. 
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gondii. The following stainings are shown: T. gondii SAG1 (red), GRA7 (green), DAPI staining for 
nuclei (blue). A representative image is shown. The scale bar represents 20 µm. 
 
Therefore, to study the role IRGs play for the M. glareolus resistance phenotype, I first applied the cell 
culture-based system developed in this thesis and presented in chapter 6.1.5. However, as already shown, 
we were not able to replicate results from literature with regards to positive and negative control cell 
lines. Therefore, we did not pursue the use of the cell culture system in this context. 
We overcame this problem by using another recently published cell-based system (115). Using CRISPR-
Cas9, the group of Tobias Steinfeldt (University of Freiburg, Germany) established a clonal CIM Δb2b1 
cell line lacking Irgb2-b1CIM, which renders the cells susceptible to virulent parasite infection. The cell 
line is a useful tool to screen resistant Irg genes, since reintroduction of Irgb2-b1CIM rescues host 
resistance to virulent parasites. We decided to complement CIM Δb2b1 with the cloned vole tandem 
Irgb2-b1 from BVK168 cells, herein named Irgb2-b1BVK (see sequence in Fig. 9). This allows me to 
assess the vole IRGb2-b1 phenotype during infection in otherwise susceptible cells. Preliminary analysis 
of the RNAseq data of BVK168 IFN-γ-induced cells (chapter 6.1.3) identified the cloned Irgb2-b1BVK 
gene in the transcripts. The identified wild type gene has three different amino acids caused by SNPs in 
the primer binding regions which were corrected before cloning. Furthermore, the last three codons 
missing at the C-terminal because of the SapI site (as explained in chapter 6.1.5.1) were introduced. 
Two different clonal cell lines were established: the first with the Irgb2-b1BVK wild type sequence (CIM 
Δb2b1-Irgb2-b1BVK) and the second with the same in frame with an HA-tag (CIM Δb2b1-Irgb2-b1BVK 
HA). Gene insertion was performed by Steinfeldt according to published protocols (115). As visible in 
Fig. 36, the established CIM Δb2b1-Irgb2-b1BVK HA cell line constitutively expresses an HA-tag protein 
at the size of IRGb2-b1, confirming successful cloning of the gene. Confirming our results in Fig. 35a, 
the anti-IRGb2-b1 antibody does not cross-react with the vole tandem IRG-like protein in CIM Δb2b1-
Irgb2-b1BVK cells (Fig. 36). Experiments on the resistance phenotype associated with the introduced 




Fig. 36. Creation of clonal cell lines expressing vole IRGb2-b1. Western Blot with anti-tandem IRG 
serum, anti-HA-tag and anti-β-actin of lysates from CIM, CIM Δb2b1-Irgb2-b1BVK and CIM Δb2b1-
Irgb2-b1BVK HA cells. Cells were treated for 24 h with mouse IFN-γ 200 U/ml or left untreated as control. 
First and eight lanes with molecular weight marker (with sizes in kDa given to the left). The Western 




Wildlife has a recognized central role in zoonotic transmissions (184) of which small mammals alone 
are responsible of nearly 60 % (185). Within Rodentia, voles are a reservoir for 20 % of zoonotic 
pathogens and are predicted to gain even more relevance in the near future (186). Whereas research on 
zoonotic potentials in the fields of viruses and bacteria is proceeding, identification of eukaryotic 
parasitic reservoirs in nature is still neglected (184). In the last two decades, a considerably small number 
of works focused on T. gondii prevalence in Mammals have been published (187). Therefore, research 
on parasitic infections in small mammals, particularly in voles, requires further investigation. This thesis 
makes a contribution to this field by investigating the potential of wild rodents, in particular voles as M. 
glareolus and Microtus spp., as reservoirs for T. gondii in Europe. 
Further adding to their research value as natural reservoirs for pathogens, voles are gaining interest in 
the expanding field of wild or eco-immunology. This branch of immunology focuses on gaining new 
insights on immunologic systems by mimicking natural contexts (57). The add-on derives from either 
the direct study of natural populations or by using wild-derived systems in experiments performed in a 
controlled environment. The vast majority of research studies in biology, including infection biology, 
are based on the use of M. musculus as model organism. Despite the crucial role of laboratory mouse 
systems for advancing in basic biological knowledge, an increasing body of evidence highlights the 
numerous inadequacies of this model (as described for example in these studies (57, 188, 189)). A 
published review which I co-authored (58) and in which we collected results from numerous studies, 
reports issues encountered when using M. musculus as a model for biomedical research, arguing for 
caution in the use of this and other animal models. In the specific example of T. gondii research, the 
definition of parasite virulence in laboratory mice does not reflect the natural susceptibility of M. 
musculus to T. gondii infection. Lilue et al. showed that the extensive inbreeding of T. gondii mouse 
models led to the genomic conservation of Irg genotypes which are associated with a susceptible 
phenotype to infection. This does not reflect the high natural variability of Irg genes which is comparable 
to that of the Major Histocompatibility Complex (MHC, (7)). The study of Lilue et al. evidences how 
the use of laboratory models influenced conclusions on mouse susceptibility in nature, which should be 
revised. In Ehret et al. we also suggest alternatives to the use of laboratory inbred strains. Rodents of M. 
glareolus, Microtus spp. and Apodemus spp. have already been suggested as possible models for 
infection studies. These rodent species are largely diffused, they are natural reservoirs of numerous 
zoonotic pathogens, and carry the genetic variability lacking in inbred mice (51, 188, 189). Both wild 
rodents and wild-derived colonies can help identifying genes linked to susceptibility to pathogens (190). 
The main drawback with using non-model organisms is the lack of genomic references and tested 
reagents, opposite to the murine model that has a long-established set of tools. Nevertheless, significant 
technological advancements combined with an increasing attention from the scientific community are 
helping filling this gap (57, 189). Here, we provide new tools, namely the recombinant vole IFN-γ and 
a reporter cell line to assess its activity, as well as novel cell culture-based systems, to foster research 
on non-model species. I also want to emphasize the need for similar models particularly in the field of 
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parasitology, which is concerned with pathogens with commonly complex life cycles and which per 
definition infect several hosts. 
In the context of research on T. gondii, it has already been suggested that wildlife, particularly rodent 
species different from M. musculus, might be important reservoir for persistence of certain genotypes 
(191). Indeed, in a recent study Galal et al. show that autochthonous non-murine rodent species in 
Senegal are tolerant to infection with virulent T. gondii genotypes, and develop chronic infection (192). 
On the contrary, the same parasite genotypes do not infect M. musculus despite sampling in the same 
geographical area. The authors speculate that the more recent arrival of M. musculus, imported during 
the Colonial era, did not allow for co-evolution processes between host and pathogen. This work 
highlights the need to foster research in natural, non-laboratory systems. The same co-evolution 
mechanism was suggested for virulent T. gondii, such as RH and GT1 strains, and wild-derived M. 
musculus castaneus from Asia, where these genotypes are more common (7). Interestingly, Hassan et 
al. recently showed that the locus encompassing the Irg genes was associated with resistance not only 
in M. musculus castaneus species, but also in the other subspecies M. musculus musculus, regardless of 
breeding approach (62). On the contrary, M. musculus domesticus, whose genome is conserved in 92 
% (including loci for Irgs) of laboratory inbred strains (193), displays susceptibility to virulent infection. 
This work further highlights the critical protective role of IRG proteins during T. gondii infection in a 
relevant host such as M. musculus. 
With the current work we provided new tools to approach research on the non-model organism M. 
glareolus and closely related voles. Furthermore, we investigated the role of non-murine rodent species 
as intermediate hosts for virulent T. gondii genotypes in Europe. We considered M. glareolus, Microtus 
spp. and Apodemus spp. since they are major prey of the domestic cat. Moreover, current data indicate 
that these three rodent groups display lower susceptibility to and higher prevalence of T. gondii 
compared to the more often studied Mus spp. Considering the major role of the IRG immune response 
in mediating resistance in certain M. musculus subspecies, we hypothesized that the same mechanism is 
conserved in these other rodents species.  
7.1 Development of a cell culture-based system to study Irg-like genes in non-murine wild rodents 
7.1.1 Irg-like genes variability in wild rodents 
The complexity of Irg sequences, together with the lack of good genomic references, constituted a real 
challenge to obtain an overview of this gene family in non-murine rodents. The RNAseq data currently 
in analysis will provide a comprehensive picture of expressed Irg-like genes in the available wild 
rodents-derived cell lines. In the recent years transcriptomic analysis made remarkable advances and 
data annotation of non-model organisms is now approachable (189). Transcriptomic data will allow us 
to design specific primers to amplify individual Irg-like genes. The highly repetitive nature of Irg genes 
poses an extra challenge: it is not possible to us to discriminate between different alleles of the same 
gene or two similar genes in two distinct loci, for which availability of a relative genome is necessary. 
For this reason, I couldn’t draw conclusions about the correspondence between cloned tandem Irg-like 
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genes from cDNA and identical sequences from cloned gDNA, as in the case of AAL-R tandem 1 (Fig. 
8a), since gene duplication cannot be excluded. A good annotated genome is likely to be provided for 
bank voles in the near future, given the common interest of other groups (Rainer Ulrich, personal 
communication). In this project I cloned and sequenced single Irg-like genes, which is a tedious and 
time-consuming approach. Furthermore, PCR amplification of Irg-like sequences from gut-derived 
gDNA was largely unsuccessful (Fig. 10b). Many reasons could account for the lack of PCR products: 
lack of binding of the primers, presence of an excessive amount of inhibitors as already observed for 
CytB amplification (Fig. 10a), or amplification below detection limit since the genes are single-copy. 
Availability of gDNA derived from tissues other than the intestine with less PCR inhibitors would be 
beneficial for the project. I suggest for future work to streamline the collection of Irg-like sequences via 
for example meta-barcoding, which allows pooling of different samples and is possible for non-model 
organisms, as recently reviewed by Schoetterer et al. (194). For example, the T cell receptor (TCR) 
variability was characterized via high-throughput sequencing in a collection of M. glareolus samples 
(195). Profiling of immune genes, like TCR, Irg and MHC, will surely foster immunological studies in 
relevant reservoirs in the wild. Successful examples are given by studies reporting a correlation between 
specific MHC alleles and nematode infection in M. glareolus (196) and genetic diversity of different 
cytokines and infection with several pathogens in a well-studied population of M. agrestis (121). 
Different polymorphisms and expression levels of host immune genes might ultimately lead to 
differences in the geographic distribution of pathogens (119).  I envisage that, with this established set-
up, we will be able to identify immune genes correlated with infection to T. gondii in German samples 
of M. glareolus, Microtus spp. and Apodemus spp. already available to us (49). 
Despite resource limitation, I increased knowledge about putative Irg genes in non-murine rodents. First, 
analysis of the M. ochrogaster transcriptome revealed that Irg-like genes disposition is conserved with 
Mus musculus (Fig. 6). Putative effector genes and two tandem Irg-like genes are present in this vole 
species. Their presence hints to a possible role in cell-autonomous defense against intracellular 
pathogens like T. gondii, since not relevant intermediate hosts like humans lost the genes (197). Tandem 
Irg-like genes are not only expressed in M. ochrogaster, but also in our German wild rodents-derived 
cell lines (Fig. 7). Several results indicate the presence of more than one putative tandem-Irg in these 
rodent species: Irg-like genomic loci are amplified as 9 and 11 kb-long PCR products and are transcribed 
as 2.5 kb-long mRNA (Fig. 8a and 8b). The two bands from PCR-amplied gDNA were observed for 
murine Flp-In-3T3 cells, M. arvalis FMN-R cells and A. agrarius AAL-R cells, and have a similar size 
to those of reference M. musculus and M. ochrogaster genomes. In spite of the presence of a single band 
for M. glareolus BVK168 cells, we cannot exclude presence of more than one tandem since introns 
might vary in size. Furthermore, Irg-genes heterozygosity was observed in wild-derived M. musculus 
((163), Jonathan Howard personal communication) and could characterize our samples as well. Mixed 
nucleotides from sequencing of PCR products for all the mentioned wild rodent species confirm the 
presence of more than one putative tandem Irg gene or allele (Fig. 8c). The A. agrarius tandem 2 IRG-
like protein is characterized by many stop codons at the C-terminal (Fig. 9). Further work will assess 
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whether the repetitive residues in the sequence caused a frame-shift (Appendix Fig. 37) or if the gene is 
a pseudogene, whose presence in the Irg family has already been described in Mus spp. (7). Future 
availability of good quality genomic and transcriptomic data of the same cell lines will help to interprete 
these results.  
I observed that the IRGb2-like subunit only (with the C-terminal of IRGb1) binds the PVM of virulent 
parasites (Fig. 15b). This observation recalls published results from Murillo-Leon et al. on the 
IRGb2CIM-subunit, which is sufficient for binding and to confer resistance in in vitro infections (115). 
They concluded that the molecular mechanism of resistance resides within residues in the Irgb2 exon. 
We observed variability in the IRGb2-like subunit of wild rodents’ samples, in residues where the 
resistant IRGb2CIM differs from the susceptible IRGb2BL6 (Fig. 11). Notably, these different residues are 
enriched at the putative interface with T. gondii virulence factor ROP5, suggesting positive selection at 
this site (Fig. 12). The highest amino acid diversity between IRGb2CIM and IRGb2BL6 was observed in 
the αD and H4 domains (7), which are also diverse in our wild rodents’ samples (Fig. 9). Analysis of a 
higher number of samples is necessary to support the hypothesis of positive selection in these domains 
and to identify putative critical residues for resistance. 
Polymorphisms directly influencing host susceptibility to infection can also be found in genes upstream 
in the pathway leading to Irg genes expression. For example Rohfritsch et al. found polymorphisms in 
TLR and JAK-STAT-associated genes, e.g. IL12rb1, in a wild population of M. glareolus to be 
associated with tolerance to Puumala virus infection (198). Similar mechanisms might exist for infection 
with other pathogens, as the protozoan T. gondii. Also SNPs in non-coding regions could affect gene 
expression and lead to different susceptibility to infection. M. glareolus SNPs in non-coding regions of 
the immune related gene IFIH1, important for virus sensing, influence its expression levels (199). 
7.1.2 Not reproducibility of the resistance phenotype in the positive control cell line 
I developed the Flp-In-3T3-based cell system to investigate the phenotype related to IRG-like proteins 
from wild rodents during infection with T. gondii. I first tested the system by establishing a positive 
control cell line expressing the resistant Irgb2-b1CIM and a negative control cell line expressing the 
susceptible Irgb2-b1BL6 (Fig. 14a). I expected the created Flp-CIM and Flp-BL6 to be resistant and 
susceptible to virulent T. gondii infection respectively. In Table 20 I graphically summarize the outcome 
of in vitro infections performed on murine and vole cell systems in this project. I compare my results to 
published work on inbred mouse cells and wild-derived M. musculus castaneus cells. In literature, IFN-
γ-treated BL6 murine embryonic fibroblasts (MEFs) drastically decrease type II T. gondii parasite 
burden and display an increase of 25 % in necrotic cells compared to untreated control cells at 24 hpi 
(7). This in vitro phenotype is correlated with host resistance in vivo and we refer to it as the “resistance 
phenotype” (7). M. musculus castaneus CIM strain display the same in vitro phenotype to infection with 
both medium virulent type II and virulent type I strains, and are resistant to the same in vivo (7, 115). 
Therefore, data from literature suggest that host resistance is linked to IFN-γ-mediated host cell death. 
On the contrary, BL6 MEFs limit parasite burden of type I T. gondii but do not undergo cell death (7). 
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Since infection with the same strain in vivo is lethal for inbred mice, we refer to the lack of host cell 
death as the “susceptible phenotype”.  
Tab. 20. Infection phenotype with virulent and intermediate virulent T. gondii in vole and murine 
systems. A graphical report of the performed in vitro experiments in this study and published work on 
inbred mouse cells and wild-derived M. musculus castaneus cells. Highlighted in pink the cell types that 
display >20 % cell death to type I T. gondii infection. This in vitro phenotype is associated in M. 
musculus castaneus CIM mice with in vivo resistance to type I infection. Reported in vitro assays are 
diverse. Host cell death expressed in percentage was detected by Propidium Iodide staining in this study, 
whereas in published work was deducted from cell viability assays. T. gondii burden was quantified in 
a flow-cytometry-based assay in this as well as published work; other works also quantified parasite 
burden by 3H-uracil incorporation or T. gondii-mediated enzymatic reactions. T. gondii intracellular (IC) 
growth refers to the number of parasites counted per vacuole. Na = not assessed. MEF = murine 
embryonic fibroblasts. BMDMs = Bone Marrow-Derived Macrophages. When not indicated, data from 
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Flp-In-3T3, and the derived Flp-CIM and Flp-BL6, do not mirror the phenotype displayed by murine 
fibroblast cultures in literature. The parental Flp-In-3T3 cells display an IFN-γ-mediated increase of ~15 
% in necrotic cells compared to untreated controls during both type I and II T. gondii infection. Results 
on Flp-In-3T3 cells from Propidium Iodide (PI) stainings and from a preliminary cytotoxicity assay are 
in agreement (Fig. 16, Appendix Fig. 39). The necrotic death phenotype for type II infection is not to 
the extent of published data. First results obtained with the cytotoxicity assay, which uses the release of 
lactate dehydrogenase (LDH) from dying cells as proxy for cell death, made us questioning the validity 
of the assay and was not performed further. However, the PI-assay confirmed this phenotype. 
Surprisingly, the same proportion of dying cells was observed following type I infection, indicating that 
cells are not completely susceptible to the parasite (Fig. 16). The high concentration of mouse IFN-γ 
used (200 U/ml), chosen accordingly to previous studies (7), could account for this modest resistant 
phenotype during virulent infection. Indeed, already half of the IFN-γ concentration was shown to 
partially limit virulent parasite proliferation in murine inbred cells (7, 182). In our experiments IFN-γ 
was the only inducer of host immune response, since the main aim was the expression of Irg genes. 
However, during infection cells receive more stimuli and studies showed the importance of the TNF-α 
pathways’ activation in parasite control, both in hematopoietic and not hematopoietic cells of mouse 
and human origin (74, 76, 200). The IFN-γ/TNF-α axis is not dispensable in parasite control (74), even 
though NIH/3T3 cells’ control of virulent parasite does not significantly increase when stimulated with 
both cytokines (182).  
As expected, since already the Flp-In-3T3 wt phenotype did not reproduce published results, Flp-BL6 
and Flp-CIM did not either (Fig. 16). A lower percentage of positive control IFN-γ-treated Flp-CIM 
cells underwent cell death compared to the parental strain during parasite infection. Both cell lines did 
not display visible differences in parasite growth and preliminary counts of type I parasite number per 
vacuole confirmed no differences between Flp-BL6 and Flp-CIM cells (Appendix Fig. 38). Control of 
type II parasite intracellular growth was to the same extent in both cell lines (Appendix Fig. 38). 
Flp-In-3T3 cells express an unexpectedly high amount of endogenous IRGb2-b1 (Fig. 17c), similarly to 
the parental strain NIH/3T3 (not shown) but much higher to what previously published on BL6 MEFs 
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(163). Establishment of a primary murine fibroblast culture confirmed the lower amount of IRGb2-b1 
in primary cells compared to immortalized cell lines available to us (Fig. 17c). Since the amount of 
endogenous protein greatly exceeded the transfected one (Fig. 17a), I speculated that the two might 
interfere and directly cause the not reproducibility of the T. gondii infection phenotype in Flp-In-3T3 
transfected cells. However, via creation of the knock-out cell line, Flp Δb2-b1, I proved that the 
endogenous protein is not influencing for the phenotype. Established Flp Δb2-b1-CIM and Flp Δb2-b1-
BL6 cell lines displayed the same phenotype to T. gondii infection in a PI-assay as the cell lines with 
the endogenous Irgb2-b1 (Fig. 18b). I concluded that this specific cell culture-based system cannot be 
used to study Irg genes since it does not reproduce the resistance phenotype for still unknown reasons. 
Unfortunately, Flp-In-3T3 cells were the only available murine cell type with the FRT cloning-based 
system. To still benefit of the produced plasmids and of the cloning strategy, production of different 
mouse cell systems with introduced FRT sequence is possible. To investigate bank vole IRGb2-b1-like 
role in resistance to T. gondii, we cloned Irgb2-b1BVK in CIM Δb2b1 via an alternative lentiviral system 
since both this cell line and protocol were established (115). Characterization of the T. gondii infection 
phenotype in this cell line is currently ongoing. 
Because of the use of degenerated primers, the Irgb2-b1 sequences we cloned in pES51-bl were all 
characterized by the presence of a myristoylation MGXXS sequence at the N-terminal (Fig. 7 and 9), 
which is signature of most murine effectors and decoy Irg genes (91). However, the original Irgb-b1CIM 
sequence has instead a MDXXS sequence that, because of our approach, was mutated into MGXXS, 
turning the protein into a putative target of myristoylation. The latter is a post-translational modification 
that facilitates membrane binding (83). Whether IRGs are target of myristoylation and the role of the 
modification on the protein function were never assessed. The mutated sequence was cloned in the Flp-
CIM cell line first and in the Flp Δb2b1-CIM cell line after. We cannot exclude that this mutation was 
the direct cause of the not reproducibility of the resistance phenotype in created cell lines. However, 
Mus musculus Irgb2-b1PWK/Ph allele is also associated with resistance to virulent T. gondii in vivo and in 
vitro and has the myristoylation sequence in common with the susceptible Irgb2-b1BL6 ((62), Catalina 
Alvarez personal communication). Of note if the presence of cysteines, which are target of 
palmitoylation, all throughout the sequence including the C-terminal which is a putative target site for 
this modification. Palmitoylation, similarly to myristoylation, facilitates protein membrane binding, as 
well as farnesylation which is a common modification of other small GTPases as Ras proteins (201). 
Post-translational modifications of IRG proteins in general, and of IRGb2-b1 in particular, warrant 
investigation and might shed light on their mechanism of actions which are still debated. 
7.1.3 Expression levels of Irg genes in Flp-In-3T3 cells 
Irgb2-b1 is highly expressed in resistant murine cell lines, i.e. M. musculus castaneus CIM and M. 
musculus musculus PWK/Ph (7), whereas specific residues associated with resistance are not clearly 
recognizable (Fig. 9). Thus, we can speculate that the expression level of resistant alleles might be 
another crucial factor in Irg-mediated resistance. In vitro systems where the expression of these genes 
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can be easily controlled should be developed to define the importance of protein abundance over gene 
sequence. Promoters with different strength in gene expression can be assembled via Golden Gate in 
plasmids cloned with known resistant and susceptible Irgb2-b1 genes and transfected in Flp-based 
systems. Studies on a natural population of voles already linked expression levels of different immune 
and not immune genes with susceptibility to different pathogens (202).  
Excessive amounts of alleles have also been observed to cause the not reproducibility of resistance 
phenotype in expression cell systems. For example, overexpression of resistance-mediating Irga6 
unexpectedly led to an increased susceptibility to C. trachomatis in mouse cells (123). The authors 
speculated that the protein excess might interfere with other players in the host immune response and 
eventually reverse the phenotype. Similarly, the EF-1α promoter of choice to induce expression of 
introduced Irg sequences in Flp-In-3T3 cells is a strong promoter. We cannot exclude that non-
physiological amounts of xenogenous resistant IRGb2-b1CIM hamper, instead of mediating, the host 
immune response. Low expression or polymorphisms in effectors Irg genes or other important 
mediators, like Irga6 or GBP2 necessary for its loading on the PVM (203), could also account for the 
lack of reproducibility of the infection phenotype in Flp-In-3T3 cells. M. musculus castaneus CAST/Ei 
cells express high levels of a resistance-associated Irgb2-b1 allele but not of effector Irg genes, like 
Irga6 and Irgb6 (163). Nevertheless, CAST/Ei cells display the resistance phenotype to type I infection. 
Since host resistance is a result of all these immune players, having a complete picture of Flp-In-3T3 
cell-autonomous mediators would help to interprete the infection outcome. 
7.1.4 Genetic diversity of both laboratory host cells and parasites strains  
In this study we address only the host genetic variability, keeping as constant the parasite background 
by using laboratory strains. However, it is well known that due to continue passaging, especially of the 
most commonly used RH strains, several mutations accumulated in the parasite genome resulting in 
strains highly different from early isolates (204). Laboratory strains adapted to in vitro cultures and are 
characterized by a higher extracellular survival, faster growth, formation of bigger plaques and inability 
to form orally infectious cysts. Additionally, they recruit less IRGa6 on the PVM and they are more 
resilient to host-mediated killing compared to fresh isolates (205). Thus, the use of laboratory-adapted 
virulent strains might contribute to the lack of reproducibility in our results. To properly address the 
hypothesis that wild rodents are resistant to virulent T. gondii strains in vivo and in vitro, fresh isolates 
should be used, which unfortunately are not easily accessible.   
At the same time, a recent whole genome sequencing of 14 different stocks of one of the most diffused 
laboratory cell lines, the cervical cancer HeLa cells, revealed an enormous genetic diversity which 
contributes for sure to the current reproducibility crisis in the scientific community (206). These genetic 
differences were associated with different phenotype during infection with Salmonella (206). We cannot 
exclude the same happening for another largely diffused cell line, as the NIH/3T3 cells used in this 
study, during T. gondii infection. Furthermore, Flp-In-3T3 cell line could behave differently compared 
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to parental NIH/3T3 cells, as already documented in a study where loss of multipotency was observed 
(207).  
7.2 Role of non-murine wild rodents as reservoir for virulent T. gondii  
7.2.1 Detection of T. gondii infection in wild rodents 
Data collected in chapter 3.2.2 of the introduction indicate that non-murine species as Microtus spp., M. 
glareolus and Apodemus spp., have a higher T. gondii prevalence and are less susceptible to virulent 
parasite infection. Some considerations have to be added in this regard. There is currently no gold 
standard for assessing anti-T. gondii antibodies prevalence and chronic infection, and a systematic 
comparison of different diagnostic methods in terms of sensitivity and specificity has been performed 
only in few isolated cases (192, 208). This makes interpretation of results between different studies 
using different detection methods hazardous. The most used techniques include the Enzyme-Linked 
Immunosorbent Assay (ELISA) and the Modified Agglutination Test (MAT), the latter not relying on 
cross-reactivity of antibodies therefore of broader use. PCR amplification of specific parasite markers, 
even though necessary to assess the genotype, is currently less in use as diagnostic tool since it requires 
a DNA extraction step from bradyzoites. Differences in prevalence within the same rodent species could 
also be due to technical issues related to the test in use, e.g. not cross-reactivity of an antibody or less 
sensitivity of the technique. Finally, rats could be serologically negative even when they harbour T. 
gondii cysts (209) via still unclear mechanisms. This leads to underestimation of the prevalence rates 
and might happen for other rodent species as well. 
Another factor influencing T. gondii prevalence data is the sampling. There is a positive correlation 
between rodent seroprevalence to T. gondii and proximity to human populated areas (210) where the 
probability of getting infected via cat feces is higher (211), as shown by studies in south France. 
Information regarding oocysts density, which might explain geographical seroprevalence heterogeneity, 
are scarce in Europe (212). Studies conducted in urban areas in UK and Senegal reported higher 
prevalences data than in rural areas (59, 192). Sampling might explain why T. gondii rodent positive 
samples were not identified in Germany in one study (18), whereas a more recent work in Berlin found 
a high percentage of infected rodents (49). In the latter all rodents trapped in woods where not infected 
with T. gondii, whereas prevalence was higher in the urban environment. 
However, studies using different methods come to the same conclusion confirming non-murine spp. 
having higher T. gondii prevalence than Mus spp. in Europe. All mentioned variables bring even higher 
confidence to this assertion, which is further reinforced by the mentioned in vivo studies. 
Concerning the present genotypes, most of the studies in literature genotype T. gondii on the basis of 
few, sometimes a single, genetic markers. The importance of an increased number of genetic markers is 
highlighted by the work from Schares et al. who re-classified German isolates as atypical instead of 
classic type II strains when using nine markers instead of the previously used four (183, 213). This result 
brings evidence to consider more reliable studies with a higher genetic resolution, even though less 
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common. Studies in Europe describing virulent alleles in animal and human isolates on the basis of a 
single marker, mostly SAG2, should be expanded to investigate other markers (214-216). It has not been 
described so far whether certain within the 11 markers are more representative of genotype virulence 
than others, precluding the possibility of using a subset of them. The only molecular characterization 
with all the 11 markers in living voles – the Asiatic Microtus fortis – confirmed the high prevalence of 
T. gondii infection (53.8 %) and chronic infection with virulent genotypes (66, 67). This study supports 
the hypothesis that voles can be reservoir of virulent strains and European voles should be investigated 
further. 
7.2.2 T. gondii infection of M. glareolus cells 
7.2.2.1 T. gondii growth in M. glareolus cells 
As reported in Tab. 20 and highlighted in pink, M. glareolus cells display a resistance phenotype to 
virulent parasite infection and decreased parasite burden following IFN-γ treatment (Fig. 32 and 34). 
This phenotype recalls M. musculus castaneus CIM cells during infection with both type I and II T. 
gondii. Similarly, I observe a drastic decrease in the population of living infected cells, which will 
further support dissemination. Despite a decrease in parasite burden, T. gondii intracellular growth in 
different M. glareolus cell types did not change following IFN-γ treatment (Fig. 31). A decrease in 
overall number of infected cells without affecting intracellular parasite growth was already reported in 
other studies (203). However, this phenotype is in contrast with results from the flow cytometry-based 
assay. In the latter the MFI was measured on the population of living infected cells and would imply an 
increase in vacuoles with only one or two parasites following IFN-γ treatment. Possible explanations 
are a) the higher number of cells analyzed per condition in the flow cytometry assay compared to the 
parasite counts (20,000 vs 100) which provides higher confidence in the results; b) an effect on the 
number of vacuoles per cell rather than number of parasites per vacuole.  
Of note is that, despite use of the same parasite strain and amount, BVK168 cells support a higher 
virulent parasite growth compared to primary vole cells and murine cells (Fig. 31). The phenotype could 
be either cell type-specific or due to changes during the spontaneous immortalization (125). A difference 
between immortalized and primary kidney African green monkey cell cultures has been observed, but 
contrary to our results, primary monkey-derived cultures sustain higher T. gondii growth (174). A 
comparison with primary bank vole cells should be performed to allow interpretation of the phenotype. 
Surprisingly, BVK168 cells infected with the virulent strain show an equal number of plaques following 
IFN-γ treatment, but of bigger size (Fig. 28b). This puzzling result made me consider different possible 
explanations. First, I observed that T. gondii blocks the STAT1-mediated pathway in vole cells when 
infection preceds the IFN-γ treatment, as demonstrated with the established reporter cell line (Fig. 29). 
It should be assessed whether the parasite is also able to block the pathway of IFN-γ stimulated cells. 
This blocking of the host immune response would explain the invariate number of plaques in the assay. 
The bigger plaque size could be explained by IFN-γ-induced premature egress of parasites from dying 
cells and infection of neighboring cells. The heavy infection of not necrotic cells in BVK168 cells and 
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the decrease in live uninfected BMDMs compared to untreated control cells support this hypothesis (Fig. 
32b and 34a). Induced egress of parasites is a conserved mechanism in human (150, 217) and mouse 
cells (105, 218), in the latter proved to happen in vivo via adoptive transfer (218). This phenomenon is 
directly triggered by immune cells, mostly macrophages, in a Ca2+-dependent fashion in murine models 
(218) and by nitric oxide (NO) in human cells (217). Whether in one study the prematurely egressed 
parasites were observed to lose the capacity to invade human fibroblasts (150), others showed 
unchanged virulence both in vitro and in vivo (150, 217, 218). According to the model suggested by 
Tomita et al., premature egress is also a form of host resistance since it does not support parasite growth 
and increases the chance for IFN-γ-primed immune cells to mediate parasite killing and clear infection 
(218). It is easy to imagine that different cell types are present at the infection site, and freshly egressed 
parasites from kidney cells or fibroblasts can be phagocytized and killed by neighboring macrophages.  
7.2.2.2 IFN-γ-dependant M. glareolus cell death following virulent T. gondii infection 
M. glareolus cells undergo IFN-γ-mediated cell death when infected with type I but not type II strains, 
regardless of the cell type – i.e. kidney cell line, primary fibroblasts and BMDMs – as measured by the 
increase in Propidium Iodide stained nuclei (Fig. 32a). Phenotype in BMDMs was confirmed with a 
flow cytometry-based assay by using a fixable dye specific for dead cells (Fig. 34). A preliminary 
cytotoxicity assay performed on BVK168 cells confirmed the IFN-γ-dependent resistance phenotype 
(Appendix Fig. 39). Taken together, all results confirm that IFN-γ-treated M. glareolus cells die when 
infected with virulent T. gondii. Results from literature observed the infecting parasites to die within the 
dying cells (109). Therefore, host-killing was interpreted as defense mechanism.  
Activation of the programmed cell death named pyroptosis has been documented in murine 
macrophages (109). However, a different cell death mechanism has been observed during type III 
infection (219). The hypothesis that a combination of different parasite strains and host cell types and 
species triggers different cell fate is a likely scenario. Type II T. gondii infection in M. glareolus 
BMDMs do not induce an increase in the amount of necrotic cells (Fig. 34). However, IFN-γ-treatment 
halves the amout of infected BMDMs and type II parasite burden (Fig. 34). The phenotype in vole 
BMDMs does not mirror what happens in M. musculus infection with medium virulent strains and might 
represent a novel mechanism of parasite control (109). These data do not exclude as well the possibility 
that M. glareolus is susceptible to type II T. gondii genotypes, similarly to other European mammals	
(220).  
The use of recTgLEA protein as control proved that STAT1 signaling induction and subsequent 
expression of Irg-like genes are specifically induced by recMgIFN-γ (Fig. 24 and 27), and not by 
contaminants in the preparation. The displayed resistance phenotype during T. gondii infections on vole 
cells is IFN-γ-dependent, therefore not caused by possible contaminants. However, the latter could 
influence parasite replication and fitness and the experiments included only a control with untreated 
cells. Despite antiviral potency of recMgIFN-γ was shown to be strictly associated with the cytokine 
compound (Fig. 25), future infection experiments with T. gondii should include recTgLEA as control. 
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7.2.2.3 Expression of Irg-like genes in M. glareolus cells 
M. glareolus parasite control during infection with both strains is dependant on type II cytokine 
stimulation. Despite a pool of IFN-γ-induced genes is expressed even in absence of the STAT1 
transcriptional factor, the IRG family of protein in not within this class (171). Transcriptomic analysis 
in different inbred mouse cell types reports that Irgb2-b1 is not highly expressed (Gene ID 620913) 
compared for example to another Irg gene like Irga6 ((182), Gene ID 60440). Lilue et al. further 
confirmed this low Irgb2-b1 expression in murine fibroblasts of susceptible mice (7). On the contrary, 
Irgb2-b1 is highly expressed in fibroblast cells of resistant mouse strains, i.e. M. musculus castaneus 
CIM and M. musculus musculus PWK/Ph (7, 62). Preliminary data suggest that Irgb2-b1-like genes are 
not significantly induced following IFN-γ treatment in M. glareolus BMDMs and primary fibroblasts 
compared to untreated controls (not shown), whereas kidney cells show a 8-fold increase (Fig. 24). 
However, all cell types display a resistance phenotype to virulent parasite infection in an IFN-γ-
dependant fashion. Surely Irgb2-b1-like mRNA abundance should be further assessed in these cell types 
in the future and the Irgb2-b1-like genes from primary cells sequenced. The RNAseq analysis currently 
ongoing will shed lights on the complete structure of the Irg family in these non-model organisms and 
serve as pioneering work for future sequence analysis.  
Unfortunately, antibodies developed against murine IRG proteins do not cross-react with voles, likely 
due to differences in the recognized peptide sequences (Tab. 19). Therefore, a direct comparison 
between IRGb2-b1 protein in murine and vole cells via anti-IRGb2-b1 antibody is not possible (Fig. 
35a). This lack of cross-reactivity precludes us to assess IRG protein loading directly in the wild rodents-
derived cell lines. However, studies report contradictory results about correlations between PVM IRGs 
coating and parasite killing. Indeed, whereas resistant CIM-derived cells load IRG on almost all PVM 
compared to susceptible mice cells (7), parasites with coated vacuoles have been observed escaping the 
host cell (62, 221). Thus IRGs loading, even though providing information regarding host immune 
kinetic, is still a debated proxy for parasite killing.  
7.2.2.4 Other resistance mechanisms to T. gondii infection in rodents 
I do not exclude that IFN-γ-related mechanisms other that IRGs mediate M. glareolus resistance to 
parasite infection. Reactive oxygen species (ROS) and nitric oxyde (NO) have been described to limit 
T. gondii growth in different species and cell types (77). Therefore, I performed a Griess assay to 
measure production of nitrite/nitrate (NO2-/NO3-), which are the final oxydative product of nitric oxyde 
(NO), to assess the role of this mechanism in host resistance. I used the supernatant from M. glareolus 
BMDMs during the PI-assay in Fig. 32, where a resistant phenotype towards virulent parasites was 
observed. However, no detectable increase in the nitrite/nitrate ratio in vole BMDM was observed under 
any conditions, contrary to Mus musculus BMBDs treated with LPS used as positive control (Appendix 
Fig. 40). These results suggest that NO does not play a role in vole resistance to T. gondii, similarly to 
what observed in other studies on mice (74). However, the lack of phenotype could also be explained 
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by a natural lower nitrite/nitrate ratio which reduces the possibility of NO2- detection, similarly to human 
cells.  
Another recently identified family of IFN-γ-induced small GTPases, named GTPase IMmunity 
Associated Proteins (GIMAP), was associated with Lewis (LEW) rat resistance to virulent parasite 
infection compared to susceptible Brown Norway (BN) rats (222). Rats always constituted a classic 
animal model to study T. gondii (209) and are particularly suited to study susceptibility to infection since 
the mentioned common laboratory strains display opposite outcomes (223). GIMAPs localize at the 
PVM and restrict parasite growth via lysosomal fusion (222). However, the mechanism is cell-specific 
and takes place only in hematopoietic cells and not in intestinal epithelial cells, which highlights the 
importance of the cell types used in experiments. The role of IRGb2-b1-like proteins in LEW rat 
resistance to T. gondii is currently being investigated (Jeroen Saeij, personal communication). Until 
now, the major recognized mediator of resistance in LEW rats is the inflammasome sensor Nlrp1. 
Specific polymorphisms in the gene are conserved in all T. gondii refractory rat strains (224-226). 
Inflammasome activation eventually leads to host programmed cell death via pyroptosis. Similarly to 
rats, allelic variation of Nlrp orthologous loci accounts for species-specific inflammasome induction 
during T. gondii infection – and thus outcome – in laboratory mouse strains (227, 228) and human cells 
(229, 230). The other major family of GTPases involved in host defense to T. gondii, GBPs, regulates 
activation of the inflammasome (231). A regulation by IRG proteins deserves further investigation.  
Finally, apart from the well-studied role of type II interferon, other IFN-γ-independent mechanisms 
appeared to play a critical role in T. gondii infection. For example IFN-ß response is activated in murine 
macrophages during infection with virulent atypical strains from South America and is associated with 
parasite killing independently of IFN-γ pathway activation (200). The importance of type I interferon 
pathway is also evident from the conserved parasite mechanisms directly evolved against it (90). The 
role of IFN-ß in different host species and cell types has not been addressed yet. 
GIMAPs, inflammasome and IFN-ß pathways activation are just example of other defense mechanisms 
important in other T. gondii intermediate hosts and which impact during infection needs to be explored 
in voles. 
7.3 New tools for research on non-model organisms  
7.3.1 Production of a recombinant M. glareolus IFN-γ 
The field of eco-immunology would greatly benefit from availability of still lacking immunological 
resources, such as cytokines, as already recognized by Zimmerman et al. (232). Here we provide the 
key recombinant M. glareolus IFN-γ cytokine, for which I demonstrated its activity not only on the same 
species, but also on a closely related vole species as M. arvalis. Availability of this cytokine allows 
addressing immunological responses of wild rodent cell lines in vitro during infection with pathogens 
that activate the type II interferon response. These include a multitude of bacteria, viruses and, as 
demonstrated here, intracellular parasites such as T. gondii. 
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RecMgIFN-γ was produced in high yield in E. coli and mostly in its active dimeric form of ca. 36 kDa. 
Detected proteins of different molecular weight were interpreted as monomeric, trimeric and higher 
order aggregates of the protein (Fig. 20). Such aggregates are known to occur with recIFN-γ under non-
native conditions (233-236), as is e.g. the case during SDS-PAGE. The small 15 kDa protein not reactive 
with an anti-6His-tag antibody (Fig. 20a) was inconsistently observed in different preparations. A 
possible explanation is the bacterial strain of choice, OmniMax 2T1R, which provided better expression 
results compared to other strains, but which expresses the outer membrane protease OmpT (Steffen 
Zander, personal communication). This protease is known to cut within the C-terminal stretch of basic 
amino acids of H. sapiens IFN-γ (237, 238), resulting in the frequently observed truncated, but otherwise 
stable ca. 15-16 kDa IFN-γ (237, 239). We therefore assume that this protein is a C-terminal degradation 
product and is co-purified by dimer formation with a 6His-tagged monomer. Given the lack of 
availability of anti-vole IFN-γ antibodies which directly target the C-terminal stretch, only a mass 
spectrometry analysis of the protein suspension would validate this current hypothesis and might be 
performed in future studies. 
Of note is the extended conserved C-terminal stretch in voles and human IFN-γ sequences, which is not 
present in murine species (Fig. 19b). Interestingly, C-terminal deletion mutants of recombinant human 
IFN-γ up to the basic stretch showed higher antiviral activity than the corresponding wild-type cytokine 
(239-242). This observation was attributed to a higher stability of the truncated protein (239). Another 
possible explanation is related to the recent work from Dufour et al. (243) who found an association 
between truncation in the C-terminal of human and murine IFN-γ and an anti-inflammatory mechanism. 
The cleavage happens in two sequential steps, the first targeting exactly the extended C-terminal which 
is shared between voles and human proteins, and the second upstream of the basic stretch. This finding 
indicates that this cleavage might take place in vole species as well, to activate specific immune 
pathways. However, a molecular mechanism, identification of the target of the truncated domain and 
information on whether differently conserved amino acids between species activate different pathways, 
are still missing. It is tempting to speculate that the extension beyond the basic stretch has evolved 
differently in different species to allow fine-tuning of the interaction between IFN-γ and its specific 
receptor molecules and thus cellular activation. 
We show that recMgIFN-γ is active on other vole species than M. glareolus, like M. arvalis, likely due 
to sequence similarity. This cross-reactivity increases the applicability of this cytokine, which can be 
used to study the immunological response to pathogens in other rodents. For example, the zoonotic 
parasite Babesia microti is highly prevalent (up to 45 %) in European populations of M. arvalis (244) 
and causes basesiosis in humans with malaria-like symptoms  (245). The genetic background of inbred 
mice has been shown to influence the phenotype to infection (246) and could be the reason behind 
contradictory results on the dispensability of IFN-γ during B. microti infection (247, 248). The provided 
recMgIFN-γ and a M. arvalis-derived cell line could shed light on the immune response to infection in 
the natural reservoir and provide a better background for epidemiological studies. Since M. glareolus 
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shares more that 90 % of IFN-γ sequence homology with M. agrestis and M. ochrogaster, and 73.6 % 
with Peromyscus maniculatus (Fig. 19a), we hypothesize that recMgIFN-γ cross-reacts also with these 
other rodent species and its use in research can be extended even further. 
I also observed that the commercial murine IFN-γ is active on A. agrarius cells (Fig. 21 and 23). An 
unusual dot-shaped nuclear signal of phospho-Ser727-STAT1 was observed in the A. agrarius AAL-R 
cell line compared to other vole and murine cells. The signal resembles the cytokine-induced 
paracrystalline forms of STAT3 observed by Droescher et al (249), which are more resilient to 
dephosphorylation and stay longer in an activated form. However, an association between this 
observation and the biological meaning was not further investigated. Apodemus spp. are more closely 
related to Mus spp. and are reservoirs of numerous pathogens (51). Many of the reagents already existing 
for the murine model can and should be validated for research on other Muridae. For example, 
preliminary results with an immunofluorescence assay applying anti-murine IRG antibodies showed a 
positive signal in A. agrarius cells (not shown), demonstrating the potential with that approach. 
However, the same assay did not return any reaction against M. glareolus (Tab. 20) and M. arvalis 
proteins (not shown). 
Apart from type II interferon, we also report evidence of activity of the human hybrid type I interferon 
(IFN-αB/D) on bank vole cells (Fig. 25). Cross-activity of this cytokine was expected since type I 
interferon is less divergent than type II interferon and because activity of IFN-αB/D was already 
demonstrated in many and diverse mammalian species (144).  
7.3.2 Establishment of M. glareolus in vitro systems 
With the current work I established novel cell cultures of M. glareolus. In particular, I optimized 
protocols for differentiation of Bone Marrow-Derived Macrophages (BMDMs) and for the culturing of 
ear and tail-derived fibroblasts. Monocytes number increased significantly when a cocktail of both 
murine and human differentiating factors were used. This indicates that bank vole signalling pathways 
might share more identity with human than murine systems. This observation is also in line with other 
M. glareolus-derived cell culture-systems that were responsive to human factors (Estefania Delgado 
Betancourt, personal communication). The differentiated cells phenotypically resemble macrophages 
and display phagocytic capacity (Fig. 30a). However, the latter is not homogeneous in the culture which 
might indicate a not complete differentiation. Optimization of the differentiation protocol and further 
phenotypic characterization will be performed in the future. The observed polynucleated cells (Fig. 31d) 
can be residual megakaryocytes. This would explain the higher susceptibility to T. gondii. However, 
they appeared to increase in number following infection. Formation of multinucleated macrophages 
following T. gondii infection has been already observed in human macrophages (250). IFN-γ treatment 
is one of the main inducer of fusion, and the monocyte fusion capacity progressively decreases along 
with differentiation into macrophages (251). Formation of these giant cells has also been hypothesized 
to be an active defense process, with fresh monocytes fusing with infected macrophages to foster 
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intracellular pathogen killing (251). Therefore, the big vacuoles present in multinucleated cells might 
contain parasites that display advantages and resist cellular killing. 
The available BVK168 kidney cell line was already characterized and tested for susceptibility to 
different pathogens. To our knowledge we performed the first in vitro parasite infection in bank voles. 
BVK168 cells also proved to be easily transfectable with several transfection methods, which allowed 
me to establish the luciferase reporter cell line BVK-LucA. The most obvious use of BVK-LucA was to 
test recMgIFN-γ activity, as shown in Fig. 27. The non-linear dose-response with higher cytokine 
concentration (200 ng/ml) might be related to the recycling kinetics of the receptor subunit IFN-γR1, as 
reviewed before (79), or by IFN-γR1 expression inhibition via an autocrine-mediated loop following 
persistent activation as already observed for type I interferon (252). The observed maximal-fold 
induction of firefly luciferase in BVK-LucA cells is well in the range of values from other stable GAS-
dependent luciferase-expressing cell lines reported in the literature (153, 252). The valuable role played 
by this cell line is not limited to test activity on IFN-γ. BVK-LucA cells can strengthen our knowledge 
around immune-modulation in vole cells, as we have shown by demonstrating T. gondii suppression of 
STAT1-mediated gene expression (Fig. 29). This suppression confirmed that the mechanism is not 
restricted to human and murine cells, but happens in M. glareolus cells as well. BVK-LucA cells can be 
used e.g. to test virus-specific defense mechanisms against host IFN-γ immune response. Variability in 
the antiviral assay with MHV68 (Fig. 25) and CPXV Brighton Red strain (not shown) might be due to 
evolution of specific virus mechanisms act at inhibiting this cytokine pathway, as already documented 
in these families of viruses (253, 254). Availability of the BVK-LucA cell line allows us to address this 
hypothesis. Cowpox and MHV68 viruses are considered highly species-specific, and different isolates 
result in opposite phenotypes in in vivo infection in voles (174, 177). This host-pathogen specificity can 
also account for variability in our in vitro viral experiments. Availability of an increasing number of 
wild rodents-derived cell lines and of established transfection protocols, allow us to establish more 
reporter cell lines to investigate cell type and species-specificity of pathogens. Gene-specific differences 
in sequence, length and spacing of the palindromic GAS sequences have been shown to contribute to its 
affinity for STAT1 (255). Thus, future analyses of vole genomes with regard to GAS elements of known, 
well-defined IFN-γ-regulated genes might lead to even more sensitive vole reporter cell lines. 
7.3.3 Additional resources for research on M. glareolus  
Apart from the provided different cell cultures and recombinant cytokine, with the current work I 
validated tools to address in vitro studies on bank voles. For example, I showed the usefulness of selected 
reagents developed for murine models, like antibodies specific for phosphorylated and not versions of 
STAT1 and for β-actin. The suitability of Ywhaz as housekeeping gene, which was published for M. 
agrestis (134), appeared solid for M. glareolus and M. arvalis as well (Fig. 24). Importantly, β-Actin 
was the least stable gene tested as housekeeping in A. flavicollis and hamsters (256-258), whereas is the 
most commonly used for Mus musculus. This highlights the importance of genomic references 
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validation for each species, in order to avoid experimental artifacts, and is more and more frequently 
done in non-model organisms (57).  
Another contribute to the field from our work is the RNAseq of BVK168 cells which is currently being 
analyzed and sums up to the other two bank vole transcriptomes available (see Tab. 21). Purpose for 
this RNAseq was to provide a complete map of expressed Irg-like genes in the three non-murine cell 
lines (in Tab. 16), which justifies the small set of samples. However, we do not exclude to increase in 
the future the number of samples for quantitative analysis if annotation results successful. Our RNAseq 
data include both IFN-γ-induced and not induced samples, which will provide for the first time the bank 
vole interferome.  
The current work’s impact on M. glareoulus research is obvious from Tab. 21, where the complete list 
of available reagents and references is reported.  
Taken together, the tools provided with this project foster research on non-model animals as M. 
glareolus and Microtus spp.. Furthermore, preliminary results on voles’ phenotype during T. gondii 
infection support their role as intermediate hosts for the parasite. This project paves the way to needed 
parasitological research in wildlife. 
Tab. 21. Available resources for studies on M. glareolus. 
 Description Source or reference 
Ear and tail primary 
fibroblasts  
 This work 
BVK-LucA Reporter cell line for IFN-γ activity This work 
BMDM Bone Marrow Derived Macrophages This work 
recMgIFN-γ Recombinant M. glareolus IFN-γ This work 
IFN-αB/D Human hybrid type I interferon (144), proved activity 
in this work. 
Kidney transcriptome  RNAseq data of recMgIFN-γ-induced and 
not induced BVK168 cells 
This work 
Heart transcriptome  (259) 
Liver transcriptome  (260)  
Genome   GenBank 12837 
BVK168 cell line Kidney immortalized cell line (125) 
ES cells Embryonic Stem cells (261) 





Appendix Fig. 37. Cloned AAL-R tandem 2 gene has stop codons in the Irgb1-like exon. Alignment 
of the cloned AAL-R tandem 2 Irg-like gene with Irgb2-b1BL6. Irgb2-b1BL6 was used as reference and 
nucleotide positions relative to the reference are indicated above. The cloned AAL-R tandem 2 Irg-like 
gene was sequenced with different primers (names reported on the left). Each sequence is reported with 
the nucleotide sequences and relative translation. 
 
Appendix Fig. 38. Positive control Flp-CIM cell line does not display host resistance phenotype 
copared to negative control Flp-BL6. Negative control Flp-BL6 and positive control Flp-CIM cell 
lines were treated with 200 U/ml mouse IFN- γ or left untreated 24 h prior infection with avirulent (type 
II) and virulent (type I) T. gondii. 24 hpi cells were fixed and parasites per vacuole counted. Variance 





Appendix Fig. 39. Increase in necrotic cells following IFN-γ-treatment and virulent parasite 
infection in both in M. glareolus and M. musculus cells. Both M. glareolus BVK168 cell line and 
murine NIH/3T3 cell line were treated with recMgIFN-γ (200 ng/ml) or mouse IFN-γ (200 U/ml) 
respectively, or left untreated as control 24 h prior infection with medium virulent (type II) and virulent 
(type I) T. gondii. 24 hpi the amount of extracellular LDH was measured at the Tecan reader as proxy 
for necrotic cell death. Absorbance values were normalized to the maximal LDH release of each cell 
line determined by full cell lysis. Both homemade reagents and a commercial kit were used. The 
experiment was performed once with 3 technical replicates. 
 
Appendix Fig. 40. M. glareolus primary cells do not limit T. gondii proliferation via nitric oxyde. 
Griess assay to measure the amount of nitrite/nitrate (NO2-/NO3-) in solution, as indirect measure of 
nitric oxyde (NO) production. Vole cells (BMDMs and primary fibroblasts) were treated with 
recMgIFN-γ (200 ng/ml) and murine BMDMs with mouse IFN-γ (200 U/ml) or left untreated as control 
24 h prior infection with medium virulent (type II) and virulent (type I) T. gondii. Treatment with LPS 






Tab. 21 Instrument list 
Instrument Company 
2100 Bioanalyzer Agilent Technologies Inc., CA, USA 
ABI 7500 Real-Time PCR system Applied Biosystem, Foster City, CA, USA 
Accu-jet® pro pump Brand GmbH, Wertheim, D 
Äkta Purifier FPLC system GE Healthcare, München, D 
Agarose gel chambers Mini-Sub® Cell  
GT System and Sub-Cell® GT System 
Bio-Rad Laboratories GmbH, München, D 
Amaxa® Nucleofector® II Device Lonza Cologne GmbH, Köln, D 
Analytical balance A200S Sartorius AG, Göttingen, D 
Canon 450D Canon Inc., Tokyo, Japan 
Centrifuge Multifuge X1 Heraeus Holding GmbH, Hanau, D 
Centrifuge Rotina 420R Hettich LabTec, Tuttlingen, D 
DNA-Workstation I Kisker Biotech GmbH&Co. KG, Steinfurt, D 
Electrophoretic gel chamber SDS Mini Bio-rad Laboratories Inc., Hercules, CA, USA 
Flow cytometer CytoFLEX Beckman Coulter Inc., Brea, CA, USA 
Gel documentation system  SERVA, Heidelberg, D 
Gel documentation system Biometra TI-3 Biometra GmbH, Göttingen, D 
Gel documentation system Universal Hood III Bio-rad Laboratories Inc., Hercules, CA, USA 
Heating block Thermomixer compact Eppendorf AG, Hamburg, D 
Hypoxia station Whitley H35 Meintrup DWS GmbH, Berlin, D 
Incubator shaker Innova®40 New Brunswick Scientific, Edison, USA 
Lightpad A930 Artograph Inc., Delano, MN, USA 
Lumi-Imager Peqlab Biotechnologie GmbH, Erlangen, D 
Luminometer Tristar LB 941  Berthold Detection Systems GmbH, Pforzheim, 
D 
Magnetic/Heating block RCT basic IKAMAG® IKA Werke, Staufen, D 
Microcentrifuge himac CT15RE Hitachi Koki, Tokyo, Japan 




Microplate reader Infinite® M200 PRO  Tecan Group Ltd., Männedorf, Schweiz 
Microscopes: AxioImager.Z1/ApoTome, 
AxioObserver.Z1 and confocal LSM780  
Carl Zeiss GmbH, Jena, D 
Microwave Retro Melissa Classico, Skødstrup, D 
Multichannel pipettes Transferpette®-8/12 Brand GmbH, Wertheim, D 
pH Meter PB-11 Sartorius, Göttingen, D 
Pipettes Pipetman Classic™ 0.2-2 µL/ 1-10 µL/  
2-20 µL/ 50-200 µL/ 200-1,000 µL 
Gilson Inc., Middleton, WI, USA 
Pipette boy Brand GmbH, Wertheim, D 
Plate shaker VWR International GmbH, Darmstadt, D 
Power PAC 3000 Bio-Rad Laboratories GmbH, München, D 
Precision balance TE1502S Sartorius AG, Göttingen, D 
Portable spectrophotometer Ultrospec 10 GE Healthcare, München, D 
Safety Cabinet Series ASW-UP IV-1906 Bleymehl GmbH, Inden, D 
Semi-dry membrane transfer system Biometra GmbH, Göttingen, D 
Spectrophotometer NanoDrop® ND-1000 Thermo Fisher Scientific Inc., Karlsruhe, D 
Spectrophotometer Quantus™ Fluorometer Promega GmbH, Madison, WI, USA 
Sterilbank Labgard Class II  Integra Biosciences GmbH, Fernwald, D 
Thermocycler DNA Engine®  Bio-Rad, München, D 
Thermocycler TPersonal Biometra GmbH, Göttingen, D 
Transilluminator 470 nm BioView Ltd., Billerica, USA 
Ultrasonic bath Sonorex RK100H BANDELIN electronic GmbH&Co.KG,  
Berlin, D 
Vacuum pump Mini-Vac power Peqlab Biotechnologie GmbH, Erlangen, D 
Vortex-Genie® 2  Scientific Industries, New York, USA  






Tab. 22 Chemical list 
Chemical Company 
Accutase Cell Detachment Solution Capricorn Scientific GmbH, Ebsdorfergrund, D 
Acetic acid 96 % Merck KGaA, Darmstadt, D 
Acrylamide 30 % Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Agarose Biozym Scientific GmbH, Hessisch Oldendorf, D 
Ammonium chloride Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Ammonium persulfate Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Amphotericin B Capricorn Scientific GmbH, Ebsdorfergrund, D 
Ampicillin Carl Roth GmbH & Co. KG, Karlsruhe, D 
Acetic acid 96 % Merck KGaA, Darmstadt, D 
ATP Carl Roth GmbH & Co. KG, Karlsruhe, D 
Bacto Tryptone Carl Roth GmbH & Co. KG, Karlsruhe, D 
Blasticidin Invivo Gen, San Diego, CA, USA 
β-mercaptoethanol Carl Roth GmbH & Co. KG, Karlsruhe, D 
Bromphenol blue Merck KGaA, Darmstadt, D 
BSA Carl Roth GmbH & Co. KG, Karlsruhe, D 
Calcium chloride  Carl Roth GmbH & Co. KG, Karlsruhe, D 
CDTA Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Chloramphenicol Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Coenzyme A Merck KGaA, Darmstadt, D 
Collagenase type IV, CLS-4 Worthington Biochemical Corp., Lakewood, NJ, 
USA 
Crystal violet neoLab GmbH, Berlin, D 
D(+)-Glucose Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
DAPI Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Direct Blue (DB) 71 Sigma-Aldrich Chemie GmbH, Schnelldorf, D 




DMEM high glucose (4.5 g/l) with sodium 
pyruvate and stable glutamine 
(GlutaMAX™) 
ThermoFischer Scientific, Waltham, MA, USA 
DMEM high glucose (4.5 g/l) without 
sodium pyruvate and phenol red, with stable 
L-glutamine 
ThermoFischer Scientific, Waltham, MA, USA 
DMEM high glucose (4.5g/l), with stable 
glutamine, with sodium pyruvate 
Capricorn Scientific GmbH, Ebsdorfergrund, D 
DMSO Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
dNTPs Carl Roth GmbH & Co. KG, Karlsruhe, D 
Doxycycline hydrochloride Fluka, Seelze, D 
DTT Carl Roth GmbH & Co. KG, Karlsruhe, D 
EDTA Carl Roth GmbH & Co. KG, Karlsruhe, D 
Ethanol ≥ 99.5 %, pure or denatured with 1 
% methyl ethyl ketone 
Carl Roth GmbH & Co. KG, Karlsruhe, D 
FCS Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Fluoromount™  Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Formaldehyde Carl Roth GmbH & Co. KG, Karlsruhe, D 
GeneRuler™ 1 kb Plus DNA Ladder Thermo Fisher Scientific Inc., Karlsruhe, D 
Glycerol Carl Roth GmbH & Co. KG, Karlsruhe, D 
Glycine Merck KGaA, Darmstadt, D 
HEPES Carl Roth GmbH & Co. KG, Karlsruhe, D 
Hydrochloric acid Carl Roth GmbH & Co. KG, Karlsruhe, D 
Hygromycin B Carl Roth GmbH & Co. KG, Karlsruhe, D 
Hoechst 33342 Invitrogen
™ Corporation, Carlsbad, CA, USA 
human M-CSF ImmunoTools GmbH, Friesoythe, D 
Imidazole Fluka, Seelze, D 
Iodonitrotetrazolium chloride (INT) Fluka, Seelze, D 




Isopropanol, pure Carl Roth GmbH & Co. KG, Karlsruhe, D 
Kanamycin Carl Roth GmbH & Co. KG, Karlsruhe, D 
Lactic acid Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Latex beads Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Lypopolysaccharide (LPS) Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Magnesium carbonate Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Magnesium chloride Carl Roth GmbH & Co. KG, Karlsruhe, D 
Magnesium sulfate Merck KGaA, Darmstadt, D 
Methanol, pure or GC Ultra grade Carl Roth GmbH & Co. KG, Karlsruhe, D 
MIDORIGreen Direct nucleic acid stain NIPPON Genetics Europe, Düren, D 
Milk powder Carl Roth GmbH & Co. KG, Karlsruhe, D 
N-(1-Naphthyl)ethylenediamine Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
NAD SERVA Electrophoresis GmbH, Heidelberg, D 
N-Methylphenazonium methyl sulfate Fluka, Seelze, D 
Sodium bicarbonate Biochrom AG, Berlin, D 
Sodium chloride Carl Roth GmbH & Co. KG, Karlsruhe, D 
Sodium citrate Merck KGaA, Darmstadt, D 
Sodium nitrate Fluka, Seelze, D 
Sulfanilamide Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Opti-MEMTM cell culture medium, 
Glutamax supplemented 
ThermoFischer Scientific, Waltham, MA, USA 
PageRuler Prestained Protein Ladder  ThermoFischer Scientific, Waltham, MA, USA 
Paraformaldehyde Carl Roth GmbH & Co. KG, Karlsruhe, D 
Penicillin/Streptomycin (100 Units/100 µg  
pro mL; 100x) 
Biochrom AG, Berlin, D 
Phosphoric acid Fluka, Seelze, D 
PIPES Carl Roth GmbH & Co. KG, Karlsruhe, D 




Potassium chloride Carl Roth GmbH & Co. KG, Karlsruhe, D 
Potassium phosphate dibasic Merck KGaA, Darmstadt, D 
Potassium phosphate monobasic Merck KGaA, Darmstadt, D 
Pronase E Merck KGaA, Darmstadt, D 
Propidium Iodide Fluka, Seelze, D 
Protease inhibitors: EDTA-free cOmpleteTM 
Mini Protease Inhibitor Cocktail and 
PhosSTOPTM 
Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Proteinase K Carl Roth GmbH & Co. KG, Karlsruhe, D 
Recombinant human M-CSF ImmunoTools GmbH, Friesoythe, D 
Recombinant mouse IFN-γ  Peprotech®, Rocky Hill, NJ, USA 
RNaseZap™ RNase Decontamination 
Solution 
ThermoFischer Scientific, Waltham, MA, USA 
Sodium deoxycholate detergent ThermoFischer Scientific, Waltham, MA, USA 
SDS Carl Roth GmbH & Co. KG, Karlsruhe, D 
TEMED Carl Roth GmbH & Co. KG, Karlsruhe, D 
Timentin Glaxo Smith Kline, London, UK 
Tricine Sigma-Aldrich Chemie GmbH, Schnelldorf, D 
Tris Merck KGaA, Darmstadt, D 
Tris-Base Carl Roth GmbH & Co. KG, Karlsruhe, D 
Triton X-100 Fluka, Seelze, D 
Trypsin/EDTA solution (10x) Biochrom AG, Berlin, D 
Tween-20 Merck KGaA, Darmstadt, D 
X-Gal Carl Roth GmbH & Co. KG, Karlsruhe, D 








Tab. 23 Consumables 
Consumables Company 
BRAND® 96-well deep well plates Merck KGaA, Darmstadt, D 
BRAND® mat cover for deep well plates Merck KGaA, Darmstadt, D 
C-Chip Disposable Hemocytometer NanoEnTek Inc., Seoul, Korea 
Cell culture flasks T25 / T75 / T150 TPP AG, Trasadingen, Schweiz 
Cell scrapers TPP AG, Trasadingen, Schweiz 
Centrifuge tubes 15 und 50 ml TPP AG, Trasadingen, Schweiz 
Combitips Eppendorf AG, Hamburg, D 
Costar® low binding microcentrifuge tubes 
(0.65 and 1.7 ml) 
Corning Inc., Corning, NY, USA 
Coverslips (10 and 12 mm Ø) VWR International GmbH, Darmstadt, D 
Cuvettes Rotilabo®  Carl Roth GmbH & Co. KG, Karlsruhe, D 
Inoculation loops VWR International GmbH, Darmstadt, D 
Microtiter plates 6/12/24/48/96-well TPP AG, Trasadingen, CH 
Microtiter µ-plate 96-well black Ibidi GmbH, Planegg, D 
Nitrocellulose membrane  GE Healthcare, München, D 
Parafilm® Pechiney Plastic Packaging, Chicago, IL, USA 
Pasteur pipettes, 3 ml  VWR International GmbH, Darmstadt, D 
Petri dishes 94x16 mm, steril  Carl Roth GmbH & Co. KG, Karlsruhe, D 
Polycarbonate 3 µm filters  Whatman, Maidstone, UK 
Serological pipettes TPP AG, Trasadingen, CH 
Slides 76x26 mm Carl Roth GmbH & Co. KG, Karlsruhe, D 
Syringes Omnifix® 5 / 10 / 20 ml B. Braun Melsungen AG, Melsungen, D 
Syringe filters Minisart 0.2 / 0.45 / 0.7 µm Sartorius AG, Göttingen, D 
Vacuum MidisartTM 2000 filters Sartorius
 GmbH, Göttingen, D 
Reaction tubes 0.5/1.5 ml 
Whatman paper 
 
VWR International GmbH 
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